WO2012010684A2 - Double salt-containing antiperspirant roll-ons - Google Patents

Double salt-containing antiperspirant roll-ons Download PDF

Info

Publication number
WO2012010684A2
WO2012010684A2 PCT/EP2011/062610 EP2011062610W WO2012010684A2 WO 2012010684 A2 WO2012010684 A2 WO 2012010684A2 EP 2011062610 W EP2011062610 W EP 2011062610W WO 2012010684 A2 WO2012010684 A2 WO 2012010684A2
Authority
WO
WIPO (PCT)
Prior art keywords
kai
weight
aluminum
composition according
preferred
Prior art date
Application number
PCT/EP2011/062610
Other languages
German (de)
French (fr)
Other versions
WO2012010684A3 (en
Inventor
Bernhard Banowski
Barbara Heide
Natascha Schevardo
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2012010684A2 publication Critical patent/WO2012010684A2/en
Publication of WO2012010684A3 publication Critical patent/WO2012010684A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0208Tissues; Wipes; Patches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/23Sulfur; Selenium; Tellurium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25Silicon; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26Aluminium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/28Zirconium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29Titanium; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/87Application Devices; Containers; Packaging
    • A61K2800/874Roll-on

Definitions

  • the present invention relates to antiperspirant roll-ons of the type of oil-in-water cosmetic emulsions, which are particularly suitable for application with a roll applicator and in addition to a high storage stability, a non-greasy feel on the skin and a fast drying time also an improved antiperspirant and deodorant effect wherein the emulsions contain at least one alum-type double salt, 0.0005-1% by weight of at least one silicon oxide-containing compound selected from hydrophilic silicas and / or hydrophobically modified silicas and / or sheet silicates, and at least one polysaccharide.
  • Antiperspirant or antiperspirant compositions are an important part of daily personal hygiene. They should ensure that the sweat production is reduced and formed sweat does not lead to unpleasant body odor.
  • Antiperspirant active substances in particular based on aluminum salts, are already well known in the art. The use of alum, KAI (S0 4) 2 ⁇ 12 H 2 0, as deodorant for reducing body odor is known. However, the known active ingredients are still in need of improvement in their sweat-reducing or deodorising effect.
  • M 1 a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions
  • M 1 " a trivalent cation selected from aluminum,
  • a first object of the present invention are oil-in-water emulsions containing a. at least one antiperspirant active ingredient selected from aluminum chlorohydroxides, aluminum zirconium chlorohydrates and mixtures thereof,
  • composition is formulated as a cream, gel, solution or impregnated on a substrate.
  • the antiperspirant active ingredient a) is selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof.
  • Preferred antiperspirant active ingredients a) are water-soluble.
  • water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C.
  • Particularly preferred antiperspirant Wrkstoffe are selected from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al 2 (OH) 5 CI ⁇ 1 -6 H 2 0] n, preferably [Al 2 (OH) 5 CI 2-3 ⁇ H 2 0 ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1 -6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form.
  • the preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g.
  • Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as “activated” aluminum chlorhydroxides and aluminum zirconium chlorohydrates, which are also referred to as “enhanced activity” as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688. Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates are typically produced by heat treating a relatively dilute solution of the salt (eg, about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
  • Activated aluminum chlorhydroxides and Aluminiumzirconiumchlorhydrate can be used as spray-dried powders and - preferably - as aqueous solutions, but also as non-aqueous solutions or non-aqueous solubilizates, for example according to US 6010688, by the addition of an effective amount of a polyhydric alcohol, the 3 bis 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt.
  • compositions containing by weight USP: 12-45% by weight, based on the total composition, of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
  • antiperspirant actives are basic calcium aluminum salts, as disclosed for example in US 2571030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide.
  • Other preferred antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
  • antiperspirant active substances are activated aluminum or aluminum-zirconium salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No. 6,042,816, containing FIG.
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • % preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight.
  • % preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, beta-alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, beta-amino-n-butanoic acid and gamma-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum or aluminum zirconium salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one An amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1: 10, and a water-soluble strontium salt in such an amount as to provide Sr: (AI + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.
  • US 6902723 containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one An amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1: 10,
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 1 0, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-1-3% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much glycine in that the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 1 0 ,.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-1-3% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt, that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid in that the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (i.e., X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a” is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1 : 1 is.
  • Preferred activated aluminum-zirconium salts are those which contain mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 .
  • Pb Y b where Y is Cl, Br, I, NQ 3 or SQ 4 , b is a rational number from 0.8 to 2 and p is the valency of Y is as disclosed, for example, in US 6074632.
  • the zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt.
  • the zirconium salt is zirconyl hydroxychloride of the formula ZrO (OH) 2 .
  • Preferred aluminum-zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5.
  • a particularly preferred salt is aluminum zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1.
  • the term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms.
  • Other preferred antiperspirant actives are disclosed in US 6663854 and US 20040009133.
  • the antiperspirant active ingredients can be present both in solubilized and in dissolved form.
  • the antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.
  • Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0.
  • the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture.
  • Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • the amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
  • Aluminiumzirconiumchlorohydrat-glycine salts formed with Betaine are still preferred in the invention ((CH 3) 3 N + -CH 2 -COO ") are stabilized.
  • Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1.
  • Corresponding compounds are disclosed, for example, in US 7105691.
  • the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5).
  • Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content also referred to as "E 5 AZCH" are disclosed, for example, in US 6436381 and US 6649152.
  • Such activated "E 5 AZCH” salts are preferred, whose HPLC peak has a 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9
  • Titanium perspirants are those aluminum zirconium salts with a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt.
  • Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
  • compositions according to the invention contain at least one antiperspirant active ingredient in a total amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight, based in each case on the total weight the anhydrous active substance (USP) in the overall composition.
  • at least one antiperspirant active ingredient in a total amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight, based in each case on the total weight the anhydrous active substance (USP) in the overall composition.
  • USP anhydrous active substance
  • At least one alum-type double salt is the general one formula M I M I "(S0 4) 2 x H 2 0 ⁇ contain, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions, M 1" is a trivalent cation, selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represent a rational number in the range of 0 to 12, inclusive 0.
  • KAI (S0 4 ) 2 KAI (S0 4 ) 2 , KAI (S0 4 ) 2 ⁇ 1 H 2 0, KAI (S0 4 ) 2 ⁇ 2 H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 0.
  • Salts with a water content of less than 12 molecules per molecule of alum are produced by heating alum. From a temperature of about 60 ° C up to 25% of the water of crystallization already escape, preferred temperatures for further dewatering are 500 ° C or less, preferably 300 ° C or less, more preferably 250 ° C or less, most preferably 200 ° C or less, most preferably 90-150 ° C.
  • Completely dewatered alum (also known as burned alum) or partially dewatered alum can be better dispersed, at least in higher concentrations, than alums having a water content of less than 12 molecules per molecule.
  • Alum particles suitable for the compositions according to the invention are those which have a number-average particle size of 0.1-150 ⁇ m, preferably 1-80 ⁇ m, particularly preferably 5-60 ⁇ m and extraordinarily preferably 10-30 ⁇ m.
  • compositions according to the invention as a double salt of alum Type b) KAl (SO 4 ) 2 .12H 2 O.
  • the amounts mentioned and the contents of water of crystallization relate to the raw material used in the preparation of the compositions according to the invention, since the compositions according to the invention are oil-in-water emulsions, the double salts are present dissolved in the aqueous phase before and thus have no crystal water content in the product, but are dissociated.
  • compositions of the invention contain at least one double salt of the alum type having the general formula M'M '' (S0 4) 2 ⁇ x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, including 0, preferably 12, represents, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 to 2 wt .-%, most preferably 0.3 - 1 wt .-%, each based on the total weight of the composition according to the invention.
  • M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions
  • M 1 represents a trivalent cation selected from aluminum, gallium,
  • compositions of the invention contain at least one double salt of the alum type b), is selected (from KAI S0 4) 2, KAI (S0 4) 2 ⁇ 1 H 2 0, KAI (S0 4) 2 ⁇ 2H 2 0, KAI (S0 4 ) 2 ⁇ 3 H 2 0, KAI (S0 4 ) 2 ⁇ 4 H 2 0, KAI (S0 4 ) 2 ⁇ 5 H 2 0, KAI (S0 4 ) 2 ⁇ 6 H 2 0, KAI (S0 4 ) 2 ⁇ 7 H 2 0, KAI (S0 4 ) 2 ⁇ 8 H 2 0, KAI (S0 4 ) 2 ⁇ 9 H 2 0, KAI (S0 4 ) 2 ⁇ 10 H 2 0, KAI (S0 4 ) 2 ⁇ 11 H z O and KAI (S0 4 ) 2 ⁇ 12 H 2 O, and mixtures thereof, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably
  • the compositions according to the invention contain from 0.0005 to 1% by weight, based on the total composition, of at least one silicon oxide-containing compound selected from hydrophilic silicic acids and / or hydrophobic modified silicic acids and / or phyllosilicates.
  • Preferred hydrophobicized phyllosilicates are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, more preferably distearonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites.
  • These hydrophobicized phyllosilicates are preferred in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component, such as. For example, propylene carbonate.
  • the gelation takes place by the addition of small amounts of activators, in particular ethanol or propylene carbonate, but also water.
  • compositions according to the invention comprise at least one activator in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, in each case based on the total weight of the composition according to the invention.
  • Further preferred compositions according to the invention comprise at least one activator selected from ethanol, propylene carbonate and water and mixtures thereof, in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, based in each case on the total weight of the composition of the invention.
  • Compositions which are preferred according to the invention are characterized in that they contain at least one hydrophobized phyllosilicate in a total amount of 0.1-1% by weight, preferably 0.2
  • Hydrophobically modified silicas which are preferred according to the invention are selected from hydrophobically modified pyrogenic silicic acids, eg. As the commercial products of Aerosil ® series from Evonik Degussa, particularly preferably silica silylate, and silica dimethyl silylate.
  • compositions according to the invention are characterized in that they contain at least one hydrophobically modified silica, preferably at least one hydrophobically modified fumed silica, in a total amount of 0.1-1% by weight, preferably 0.2-0.8% by weight, especially preferably 0.3 to 0.5 wt .-%, each based on the total weight of the composition according to the invention.
  • compositions preferred according to the invention comprise at least one hydrophobized fumed silica and at least one hydrophilic silica.
  • Hydrophilic silicas which are preferred according to the invention are selected from silicon dioxide which is not modified organically or inorganically and which does not contain any organic or inorganic coating. has direction.
  • the above-mentioned feature "no organic or inorganic coating” refers to the state of the hydrophilic silica before it is mixed with the other constituents of the compositions according to the invention After mixing it is quite possible for individual constituents of the formulation to be present on the surface of the hydrophilic silica sorbed, the feature "no organic or inorganic coating" remains unaffected. Also possibly sorbed gases do not apply according to the invention as a coating. Hydrophilic silicas which are preferred according to the invention are obtainable by precipitation.
  • hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of spherical silica particles.
  • Further hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silicon dioxide particles having a number-average particle diameter in the range from 2 to 15 ⁇ m, particularly preferably in the range from 5 to 10 ⁇ m.
  • Further preferred hydrophilic silicas according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silica particles having an oil absorption capacity of 0.7-1.5 cm 3 of liquid paraffin per gram of dry silicon dioxide, measured to DIN 53601.
  • hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles. Further inventively preferred hydrophilic silicas are obtainable by precipitation and comprise more than 80 wt .-% silica particles having a number average particle diameter in the range of 2-15 ⁇ , more preferably in the range of 5-10 ⁇ . Further hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles having a number-average particle diameter in the range from 2 to 15 ⁇ m, particularly preferably in the range from 5 to 10 ⁇ m. Further inventively preferred hydrophilic silicas are pyrogenic, so not available by precipitation.
  • hydrophilic silicic acids are available as commercial product SB-705 from Miyoshi Kasei, a spherical silica gel or spherical silica particles with the INCI name Silica having a number-average particle diameter of 5 to 6 ⁇ m and a specific surface area of about 600 m 2 / g.
  • Further preferred hydrophilic silicic acids are available as a commercial product Aerosil from Evonik Degussa, for example Aerosil 130, Aerosil 200, Aerosil 255, Aerosil 300 or Aerosil 380.
  • hydrophilic silicas are also available as commercial products: CAB-O-SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB- O-SIL M-5 (Cabot), Cosmedia Silc (Cognis), Neosil PC 50S (Ineos Silica), Sorbosil BFG 54 (Ineos Silica), Sorbosil AC33 (Ineos Silica), Sorbosil AC 35 (Ineos Silica), Sorbosil AC 37 (Ineos Silicas), Sorbosil AC 39 (Ineos Silica), Wacker HDK N 20 (Wacker chemistry), Wacker HDK S 13 (Wacker chemistry), Wacker HDK T 30 (Wacker chemistry), Wacker HDK V 15 (Wacker
  • compositions preferred according to the invention comprise at least one hydrophilic silica in a total amount of 0.0005-1% by weight, preferably 0.001-0.5% by weight, particularly preferably 0.01-0.4% by weight, even more preferably 0.05-0.3% by weight and more preferably 0.1-0.2% by weight, based in each case on the entire composition.
  • the antiperspirant emulsions according to the invention formulated as a cream, gel or solution, contain, in addition to the perspiration-reducing active ingredients, at least one cosmetic oil.
  • solution is understood as meaning a water-thin liquid having a viscosity of 0.1-900 mPas, measured under the conditions specified below.
  • oils are understood as meaning oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.
  • Volatile oils are understood in the context of the present application those oils which, at 20 ° C and an ambient pressure of 1013 hPa, have a vapor pressure of 2,66 Pa - 40,000 Pa (0,02 mm - 300 mm Hg), preferably 13 - 12000 Pa (0,1 - 90 mm Hg), more preferably 15-8000 Pa, most preferably 300-3000 Pa.
  • Cosmetic oils preferred according to the invention are selected from silicone oils, to which z.
  • dialkyl and alkylaryl such as cyclopentasiloxane, cyclohexasiloxane, dimethyl polysiloxane, low molecular weight phenyl trimethicone and Methylphenylpolysiloxan, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • Particularly preferred are volatile silicone oils, which may be cyclic, such as.
  • octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning (vapor pressure at 20 ° C about 13 - 15 Pa) are included.
  • volatile linear silicone oils having 2 to 10 siloxane units, in particular hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ) and any mixtures of two and three of L 2 , L 3 and / or L 4 such mixtures, as they are for.
  • Dow Corning® 2-1 184 Dow Corning® 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning.
  • Another preferred volatile silicone oil is a low molecular weight phenyl trimethicone having a vapor pressure at 20 ° C of about 2000 Pa as available, for example, from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
  • Volatile silicone oils are excellently suitable carrier oils for antiperspirant compositions which are preferred according to the invention, since they give them a pleasant feel on the skin and a low level of clothes soiling.
  • Antiperspirant compositions which are particularly preferred according to the invention are therefore based on a content of at least one volatile silicone oil of 30-95% by weight, preferably 40-93% by weight, particularly preferably 50-90% by weight, very preferably 55%. 85 wt .-%, each based on the total composition characterized.
  • at least one volatile non-silicone oil may also be present.
  • Preferred volatile non-silicone oils are selected from C 8 -C 6 isoparaffins, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and mixtures thereof.
  • This at least one volatile non-silicone oil is also preferably in a total amount of 30-95% by weight, preferably 40-93% by weight, more preferably 50-90% by weight, most preferably 55-85% by weight, in each case based on the total composition.
  • volatile silicone oils, isoparaffins in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, and mixtures of volatile silicone oils and isoparaffins, in particular isododecane, isohexadecane or isoeicosane, are particularly preferred .
  • Particularly preferred isoparaffins are selected from isodecane, isoundecane, isododecane, isotridecane, and mixtures of isodecane, isoundecane, isododecane and / or isotridecane.
  • compositions which are preferred according to the invention are characterized in that the at least one carrier oil under normal conditions e) at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, particularly preferably isodecane, isoundecane, isododecane, isotridecane, Isotetradecane, isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexadecane.
  • isoparaffin oil in particular isodecane, isoundecane, isododecane, isotridecane, isot
  • compositions preferred according to the invention contain as carrier liquid under standard conditions e) a mixture of e) i) a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units, and e) ii) at least one isoparaffin oil, in particular isodecane, isoundecane , Isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, more preferably isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexade
  • compositions preferred according to the invention contain as support liquid under standard conditions e) at least one n-alkane having nine to 15 carbon atoms, ie n-nonane, n-decane, n-undecane, n-dodecane, n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof. Particularly preferred are n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof.
  • mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane are particularly preferred.
  • mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane in which the proportion of n-alkanes is 5-45% by weight, based on the weight of the total Mix, matter.
  • particularly preferred antiperspirant compositions according to the invention may further contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils Effect of volatile oil on the Residue behavior according to the invention preferred antiperspirant compositions. Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, can be seen on the skin as an unsightly residue. These residues can be successfully masked with a nonvolatile oil. In addition, with a mixture of non-volatile and volatile oils, parameters such as skin feel, residue visibility and suspension stability can be fine-tuned and better adapted to consumer needs.
  • nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for. B. under the name Dow Corning ® 200 fluid with kinematic viscosities (25 ° C) in the range of 5 - 100 cSt, preferably 6 - 50 cSt or even 5 - 10 cSt, and Baysilon ® 350 M (with a kinematic viscosity (25 ° C) of about 350 cSt.
  • Silicone oils which are likewise preferred according to the invention are selected from silicones of the formula (I), where x is selected from integers of 1-20.
  • a preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone in various grades, viscosities and volatilities.
  • a non-volatile phenyl trimethicone is available, for example, from Dow Corning under the name Dow Corning 556.
  • Fine natural and synthetic hydrocarbons such as paraffin oils, C 8 -C 30 -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
  • paraffin oils C 8 -C 30 -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes
  • the ® for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G
  • non-volatile non-silicone oils which are preferred according to the invention are selected from the benzoic acid esters of linear or branched C 8 . 22 -alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and Benzoeklareoctyldocecylester, z. Available as a trade Product Finsolv ® BOD. Benzoic acid ester oils of this type are particularly suitable for masking antiperspirant active substance residues, since their refractive index comes very close to the particularly effective aluminum-zirconium mixed salts.
  • non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol.
  • More preferred non-volatile non-silicone oils are chosen from mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 _ th 30 fatty acids, provided that they are liquid under normal conditions.
  • the use of natural oils eg soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of the coconut oil is preferably in a total amount of 0, 1 to 5 wt .-%, preferably 0.2 to 3 wt .-%, particularly preferably 0.5 to 1, 5 wt .-%, each based on the total weight of the composition according to the invention.
  • Preference is given to synthetic triglyceride oils, in particular Capric / Caprylic triglycerides, z.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the dicarboxylic acid esters of linear or branched C 6 -C 0 -alkanols, in particular di (2-ethylhexyl) adipate, dioctyl adipate, dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2 ethylhexylsuccinate and di (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 6 -C 0 -alkanols in particular di (2-ethylhexyl) adipate, dioctyl adipate, dioctyl sebacate, diisopropyl sebacate, diocty
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or non-volatile non-silicone oils unsaturated fatty alcohols having 6 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • these include hexyldecyl (z. B. Eutanol ® G 16 S), hexyldecyl laurate, isononyl isononanoate, 2-Ethylhexylpal- palmitate (z. B. Cegesoft ® C 24) and 2-ethylhexyl stearate (z. B.
  • Cetiol ® 868 Also preferred are isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid 2-butyloctanoate, diisotridecylacetate, n-hexyl laurate, n-decyl oleate, oleyl oleate , Oleyl erucate, erucyl oleate and erucyl erucate.
  • non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 . 22 - Alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g. PPG-2 myristyl ether and PPG-3 myristyl ether.
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 . 22 -alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for. PPG-14 butyl ether, PPG-9-butyl ether, PPG-10-butanediol, PPG-15 stearyl ether and glycereth-7-diisononanoate.
  • non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. B. glycerol carbonate or dicaprylyl carbonate (z. B. Cetiol ® CC).
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils, volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols containing 6 to 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 .
  • a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5-40-50% by weight, even more preferably 10-12-25-30% by weight, of the oil components have a refractive index n D of 1.43-1.51, preferably 1.44-1 , 49, more preferably 1, 45-1, 47-1, 485, at 20 ° C (measured at ⁇ 589 nm).
  • compositions according to the invention are characterized in that at least one oil in a total amount of 30-80 wt.%, Preferably 40-75 wt. preferably in a total amount of 50-73% by weight, most preferably in a total amount of 56-70% by weight, in each case based on the total weight of the composition.
  • oil-in-water emulsions of the present invention contain a minor amount of an oil or fat phase of from 0.5 to 6.5 percent by weight, based on the weight of the total emulsion.
  • the low proportion of dispersed oil or fat phase leads to an improved, non-greasy skin feel and supports the deodorizing effect.
  • the oil or fat phase of the oil-in-water emulsions according to the invention comprises in addition to the at least one cosmetic oil e) also optionally contained fragrances as well as optionally contained fat components which are solid or pasty at 20 ° C.
  • the emulsifiers do not belong to the oil or fat phase.
  • Preferred oils which are liquid at 20 ° C. are selected from linear and branched saturated mono- or polyhydric C 3 -C 30 -alkanols etherified with at least one propylene oxide unit per molecule, more preferably selected from propanol, glycerol, propylene glycol, Butanol, butanediol, pentanol, capric alcohol, caprylic alcohol, caprylyl alcohol, lauryl alcohol, tridecyl alcohol, myristyl alcohol, palmityl alcohol, cetyl alcohol, stearyl alcohol, arachidyl alcohol and behenyl alcohol, having 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13, 14, 15, 16, 17, 18, 19 or 20 propylene oxide units are etherified, and mixtures of these alkanol ethers.
  • oils which are liquid at 20 ° C. are selected from adducts of at least 6 propylene oxide units per molecule of mono- or polyhydric C 3 .
  • 30 -alkanols in particular butanol, butanediol, myristyl alcohol and stearyl alcohol, more preferably selected from PPG-3-myristyl ether, PPG-13-butyl ether, PPG-14-butyl ether, PPG-9-butyl ether, PPG-10-butanediol and PPG 15-stearyl ether, as well as mixtures thereof.
  • Further preferred cosmetic oils are selected from propylene glycol monoesters of branched saturated C 6 -C 30 -alkanecarboxylic acids, more preferably selected from propylene glycol monoisostearate, propylene glycol monoisopalmitate, propylene glycol monoisobehenate, propylene glycol monoisoarachinate, propylene glycol monoisomyristate, propylene glycol monoisocaprate, propylene glycol monoisocaprate and propylene glycol monoisocaprylate and mixtures thereof.
  • propylene glycol monoesters of branched saturated C 6 -C 30 -alkanecarboxylic acids more preferably selected from propylene glycol monoisostearate, propylene glycol monoisopalmitate, propylene glycol monoisobehenate, propylene glycol monoisoarachinate, propylene glycol monoisomyristate, propylene glycol monoisocaprate, propylene glycol monoisocap
  • More preferred cosmetic oils are selected from branched saturated C 0 - C 30 - alkanols, particularly preferably selected from isostearyl alcohol, isocetyl alcohol, Isomyristylalko- alcohol, isotridecyl alcohol, Isoarachidylalkohol, Isobehenylalkohol, Isocaprylalkohol, Isocaprinylalkohol, Isocaprylylalkohol, and mixtures thereof.
  • Further preferred oil-in-water emulsions according to the invention are characterized in that at least one cosmetic oil in a total amount of 0.1-5% by weight, preferably 0.3-3% by weight and particularly preferably 0.5- 2 wt .-%, each based on the total weight of the emulsion is included.
  • Preferred nonionic emulsifiers having an HLB in the range of 3 to 6 are selected from linear saturated and unsaturated C 2 to C 30 alkanols etherified with 1 to 4 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth , Trideceth, araffleth and beheneth each having 1-4 ethylene oxide units per molecule are preferred. Most preferred are steareth-1, steareth-2, steareth-3, ceteth-1, ceteth-2, ceteth-3, myristeth-1, myristeth-2, laureth-1 beheneth-2, beheneth-3 and beheneth-4, in particular steareth-2.
  • Further oil-in-water emulsions preferred according to the invention contain at least one nonionic emulsifier having an HLB value in the range from 3 to 6 in a total amount of 1.8 to 3% by weight, preferably 2 to 2.8% by weight. and particularly preferably 2.4 to 2.6 wt .-%, each based on the weight of the total emulsion.
  • the storage stability of the oil-in-water emulsions according to the invention can be further increased by the addition of at least one nonionic emulsifier having an HLB value in the range of 12-18.
  • Further inventively preferred compositions are characterized in that at least one nonionic emulsifier having an HLB value in the range of 3-6 in a total amount of 1, 8 - 3 wt .-%, based on the weight of the total emulsion, is contained is selected from linear saturated and unsaturated C 2 -C 24 alkanols etherified with 7 to 40 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth, trideceth, araffleth and beheneth each having 7 to 40 ethylene oxide units per molecule are preferred.
  • Particularly preferred nonionic emulsifiers having an HLB value in the range of 12-18 are selected from steareth, ceteth, myristeth, laureth, trideceth, araffleth and beheneth, each having 7 to 40 ethylene oxide units per molecule, especially steareth-15, steareth-20 , Steareth-21, araezeth-20, aranovath-21, beheneth-20, beheneth-21, ceteth-20, ceteth-30, ceteth-15 and myristeth-15.
  • oil-in-water emulsions preferred according to the invention contain at least one nonionic emulsifier having an HLB value in the range from 12 to 18 in a total amount of 1 to 2% by weight, preferably 1 to 2 to 1% by weight. and particularly preferably 1, 5-1, 7 wt .-%, each based on the weight of the total emulsion.
  • compositions preferred according to the invention are characterized in that they contain steareth-2 as nonionic emulsifier having an HLB value in the range from 3 to 6 and at the same time as nonionic emulsifier having an HLB value in the range from 12 to 18 steareth-21.
  • Further preferred oil-in-water emulsions according to the invention are characterized in that the weight ratio of nonionic emulsifiers having an HLB value in the range of 3-6 and nonionic emulsifiers having an HLB value in the range of 12-18 from 0.9 to 3, preferably 1, 3 - 1, 9.
  • oil-in-water emulsions which are particularly preferred according to the invention comprise steareth-2, steareth-21 and PPG-15-stearyl ether.
  • Such emulsions are characterized by a particularly high storage and temperature stability and at the same time contribute to an improved, non-sticky skin feel.
  • the oil-in-water emulsions according to the invention are distinguished by a content of at least one polysaccharide. Surprisingly, it has been found that the polysaccharide content accelerates the drying of the emulsion on the skin. Compared with a polysaccharide-free emulsion emulsions of the invention are perceived by the test persons as faster drying on the skin.
  • Polysaccharides which are suitable according to the invention are understood to mean both unmodified polysaccharides, such as, for example, xanthan or starch, and chemically modified polysaccharide derivatives, such as, for example, aluminum starch octenylsuccinate or hydroxypropylmethylcellulose, and physically modified polysaccharides, for example a starch pregelatinized by thermal treatment.
  • unmodified polysaccharides such as, for example, xanthan or starch
  • chemically modified polysaccharide derivatives such as, for example, aluminum starch octenylsuccinate or hydroxypropylmethylcellulose
  • physically modified polysaccharides for example a starch pregelatinized by thermal treatment.
  • Preferred polysaccharides according to the invention are selected from starches, in particular from corn, potatoes and wheat, their constituents such as amylose and amylopectin, starch hydrolysates and starch degradation products, such as maltodextrin, the physically or chemically modified starch derivatives, in particular the anionic starch derivatives Aluminium Staroctenylsuccinat, Natrium Positionoctenylsuccinat, Calcium Whyoctenylsuccinat, Ditialphosphaten , Hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches and sodium starch glycolate, cellulose, the chemically modified cellulose derivatives methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, hydroxypropyl ethyl cellulose, hydroxyethyl methyl cellulose and carboxymethyl cellulose.
  • compositions according to the invention are free of polysaccharide gums.
  • Preferred polysaccharides of the invention are selected from anionic and nonionic polysaccharides and mixtures thereof.
  • Preferred anionic polysaccharides are selected from aluminum starch octenyl succinate, sodium starch octenyl succinate, calcium starch octenyl succinate, distarch phosphates, hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches, sodium starch glycolate and mixtures thereof.
  • Preferred nonionic polysaccharides are selected from starches, starch hydrolysates, cellulose, methylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and mixtures thereof.
  • compositions according to the invention contain the at least one polysaccharide in a total amount of 0.01-1.0 wt.%, Preferably 0.05-0.5 and particularly preferably 0.09-0.2 wt on the total weight of the emulsion.
  • Oil-in-water emulsions which are extraordinarily preferred according to the invention are characterized in that, in addition to steareth-2, steareth-21 and PPG-15-stearyl ether, aluminum starch octenyl succinate is contained as polysaccharide.
  • This polysaccharide is available, for example, under the trade names Dry Flo and Dry Flo Plus from National Starch.
  • extraordinarily preferred oil-in-water emulsions are characterized in that, in addition to steareth-2, steareth-21 and PPG-15-stearyl ether, at least one distarch phosphate is contained.
  • This polysaccharide is available, for example, from Agrana under the trade name Maize PO 4 PH "B.”
  • Such emulsions are distinguished by particularly high storage and temperature stability, an outstanding, non-sticky skin feel and optimal drying properties on the skin.
  • the proportion of water in the composition according to the invention is preferably at least 60% by weight, preferably 65 to 90% by weight, particularly preferably 70-85% by weight, most preferably 75-80% by weight, based in each case on total composition.
  • oil-in-water emulsions are characterized in that a total of at most 3 wt .-%, preferably at most 1 wt .-% and particularly preferably 0 wt .-%, each based on the weight of the total emulsion, of monovalent - C 3 alkanols, such as ethanol or isopropanol.
  • the emulsions according to the invention can be destabilized under certain conditions by an addition of ethanol or isopropanol, in particular in higher amounts, for example 5 wt .-% and more, in their storage and / or temperature stability.
  • oil-in-water emulsions according to the invention were developed in particular for roll-on products, that is to say for application with a ball applicator or roll-on applicator.
  • the emulsion must not be too viscous or too viscous.
  • Oil-in-water emulsions preferred according to the invention are therefore characterized by a viscosity in the range from 1000 to 5000 mPas, preferably 1500 to 4000 mPas and particularly preferably 1700 to 2200 mPas.
  • viscosity data refer to measurements made with a Brookfield viscometer performed 1 day after preparation of the emulsion with spindle RV 4, at a shear rate (spindle speed) of 20 s " without helipath at an ambient temperature and a sample temperature of 20 ° C become.
  • compositions according to the invention contain at least one deodorising aromatic alcohol of the structure (AA-1),
  • R - R 6 independently of one another a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or Alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms
  • R 7 - R independently a hydrogen atom, a halogen atom, especially a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, especially by a methoxy group
  • m 0 or 1
  • n, o, p can independently be integers from 0 to 10, wherein at least one of the values n, o, p is 0.
  • Deodorising aromatic alcohols of structure (AA-1) which are preferred according to the invention are selected from phenoxyethanol, phenoxyisopropanol (3-phenoxy-propan-2-ol), anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1,1 Dimethyl 3-phenylpropane-1-ol, benzyl alcohol, 2-phenylethane-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptane -1-ol, 2,2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) propan-1-ol, 2-ethyl-3-phenylpropan-1 - ol, 2-ethyl-3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-prop
  • Examples of the C to C 5 -alkyl radicals mentioned as substituents in the compounds used according to the invention are the groups methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl.
  • Ethyl, methyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl are preferred alkyl radicals, particularly preferred are methyl and n-pentyl.
  • C r to C 4 -alkoxy radicals preferred according to the invention are, for example, a methoxy or an ethoxy group.
  • a C r to C 5 -hydroxyalkyl group a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group may be mentioned.
  • a 2-hydroxyethyl group is particularly preferred.
  • a particularly preferred C 2 to C 4 polyhydroxyalkyl group is the 1,2-dihydroxyethyl group.
  • halogen atoms are F, Cl or Br atoms, Cl atoms are very particularly preferred.
  • Particularly preferred deodorant aromatic alcohols of structure (AA-1) according to the invention are selected from anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1, 1-dimethyl-3-phenyl-propan-1-ol, 3 Phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2,2-dimethyl-3-phenylpropan-1-ol and 2-n-pentyl 3-phenylpropane-1-ol. Extraordinary preference is given to 2-benzylheptene-1-ol.
  • compositions according to the invention contain, in addition to the at least one deodorant double salt of the alum type b) and in addition to the claimed component c), at least one further deodorant active substance.
  • deodorant active ingredients are selected from mineral deodorant active substances, odor absorbers, inorganic moisture absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and also enzyme inhibitors and, particularly preferred, combinations of said deodorant active substances.
  • the mineral deodorant or moisture absorbents preferably include odor-absorbing and / or moisture-absorbing silicates such.
  • Unmodified silicates serve as odor absorbers or moisture absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention.
  • the silicates which are particularly advantageous according to the invention include, in particular, unmodified phyllosilicates and, among these, in particular montmorillonite, kaolinite, IIIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum.
  • Such mineral deodorant or moisture absorbents are preferably in a total amount of 0.1 to 5 wt .-%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the entire composition, included.
  • Further advantageous odor absorbers are, for example, zinc ricinoleate, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.
  • germ-inhibiting or antimicrobial active substances are understood to mean those wrinkles which reduce the number of skin germs participating in the formation of the odor or inhibit their growth.
  • These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci.
  • Preferred germinal or antimicrobial active substances according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a series of plant extracts and zinc compounds.
  • triclosan chlorhexidine and chlorhexidine gluconate
  • 3,4,4'-trichlorocarbanilide bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphen bromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalconium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride.
  • phenol disodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as.
  • chlorophyllin copper complexes ⁇ -monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably a- (2-ethylhexyl) glycerol, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
  • Sensiva ® SC 50 ex Schülke & Mayr
  • carboxylic acid esters of mono-, di- and triglycerol eg glycerol monolaurate, diglycerol monocaprinate
  • lantibiotics and plant extracts eg green tea and components of lime blossom oil.
  • deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs forming a healthy skin micro flora.
  • active ingredients which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; These include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances.
  • the enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, ⁇ -glucuronidase, aminoacylase, cystathionine beta-lyase esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate.
  • Further preferred deodorant impurities are selected from silver salts, in particular silver citrate, dihydrogen silver citrate, silver lactate and silver sulfate, soluble complex salts of silver, colloidal silver and silver zeolites.
  • compositions according to the invention comprise at least one additional deodorant active ingredient chosen from silver salts, soluble complex salts of silver, colloidal silver and silver zeolites, arylsulfatase inhibitors, ⁇ -glucuronidase inhibitors, aminoacylase inhibitors, cystathionine beta-lyase inhibitors, esterase Inhibitors, lipase inhibitors and lipoxygenase inhibitors, ⁇ -monoalkyl glycerol ethers having a branched or linear saturated or unsaturated, optionally hydroxylated C 6 -C 22 -alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic components, trialkyl citric acid esters , in particular triethyl citrate, active substances which reduce or inhibit the growth of the number of odoriferous skin microorganisms from the group of staphylococci, corynebacteria, anaerococci, micrococci
  • compositions according to the invention contain at least one additional deodorant active ingredient in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, more preferably 0.3-5% by weight and most preferably 0.4 - 1, 0 wt .-%, further preferably 0.5 - 0.9 and 0.6 - 0.8 wt .-%, based on the total weight of the active substance in the total composition.
  • Further compositions preferred according to the invention comprise at least one further mineral deodorant active or sweat-absorbent or moisture-absorbent, with particularly preferred compositions containing the additional mineral / deodorant active ingredient or sweat absorbents or moisture absorbents in a total amount of 0.1-5% by weight. -%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the total composition.
  • compositions contain 0.01 to 5 wt .-%, preferably 0.05 to 2 wt .-%, particularly preferably 0.1 to 1 wt .-%, each based on the total composition, one of a natural mineral water , a thermal water or a natural healing mineral mixture obtained.
  • Natural mineral water is based on the definition of the German Mineral and Table Water Ordinance (MinTafWV, ⁇ 2) .
  • the mineral residue is the solid residue of the named waters.
  • Occupationally preferred mineral mixtures originate from the thermal water of La Toja (Spain), Bad Blumau, Bad Radkersburg, Aachen, Wiesbaden (all Germany), Carlsbad (Czech Republic), La Bourboule, Enghien-les-bains, Allevard-les-bains, Digne, Nyrac-les-bains, Lons le Saunier, Eaux Bonnes, Rochefort, les Fumades, Saint Christau, Uriage-les-bains, la Roche-Posay (all France) or the natural mineral or medicinal waters of Evian, Volvic, Vichy, Avene, Vittel (all France), Gerolstein or laboringen ( Germany).
  • Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development.
  • Preferred antioxidants are imidazole and imidazole derivatives (eg urocaninic acid), peptides, such as e.g. B.
  • D, L-carnosine, D-carnosine, L-carnosine and their derivatives eg, anserine
  • carotenoids eg, carotenes (eg, ⁇ -carotene, ⁇ -carotene, lycopene) and their derivatives
  • Lipoic acid and its derivatives eg dihydrolipoic acid
  • aurothioglucose propylthiouracil and other thio compounds
  • Ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters and their salts, dilauryl thiodipropionat
  • silibene and stilbene derivatives eg stilbene oxide, trans-stilbene oxide
  • suitable derivatives salts, esters, sugars, nucleotides, nucleosides, peptides and lipids
  • Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids, as well as butylhydroxytoluene and butylhydroxyanisole.
  • the total amount of antioxidants in preferred erfindungsge- Compositions is 0.001 to 10 wt .-%, preferably 0.05 to 5 wt .-% and especially 0.1 to 2 wt .-%, based on the total composition.
  • compositions according to the invention therefore contain at least one complexing agent.
  • the oil-in-water emulsions according to the invention contain at least one organic UV filter substance.
  • the organic UV filters preferred according to the invention are selected from the derivatives of dibenzoylmethane, cinnamic acid esters, diphenylacrylic acid esters, benzophenone, camphor, p-aminobenzoic acid esters, o-aminobenzoic acid esters, salicylic acid esters, benzimidazoles, symmetrically or asymmetrically substituted 1,3,5-triazines, monomers and oligomeric 4,4-diarylbutadiene carboxylic acid esters and carboxylic acid amides, ketotricyclo (5.2.1 .0) decane, benzalmalonic acid esters, benzoxazole and any desired mixtures of the stated components.
  • the organic UV filters can be oil-soluble or water-soluble.
  • the benzoxazole derivatives are advantageously present in dissolved form in the cosmetic preparations according to the invention.
  • Preferred emulsions according to the invention comprise at least one organic UV filter substance in a total amount of 0.1-30% by weight, preferably 0.5-20% by weight, more preferably 1.0-10% by weight and most preferably 2 or 3 - 7 wt .-%, each based on the total composition.
  • oil-in-water emulsions preferred according to the invention are characterized in that the oil or fat phase comprises at least one perfume.
  • perfume oils or perfume oil ingredients can be used as perfume component perfumes.
  • perfume oils or perfume oil ingredients can be used as perfume component perfumes.
  • perfume oils or perfume oil ingredients can be used as perfume component perfumes.
  • perfume oils or perfume oil ingredients can be used as perfume component perfumes.
  • perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate (DMBCA), phenylethyl acetate, benzyl acetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate.
  • DMBCA dimethylbenzylcarbinyl acetate
  • the ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8 - 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, Lilial and Bourgeonal, to the ketones such as the Jonone, alpha-lsomethylionon and methylcedryl ketones, among the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene.
  • fragrance oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • perfume oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil.
  • suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and laudanum oil and orange blossom oil, neroli oil, orange peel oil and Sandalwood oil.
  • Particularly preferred cosmetic emulsions according to the invention contain at least one perfume component in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, particularly preferably 1-1, 5 wt .-%, each based on the total composition.
  • oil-in-water emulsions are characterized in that they are packaged in a container with ball applicator or roll-on applicator.
  • Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention, for the antiperspirant treatment of the skin, in particular the armpit skin and / or the skin of the feet.
  • Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for antiperspirant treatment of the skin, especially the armpit skin and / or the skin of the feet, with non-greasy skin feel.
  • Another object of the present invention is a cosmetic, non-therapeutic method for antiperspirant treatment of the skin, in particular the underarm skin and / or the skin of the foot, which is characterized in that an inventive oil-in-water emulsion in an effective amount to the Skin is applied.
  • Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for the deodorizing treatment of the skin.
  • Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for the deodorant skin treatment with a non-greasy feel on the skin.
  • Another object of the present invention is a cosmetic, non-therapeutic method for deodorizing skin treatment, which is characterized in that an inventive oil-in-water emulsion is applied in an effective amount to the skin.
  • the emulsion according to Example 1 had a viscosity of 1800 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
  • the emulsion according to example 2 had a viscosity of 2000 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
  • the emulsion according to example 3 had a viscosity of 2200 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
  • the emulsion according to example 4 had a viscosity of 1700 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
  • Example 5 Antiperspirant Emulsion (O / W) According to the Invention
  • the emulsion according to Example 5 had a viscosity of 1800 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
  • the emulsions according to Examples 1-5 were each filled into a bottle with a roller applicator and were thus ready for sale.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to antiperspirant roll-ons of the cosmetic oil-in-water emulsion type which are especially suitable for application with a roll-on applicator and have, in addition to a long shelf life, a non-greasy feeling on the skin and a short drying time, an improved antiperspirant and deodorant effect. The emulsions contain at least one antiperspirant double salt of the alum type, 0.0005 – 5 wt.-% of at least one silicon oxide-containing compound, selected from hydrophilic silicic acids and/or hydrophobically modified phyllosilicates, and at least one polysaccharide.

Description

"Doppelsalz-haltige Antitranspirant-Roll-Ons"  "Double-salt antiperspirant roll-ons"
Die vorliegende Erfindung betrifft Antitranspirant-Roll-Ons vom Typ der kosmetischen Öl-inWasser-Emulsionen, die insbesondere zur Applikation mit einem Rollapplikator geeignet sind und neben einer hohen Lagerstabilität, einem nicht-fettenden Hautgefühl und einer schnellen Trocknungszeit auch eine verbesserte schweißhemmende und deodorierende Wirkung aufweisen, wobei die Emulsionen mindestens ein Doppelsalz vom Alaun-Typ, 0,0005 - 1 Gew.-% mindestens einer Siliciumoxid-haltigen Verbindung, ausgewählt aus hydrophilen Kieselsäuren und/oder hydrophob modifizierten Kieselsäuren und/oder Schichtsilikaten, sowie mindestens ein Polysaccharid enthalten. The present invention relates to antiperspirant roll-ons of the type of oil-in-water cosmetic emulsions, which are particularly suitable for application with a roll applicator and in addition to a high storage stability, a non-greasy feel on the skin and a fast drying time also an improved antiperspirant and deodorant effect wherein the emulsions contain at least one alum-type double salt, 0.0005-1% by weight of at least one silicon oxide-containing compound selected from hydrophilic silicas and / or hydrophobically modified silicas and / or sheet silicates, and at least one polysaccharide.
Schweißhemmende oder auch Antitranspirant-Zusammensetzungen sind ein wichtiger Bestandteil der täglichen persönlichen Hygiene. Sie sollen dafür sorgen, dass die Schweißproduktion reduziert wird und gebildeter Schweiß nicht zu unangenehmem Körpergeruch führt. Schweißhemmende Wrkstoffe, insbesondere auf der Basis von Aluminiumsalzen, sind im Stand der Technik bereits bestens bekannt. Die Verwendung von Alaun, KAI(S04)2 12 H20, als deodorierendes Mittel zur Reduzierung von Körpergeruch ist bekannt. Die bekannten Wirkstoffe sind allerdings in ihrer schweißreduzierenden bzw. deodorierenden Wrkung immer noch verbesserungswürdig. Antiperspirant or antiperspirant compositions are an important part of daily personal hygiene. They should ensure that the sweat production is reduced and formed sweat does not lead to unpleasant body odor. Antiperspirant active substances, in particular based on aluminum salts, are already well known in the art. The use of alum, KAI (S0 4) 2 12 H 2 0, as deodorant for reducing body odor is known. However, the known active ingredients are still in need of improvement in their sweat-reducing or deodorising effect.
Aufgabe der vorliegenden Anmeldung war es daher, eine schweißhemmende kosmetische Zusammensetzung mit verbesserter schweißhemmender und deodorierender Wirkung bereitzustellen. Überraschend wurde gefunden, dass die gestellte Aufgabe gelöst wird durch Zusammensetzungen, die eine Mischung aus mindestens einem Doppelsalz vom Alaun-Typ mit der allgemeinen Formel MIMI"(S04)2 x H20 (mit M1 = ein einwertiges Kation, ausgewählt aus Kalium-, Natrium-, Rubidium-, Cäsium- und Ammonium-Ionen; M1" = ein dreiwertiges Kation, ausgewählt aus Aluminium-, Gallium-, Indium-, Scandium-, Titan- und Vanadium-Ionen; x = rationale Zahl im Bereich von 0 bis 12, einschließlich 0), mindestens einen schweißhemmenden Wrkstoff, ausgewählt aus Alumi- niumchlorhydroxiden, Aluminiumzirconiumchlorhydraten und Mischungen hiervon, 0,0005 - 1 Gew.-% mindestens einer Siliciumoxid-haltigen Verbindung, ausgewählt aus hydrophilen Kieselsäuren und/oder hydrophob modifizierten Kieselsäuren und/oder Schichtsilikaten, sowie mindestens ein Polysaccharid enthalten. The object of the present application was therefore to provide an antiperspirant cosmetic composition with improved antiperspirant and deodorant action. Surprisingly, it has been found that the stated object is achieved by compositions comprising a mixture of at least one alum-type double salt having the general formula M 1 M 1 (SO 4 ) 2 .H 2 O (with M 1 = a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions; M 1 "= a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions; x = rational number in the range of 0 to 12 inclusive, 0), at least one antiperspirant active selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof, 0.0005-1 wt% of at least one silica-containing compound selected from hydrophilic silicas and / or hydrophobically modified silicas and / or phyllosilicates, and at least one polysaccharide.
Alle Angaben über die Aggregatzustände der verwendeten Ausgangsstoffe (fest, flüssig...) in dieser Anmeldung beziehen sich auf Normalbedingungen.„Normalbedingungen" sind im Sinne der vorliegenden Anmeldung eine Temperatur von 20 °C und ein Druck von 1013,25 mbar. Schmelzpunktangaben beziehen sich ebenfalls auf einen Druck von 1013,25 mbar. Ein erster Gegenstand der vorliegenden Erfindung sind ÖI-in-Wasser-Emulsionen, enthaltend a. mindestens einen schweißhemmenden Wirkstoff, ausgewählt aus Aluminiumchlor- hydroxiden, Aluminiumzirconiumchlorhydraten und Mischungen hiervon, All data on the states of aggregation of the starting materials used (solid, liquid, etc.) in this application are based on standard conditions. "Normal conditions" in the context of the present application are a temperature of 20 ° C. and a pressure of 1013.25 mbar also at a pressure of 1013.25 mbar. A first object of the present invention are oil-in-water emulsions containing a. at least one antiperspirant active ingredient selected from aluminum chlorohydroxides, aluminum zirconium chlorohydrates and mixtures thereof,
b. mindestens ein Doppelsalz vom Alaun-Typ mit der allgemeinen Formel MIMI"(S04)2 x H20, wobei M1 ein einwertiges Kation, ausgewählt aus Kalium-, Natrium-, Rubidium-, Cäsium- und Ammonium-Ionen, darstellt, M1" ein dreiwertiges Kation, ausgewählt aus Aluminium-, Gallium-, Indium-, Scandium-, Titan- und Vanadium-Ionen, darstellt und x eine rationale Zahl im Bereich von 0 bis 12, einschließlich 0, darstellt; b. at least one double salt of the alum type having the general formula M I M I "(S0 4) 2 x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium Ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, inclusive of 0;
c. 0,0005 - 1 Gew.-%, bezogen auf ihr Gewicht, mindestens einer Siliciumoxid-haltigen Verbindung, ausgewählt aus hydrophilen Kieselsäuren und/oder hydrophob modifizierten Kieselsäuren und/oder Schichtsilikaten,  c. 0.0005-1% by weight, based on their weight, of at least one silicon oxide-containing compound selected from hydrophilic silicas and / or hydrophobically modified silicic acids and / or phyllosilicates,
d. mindestens ein Polysaccharid,  d. at least one polysaccharide,
e. mindestens ein kosmetisches Öl,  e. at least one cosmetic oil,
wobei die Zusammensetzung als Creme, Gel, Lösung oder auf einem Substrat imprägniert konfektioniert ist. wherein the composition is formulated as a cream, gel, solution or impregnated on a substrate.
Der Antitranspirant-Wirkstoff a) ist ausgewählt aus Aluminiumchlorhydroxiden, Aluminiumzirco- niumchlorhydraten und Mischungen hiervon.  The antiperspirant active ingredient a) is selected from aluminum chlorhydroxides, aluminum zirconium chlorohydrates and mixtures thereof.
Bevorzugte Antitranspirant-Wirkstoffe a) sind wasserlöslich. Erfindungsgemäß wird unter Wasserlöslichkeit eine Löslichkeit von wenigstens 5 Gew.-% bei 20 °C verstanden, das heißt, dass Mengen von wenigstens 5 g des Antitranspirant-Wirkstoffs in 95 g Wasser bei 20 °C löslich sind. Besonders bevorzugte Antitranspirant-Wrkstoffe sind ausgewählt aus Aluminiumchlorhydrat, insbesondere Aluminiumchlorhydrat mit der allgemeinen Formel [AI2(OH)5CI 1 -6 H20]n, bevorzugt [AI2(OH)5CI 2-3 H20]n, das in nicht-aktivierter oder in aktivierter (depolymerisierter) Form vorliegen kann, sowie Aluminiumchlorhydrat mit der allgemeinen Formel [AI2(OH)4CI2 1 -6 H20]n, bevorzugt [AI2(OH)4CI2 2-3 H20]n, das in nicht-aktivierter oder in aktivierter (depolymerisierter) Form vorliegen kann. Die Herstellung bevorzugter Antitranspirant-Wirkstoffe ist beispielsweise in US 3887692, US 3904741 , US 4359456, GB 2048229 und GB 1347950 offenbart. Preferred antiperspirant active ingredients a) are water-soluble. According to the invention, water solubility is understood as meaning a solubility of at least 5% by weight at 20 ° C., that is to say amounts of at least 5 g of the antiperspirant active are soluble in 95 g of water at 20 ° C. Particularly preferred antiperspirant Wrkstoffe are selected from aluminum chlorohydrate, aluminum chlorohydrate, in particular having the general formula [Al 2 (OH) 5 CI 1 -6 H 2 0] n, preferably [Al 2 (OH) 5 CI 2-3 H 2 0 ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 1 -6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 2-3 H 2 O] n , which may be in unactivated or in activated (depolymerized) form. The preparation of preferred antiperspirant agents is disclosed, for example, in US 3887692, US 3904741, US 4359456, GB 2048229 and GB 1347950.
Weiterhin bevorzugt sind Aluminiumsesquichlorhydrat, Aluminiumdichlorhydrat, Aluminiumchlor- hydrex-Propylenglykol (PG) oder Aluminiumchlorhydrex-Polyethylenglykol (PEG), Aluminium- oder Aluminiumzirkonium-Glycol-Komplexe, z. B. Aluminium- oder Aluminiumzirkonium-Propylenglycol- Komplexe, Aluminiumsesquichlorhydrex-PG oder Aluminiumsesquichlorhydrex-PEG, Aluminium- PG-dichlorhydrex oder Aluminium-PEG-dichlorhydrex, Aluminiumhydroxid, weiterhin ausgewählt aus den Aluminiumzirconiumchlorhydraten, wie Aluminiumzirconiumtrichlorhydrat, Aluminiumzirco- niumtetrachlorhydrat, Aluminiumzirconiumpentachlorhydrat, Aluminiumzirconiumoctachlorhydrat, den Aluminium-Zirkonium-Chlorohydrat-Glycin-Komplexen wie Aluminiumzirconiumtrichlorhydrex- glycin, Aluminiumzirconiumtetrachlorhydrexglycin, Aluminiumzirconiumpentachlorhydrexglycin, Aluminiumzirconiumoctachlorhydrexglycin, Natriumaluminiumchlorhydroxylactat, Aluminiumchlor- hydroxyallantoinat und Natrium-Aluminium-Chlorhydroxylactat. Erfindungsgemäß besonders bevorzugte Antitranspirant-Wirkstoffe sind ausgewählt aus so genannten„aktivierten" Aluminiumchlorhydroxiden und Aluminiumzirconiumchlorhydraten, die auch als Antitranspirant-Wirkstoffe„mit erhöhter Wirksamkeit (englisch: enhanced activity)" bezeichnet werden. Derartige Wirkstoffe sind im Stand der Technik bekannt und auch kommerziell erhältlich. Ihre Herstellung ist beispielsweise in GB 2048229, US 4775528 und US 6010688 offenbart. Aktivierte Aluminiumchlorhydroxide und Aluminiumzirconiumchlorhydrate werden in der Regel durch Wärmebehandlung einer relativ verdünnten Lösung des Salzes erzeugt (z.B. etwa 10 Gew.-% Salz), um dessen HPLC-Peak 4-zu-Peak 3-Flächenverhältnis zu vergrößern. Das aktivierte Salz kann anschließend zu einem Pulver getrocknet, insbesondere sprühgetrocknet werden. Neben der Sprühtrocknung ist z. B. auch die Walzentrocknung geeignet. Also preferred are aluminum sesquichlorohydrate, aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum or aluminum zirconium glycol complexes, e.g. Aluminum or aluminum zirconium-propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG-dichlorhydrex or aluminum PEG-dichlorhydrex, aluminum hydroxide, furthermore selected from the aluminum zirconium chlorohydrates, such as aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate, aluminum zirconium octachlorohydrate, the aluminum-zirconium-chlorohydrate-glycine complexes such as aluminum zirconium trichlorohydrex glycine, aluminum zirconium tetrachlorohydrex glycine, aluminum zirconium pentachlorohydrex glycine, aluminum zirconium octachlorohydrex glycine, sodium aluminum chlorhydroxactate, aluminum chlorohydroxyallantoinate and sodium aluminum chlorohydroxylactate. Antiperspirant active ingredients which are particularly preferred according to the invention are selected from what are known as "activated" aluminum chlorhydroxides and aluminum zirconium chlorohydrates, which are also referred to as "enhanced activity" as antiperspirant active ingredients. Such agents are known in the art and are also commercially available. Their preparation is disclosed, for example, in GB 2048229, US 4775528 and US 6010688. Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates are typically produced by heat treating a relatively dilute solution of the salt (eg, about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio. The activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
Aktivierte Aluminiumchlorhydroxide und Aluminiumzirconiumchlorhydrate haben typischerweise ein HPLC-Peak 4-zu-Peak 3-Flächenverhältnis von mindestens 0,4, bevorzugt mindestens 0,7, besonders bevorzugt mindestens 0,9, wobei mindestens 70% des Aluminiums diesen Peaks zuzuordnen sind.  Activated aluminum chlorhydroxides and aluminum zirconium chlorohydrates typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
Aktivierte Aluminiumchlorhydroxide und Aluminiumzirconiumchlorhydrate können als sprühgetrocknete Pulver und - bevorzugt - als wässrige Lösungen eingesetzt werden, aber auch als nicht- wässrige Lösungen oder nicht-wässrige Solubilisate, beispielsweise gemäß US 6010688, die durch den Zusatz einer wirksamen Menge eines mehrwertigen Alkohols, der 3 bis 6 Kohlenstoffatome und 3 bis 6 Hydroxyl-Gruppen, bevorzugt Propylenglycol, Sorbit und Pentaerythrit, aufweist, gegen den Verlust der Aktivierung gegen den raschen Abbau des HPLC-Peak 4:Peak 3-Flächenverhält- nisses des Salzes stabilisiert sind. Beispielsweise bevorzugt sind Zusammensetzungen, die in Gewichtsprozent (USP) enthalten: 12 - 45 Gew.-%, bezogen auf die gesamte Zusammensetzung, eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes, 55 - 82 Gew.-% mindestens eines wasserfreien mehrwertigen Alkohols mit 3 bis 6 Kohlenstoffatomen und 3 bis 6 Hydroxyl-Gruppen, bevorzugt Propylenglycol, Butylenglycol, Diethylenglycol, Dipropylenglycol, Glycerin, Sorbit und Pentaerythrit, besonders bevorzugt Propylenglycol.  Activated aluminum chlorhydroxides and Aluminiumzirconiumchlorhydrate can be used as spray-dried powders and - preferably - as aqueous solutions, but also as non-aqueous solutions or non-aqueous solubilizates, for example according to US 6010688, by the addition of an effective amount of a polyhydric alcohol, the 3 bis 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt. For example, preferred are compositions containing by weight (USP): 12-45% by weight, based on the total composition, of an activated aluminum or aluminum zirconium salt, 55-82% by weight of at least one anhydrous polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerol, sorbitol and pentaerythritol, more preferably propylene glycol.
Besonders bevorzugt sind auch Komplexe aktivierter schweißhemmender Aluminium- oder Alumi- nium-Zirconiumsalze mit einem mehrwertigen Alkohol, die 20 - 50 Gew.-%, besonders bevorzugt 20 - 42 Gew.-%, aktiviertes schweißhemmendes Aluminium- oder Aluminium-Zirconiumsalz und 2 - 16 Gew.-% molekular gebundenes Wasser enthalten, wobei der Rest zu 100 Gew.-% mindestens ein mehrwertiger Alkohol mit 3 bis 6 Kohlenstoffatome und 3 bis 6 Hydroxyl-Gruppen ist. Propylenglycol, Propylenglycol/Sorbit-Mischungen und Propylenglycol/Pentaerythrit-Mischungen sind bevorzugte derartige Alkohole. Derartige erfindungsgemäß bevorzugte Komplexe eines aktivierten schweißhemmenden Aluminium- oder Aluminium-Zirconiumsalzes mit einem mehrwertigen Alkohol sind z. B. offenbart in US 5643558 und US 6245325.  Also particularly preferred are complexes of activated antiperspirant aluminum or aluminum-zirconium salts with a polyhydric alcohol containing 20-50% by weight, more preferably 20-42% by weight, activated antiperspirant aluminum or aluminum-zirconium salt, and 16 wt .-% molecularly bound water, the remainder to 100 wt .-% is at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups. Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols. Such inventively preferred complexes of an activated antiperspirant aluminum or aluminum zirconium salt with a polyhydric alcohol are, for. As disclosed in US 5643558 and US 6245325.
Weitere bevorzugte schweißhemmende Wrkstoffe sind basische Calcium-Aluminiumsalze, wie sie beispielsweise in US 2571030 offenbart sind. Diese Salze werden durch Umsetzen von Calciumcarbonat mit Aluminiumchlorhydroxid oder Aluminiumchlorid und Aluminiumpulver oder durch Zusetzen von Calciumchlorid-Dihydrat zu Aluminiumchlorhydroxid hergestellt. Weitere bevorzugte schweißhemmende Wirkstoffe sind Aluminium-Zirconium-Komplexe, wie sie beispielsweise in US 4017599 offenbart sind, die mit Salzen von Aminosäuren, insbesondere mit Alkali- und Erdalkaliglycinaten, gepuffert sind. Further preferred antiperspirant actives are basic calcium aluminum salts, as disclosed for example in US 2571030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide. Other preferred antiperspirant actives are aluminum-zirconium complexes as disclosed, for example, in US Pat. No. 4,017,599, which are buffered with salts of amino acids, in particular with alkali metal and alkaline earth glycinates.
Weitere bevorzugte schweißhemmende Wrkstoffe sind aktivierte Aluminium- oder Aluminium-Zir- coniumsalze, wie sie beispielsweise in US 6245325 oder US 6042816 offenbart sind, enthaltend 5 Further preferred antiperspirant active substances are activated aluminum or aluminum-zirconium salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No. 6,042,816, containing FIG
- 78 Gew.-% (USP) eines aktivierten schweißhemmenden Aluminium- oder Aluminium-Zirconium- salzes, eine Aminosäure oder Hydroxyalkansäure in einer solchen Menge, um ein (Aminosäure oder Hydroxyalkansäure) zu (Al+Zr) - Gewichtsverhältnis von 2:1 - 1 :20 und bevorzugt 1 :1 bis 1 :10 bereitzustellen, sowie ein wasserlösliches Calciumsalz in einer solchen Menge, um ein Ca:(AI+Zr)- Gewichtsverhältnis von 1 :1 - 1 :28 und bevorzugt 1 :2 - 1 :25 bereitzustellen. 78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in such an amount as to form an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1; 1: 20 and preferably 1: 1 to 1:10, and a water-soluble calcium salt in such an amount to have a Ca: (Al + Zr) weight ratio of 1: 1 to 1:28 and preferably 1: 2 to 1: 25 to provide.
Besonders bevorzugte feste aktivierte schweißhemmende Salzzusammensetzungen, beispielsweise gemäß US 6245325 oder US 6042816, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 - 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 13 Gew.-% molekular gebundenes Wasser (Hydratationswasser), weiterhin soviel wasserlösliches Calciumsalz, dass das Ca:(AI+Zr)-Gewichtsverhältnis 1 :1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Aminosäure, dass das Aminosäure zu (Al+Zr) - Gewichtsverhältnis 2:1 - 1 :20, bevorzugt 1 :1 - 1 :10, beträgt.  Particularly preferred solid activated antiperspirant salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum zirconium salt and 1-16% by weight. %, preferably 4-13% by weight molecularly bound water (water of hydration), furthermore sufficient water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, is and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
Weitere besonders bevorzugte feste schweißhemmende aktivierte Salzzusammensetzungen, beispielsweise gemäß US 6245325 oder US 6042816, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
- 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 13 Gew.-% molekular gebundenes Wasser (Hydratationswasser), weiterhin soviel wasserlösliches Calciumsalz, dass das Ca:(AI+Zr)-Gewichtsverhältnis 1 :1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Glycin, dass das Glycin zu (Al+Zr) - Gewichtsverhältnis 2:1 - 1 :20, bevorzugt 1 :1 - 1 :10, beträgt. 75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-13% by weight of molecularly bound water (water of hydration), furthermore so much water-soluble calcium salt, that the Ca: (Al + Zr) weight ratio 1: 1-1: 28, preferably 1: 2-1: 25, and so much glycine that the glycine to (Al + Zr) - weight ratio 2: 1-1: 20, preferably 1: 1 - 1: 10.
Weitere besonders bevorzugte feste schweißhemmende aktivierte Salzzusammensetzungen, beispielsweise gemäß US 6245325 oder US 6042816, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66
- 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 13 Gew.-% molekular gebundenes Wasser, weiterhin soviel wasserlösliches Calciumsalz, dass das Ca:(AI+Zr)-Gewichtsverhältnis 1 :1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Hydroxyalkansäure, dass das Hydroxyalkansäure zu (Al+Zr) - Gewichtsverhältnis 2:1 - 1 :20, bevorzugt 1 :1 - 1 :10, beträgt. 75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-13% by weight of molecularly bound water, furthermore sufficient water-soluble calcium salt that the Ca: (Al + Zr) Weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and as much hydroxyalkanoic that the hydroxyalkanoic acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10 , is.
Für die Stabilisierung der schweißhemmenden Salze bevorzugte wasserlösliche Calciumsalze sind ausgewählt aus Calciumchlorid, Calciumbromid, Calciumnitrat, Calciumcitrat, Calciumformiat, Calciumacetat, Calciumgluconat, Calciumascorbat, Calciumlactat, Calciumglycinat, Calciumcarbonat, Calciumsulfat, Calciumhydroxid, sowie Mischungen davon. Für die Stabilisierung der schweißhemmenden Salze bevorzugte Aminosäuren sind ausgewählt aus Glycin, Alanin, Leucin, Isoleucin, beta-Alanin, Valin, Cystein, Serin, Tryptophan, Phenylalanin, Methionin, beta-Amino-n-butansäure und gamma-Amino-n-butansäure und den Salzen davon, jeweils in der d-Form, der I-Form und der dl-Form; Glycin ist besonders bevorzugt. Für die Stabilisierung der schweißhemmenden Salze bevorzugte Hydroxyalkansäuren sind ausgewählt aus Glycolsäure und Milchsäure. Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof. Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, beta-alanine, valine, cysteine, serine, tryptophan, phenylalanine, methionine, beta-amino-n-butanoic acid and gamma-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred. Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
Weitere bevorzugte schweißhemmende Wirkstoffe sind aktivierte Aluminium- oder Aluminium- Zirconiumsalze, wie sie beispielsweise in US 6902723 offenbart sind, enthaltend 5 - 78 Gew.-% (USP) eines aktivierten schweißhemmenden Aluminium- oder Aluminium-Zirconiumsalzes, eine Aminosäure oder Hydroxyalkansäure in einer solchen Menge, um ein (Aminosäure oder Hydroxy- alkansäure) zu (Al+Zr) - Gewichtsverhältnis von 2: 1 - 1 :20 und bevorzugt 1 :1 bis 1 :1 0 bereitzustellen, sowie ein wasserlösliches Strontiumsalz in einer solchen Menge, um ein Sr:(AI+Zr)- Gewichtsverhältnis von 1 : 1 - 1 :28 und bevorzugt 1 :2 - 1 :25 bereitzustellen.  Other preferred antiperspirant actives are activated aluminum or aluminum zirconium salts, such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum or aluminum zirconium salt, an amino acid or hydroxyalkanoic acid in one An amount to provide an (amino acid or hydroxyalkanoic acid) to (Al + Zr) weight ratio of 2: 1-1: 20 and preferably 1: 1 to 1: 10, and a water-soluble strontium salt in such an amount as to provide Sr: (AI + Zr) - weight ratio of 1: 1 - 1: 28 and preferably 1: 2 - 1: 25 provide.
Besonders bevorzugte feste schweißhemmende aktivierte Salzzusammensetzungen, beispielsweise gemäß US 6902723, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 - 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 13 Gew.-% molekular gebundenes Wasser, weiterhin soviel wasserlösliches Strontiumsalz, dass das Sr:(AI+Zr)-Gewichtsverhältnis 1 : 1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Aminosäure, dass das Aminosäure zu (Al+Zr) - Gewichtsverhältnis 2: 1 - 1 :20, bevorzugt 1 : 1 - 1 :1 0, beträgt. Particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: (AI + Zr) weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 1 0, is.
Weitere besonders bevorzugte feste schweißhemmende aktivierte Salzzusammensetzungen, beispielsweise gemäß US 6902723, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 - 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 1 3 Gew.-% molekular gebundenes Wasser, weiterhin soviel wasserlösliches Strontiumsalz, dass das Sr:(AI+Zr)-Gewichtsverhältnis 1 :1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Glycin, dass das Glycin zu (Al+Zr) - Gewichtsverhältnis 2: 1 - 1 :20, bevorzugt 1 : 1 - 1 :1 0, beträgt. Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-1-3% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much glycine in that the glycine to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 1 0 ,.
Weitere besonders bevorzugte feste schweißhemmende aktivierte Salzzusammensetzungen, beispielsweise gemäß US 6902723, enthalten 48 - 78 Gew.-% (USP), bevorzugt 66 - 75 Gew.-% eines aktivierten Aluminium- oder Aluminium-Zirconiumsalzes und 1 - 16 Gew.-%, bevorzugt 4 - 1 3 Gew.-% molekular gebundenes Wasser, weiterhin soviel wasserlösliches Strontiumsalz, dass das Sr:(AI+Zr)-Gewichtsverhältnis 1 : 1 - 1 :28, bevorzugt 1 :2 - 1 :25, beträgt und soviel Hydroxyalkansäure, dass das Hydroxyalkansäure zu (Al+Zr) - Gewichtsverhältnis 2:1 - 1 :20, bevorzugt 1 :1 - 1 : 10, beträgt. Further particularly preferred solid antiperspirant activated salt compositions, for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum or aluminum-zirconium salt and 1-16% by weight, preferably 4-1-3% by weight of molecularly bound water, furthermore sufficient water-soluble strontium salt, that the Sr: (Al + Zr) weight ratio is 1: 1-1: 28, preferably 1: 2-1: 25, and as much hydroxyalkanoic acid in that the hydroxyalkanoic acid is in the (Al + Zr) weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
Weitere bevorzugte aktivierte Aluminiumsalze sind solche der allgemeinen Formel AI2(OH)6.aXa, worin X Cl, Br, I oder N03 ist und "a" ein Wert von 0,3 bis 5, bevorzugt von 0,8 bis 2,5 und besonders bevorzugt 1 bis 2 ist, so dass das Molverhältnis von AI:X 0,9: 1 bis 2, 1 : 1 beträgt, wie sie beispielsweise in US 6074632 offenbart sind. Bei diesen Salzen ist im Allgemeinen etwas Hydratationswasser assoziativ gebunden, typischerweise 1 bis 6 Mol Wasser pro Mol Salz. Besonders bevorzugt ist Aluminiumchlorhydrat (d .h. X ist Cl in der vorgenannten Formel) und speziell 5/6- basisches Aluminiumchlorhydrat, worin "a" 1 beträgt, so dass das Molverhältnis von Aluminium zu Chlor 1 ,9:1 bis 2,1 : 1 beträgt. Further preferred activated aluminum salts are those of the general formula Al 2 (OH) 6 . a Xa, wherein X is Cl, Br, I or N0 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2, 1: 1, as disclosed, for example, in US 6074632. These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt. Particularly preferred is aluminum chlorohydrate (i.e., X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate wherein "a" is 1 such that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1 : 1 is.
Bevorzugte aktivierte Aluminium-Zirconiumsalze sind solche, die Mischungen oder Komplexe der vorstehend beschriebenen Aluminiumsalze mit Zirconiumsalzen der Formel ZrO(OH)2.PbYb darstellen, worin Y Cl, Br, I, NQ3 oder SQ4 ist, b eine rationale Zahl von 0,8 bis 2 und p die Wertigkeit von Y ist, wie sie beispielsweise in US 6074632 offenbart sind. Die Zirconiumsalze haben in der Regel ebenfalls etwas Hydratationswasser assoziativ gebunden, typischerweise 1 bis 7 Mol Wasser pro Mol Salz. Vorzugsweise ist das Zirconiumsalz Zirconylhydroxychlorid mit der Formel ZrO(OH)2.bClb, worin b eine rationale Zahl von 0,8 bis 2, bevorzugt 1 ,0 bis 1 ,9 ist. Bevorzugte Aluminium-Zirco- niumsalze haben ein AI:Zr-Molverhältnis von 2 bis 10 und ein Metall:(X+Y)-Verhältnis von 0,73 bis 2,1 , bevorzugt 0,9 bis 1 ,5. Ein besonders bevorzugtes Salz ist Aluminium-Zirconiumchlorhydrat (d.h., X und Y sind Cl), das ein AI:Zr-Verhältnis von 2 bis 10 und ein molares Metall:CI-Verhältnis von 0,9 bis 2,1 hat. Der Begriff Aluminium-Zirconiumchlorhydrat umfasst die Tri-, Tetra-, Penta- und Octachlorhydratformen. Weitere bevorzugte schweißhemmende Wirkstoffe sind in US 6663854 und US 20040009133 offenbart. Preferred activated aluminum-zirconium salts are those which contain mixtures or complexes of the aluminum salts described above with zirconium salts of the formula ZrO (OH) 2 . Pb Y b , where Y is Cl, Br, I, NQ 3 or SQ 4 , b is a rational number from 0.8 to 2 and p is the valency of Y is as disclosed, for example, in US 6074632. The zirconium salts also typically associate some hydration water associatively, typically 1 to 7 moles of water per mole of salt. Preferably, the zirconium salt is zirconyl hydroxychloride of the formula ZrO (OH) 2 . b Cl b , wherein b is a rational number of 0.8 to 2, preferably 1, 0 to 1, 9. Preferred aluminum-zirconium salts have an Al: Zr molar ratio of 2 to 10 and a metal: (X + Y) ratio of 0.73 to 2.1, preferably 0.9 to 1.5. A particularly preferred salt is aluminum zirconium chlorohydrate (ie, X and Y are Cl) which has an Al: Zr ratio of 2 to 10 and a molar metal: Cl ratio of 0.9 to 2.1. The term aluminum-zirconium chlorohydrate includes the tri-, tetra-, penta- and octachlorohydrate forms. Other preferred antiperspirant actives are disclosed in US 6663854 and US 20040009133.
Die schweißhemmenden Wirkstoffe können sowohl in solubilisierter als auch in gelöster Form vorliegen. Die Antitranspirant-Wirkstoffe können als nicht-wässrige Lösungen oder als glycolische Solubilisate eingesetzt werden.  The antiperspirant active ingredients can be present both in solubilized and in dissolved form. The antiperspirant active ingredients can be used as nonaqueous solutions or as glycolic solubilisates.
Bevorzugte Aluminiumsalze und Aluminiumzirconiumsalze weisen ein molares Metall-zu-Chlorid- Verhältnis von 0,9 - 1 ,3, bevorzugt 0,9 - 1 ,1 , besonders bevorzugt 0,9 - 1 ,0, auf. Bevorzugte Aluminiumzirconiumchlorohydrate haben im allgemeinen die empirische Formel AlnZr(OH)[3n+4- m(n+ )](CI)[m(n+ )] mit n = 2,0 - 10,0, bevorzugt 3,0 - 8,0, m = 0,77 - 1 ,1 1 (entsprechend einem molaren Metall (AI+Zr)-zu-Chlorid-Verhältnis von 1 ,3 - 0,9), bevorzugt m = 0,91 - 1 ,1 1 (entsprechend M:CI = 1 ,1 - 0,9), und besonders bevorzugt m = 1 ,00 - 1 ,1 1 (entsprechend M:CI = 1 ,0 - 0,9), weiterhin sehr bevorzugt m = 1 ,02 - 1 ,1 1 (entsprechend M:CI = 0,98 - 0,9) sowie sehr bevorzugt m = 1 ,04 - 1 ,1 1 (entsprechend M:CI = 0,96 - 0,9). Bei diesen Salzen ist im Allgemeinen etwas Hydratationswasser assoziativ gebunden, typischerweise 1 - 6 Mol Wasser pro Mol Salz, entsprechend 1 - 16 Gew.-%, bevorzugt 4 - 13 Gew.-% Hydratationswasser. Preferred aluminum salts and aluminum zirconium salts have a molar metal-to-chloride ratio of 0.9-1.3, preferably 0.9-1.1, more preferably 0.9-1.0. Preferred aluminum zirconium chlorohydrates generally have the empirical formula Al n Zr (OH) [3 n + 4 m (n +)] (Cl) [m (n +)] where n = 2.0-10.0, preferably 3.0 8.0, m = 0.77-1.11 (corresponding to a molar metal (Al + Zr) to chloride ratio of 1.3-3.0), preferably m = 0.91-1.1 1 (corresponding to M: CI = 1, 1-0.9), and particularly preferably m = 1.00-1.1 (corresponding to M: CI = 1.0-0.9), furthermore very preferably m = 1 , 02-1, 11 (corresponding to M: CI = 0.98-0.9) and very preferably m = 1.04-1.1 (corresponding to M: CI = 0.96-0.9). In general, some of the water of hydration is associatively bound to these salts, typically 1-6 moles of water per mole of salt, corresponding to 1-16% by weight, preferably 4-13% by weight of water of hydration.
Üblicherweise sind die bevorzugten Aluminiumzirconiumchlorohydrate mit einer Aminosäure assoziiert, um die Polymerisation der Zirconiumspecies während der Herstellung zu verhindern. Bevorzugte stabilisierende Aminosäuren sind ausgewählt aus Glycin, Alanin, Leucin, Isoleucin, ß-Alanin, Cystein, Valin, Serin, Tryptophan, Phenylalanin, Methionin, ß-Amino-n-butansäure und γ- Amino-n-butansäure und den Salzen davon, jeweils in der d-Form, der I-Form und der dl-Form; Glycin ist besonders bevorzugt. Die Aminosäure ist in einer Menge von 1 - 3 Mol, bevorzugt 1 ,3 - 1 ,8 Mol, jeweils pro Mol Zirconium in dem Salz enthalten. Usually, the preferred aluminum zirconium chlorohydrates are associated with an amino acid to prevent polymerization of the zirconium species during manufacture. Preferred stabilizing amino acids are selected from glycine, alanine, leucine, isoleucine, β-alanine, cysteine, valine, serine, tryptophan, phenylalanine, methionine, β-amino-n-butanoic acid and γ-amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred. The amino acid is contained in the salt in an amount of 1 to 3 moles, preferably 1 to 3 to 1.8 moles, per mole of zirconium.
Bevorzugte schweißhemmende Salze sind Aluminium-Zirconiumtetrachlorohydrat (AI:Zr = 2-6; M:CI = 0.9-1 .3), insbesondere Salze mit einem molaren Metall-zu-Chlorid-Verhältnis von 0,9 - 1 ,1 , bevorzugt 0,9 - 1 ,0.  Preferred antiperspirant salts are aluminum-zirconium tetrachlorohydrate (Al: Zr = 2-6, M: CI = 0.9-1.3), in particular salts having a molar metal-to-chloride ratio of 0.9-1.1, preferably 0 , 9 - 1, 0.
Weiterhin erfindungsgemäß bevorzugt sind Aluminiumzirconiumchlorohydrat-Glycin-Salze, die mit Betain ((CH3)3N+-CH2-COO") stabilisiert sind. Besonders bevorzugte entsprechende Verbindungen weisen ein molares Gesamt-(Betain + Glycin)/Zr-Verhältnis von (0,1 - 3,0) : 1 , bevorzugt (0,7 - 1 ,5) : 1 und ein molares Verhältnis von Betain zu Glycin von mindestens 0,001 : 1 auf. Entsprechende Verbindungen sind beispielsweise offenbart in US 7105691 . In einer besonders bevorzugten erfindungsgemäßen Ausführungsform ist als besonders wirksames Antitranspirant-Salz ein so genanntes„aktiviertes" Salz enthalten, insbesondere eines mit einem hohen HPLC-Peak 5-Aluminium-Gehalt, insbesondere mit einer Peak 5-Fläche von mindestens 33 %, besonders bevorzugt mindestens 45 %, bezogen auf die gesamte Fläche unter den Peaks 2 - 5, gemessen mit HPLC einer 10 Gew.-%igen wässrigen Lösung des Wirkstoffs unter Bedingungen, bei denen die Aluminiumspecies in mindestens 4 aufeinander folgende Peaks aufgelöst werden (mit Peaks 2 - 5 bezeichnet). Bevorzugte Aluminiumzirconiumsalze mit einem hohen HPLC-Peak 5-Aluminium-Gehalt (auch als "E5AZCH" bezeichnet) sind beispielsweise offenbart in US 6436381 und US 6649152. Weiterhin sind solche aktivierten "E5AZCH"-Salze bevorzugt, deren HPLC-Peak 4-zu-Peak 3-Flächenverhältnis von mindestens 0,4, bevorzugt mindestens 0,7, besonders bevorzugt mindestens 0,9, beträgt. Weitere besonders bevorzugte Antitranspirant-Wrkstoffe sind solche Aluminiumzirconiumsalze mit einem hohen HPLC-Peak 5-Aluminium-Gehalt, die zusätzlich mit einem wasserlöslichen Strontiumsalz und/oder mit einem wasserlöslichen Calciumsalz stabilisiert sind. Entsprechende Salze sind beispielsweise in US 6923952 offenbart. Aluminiumzirconiumchlorohydrat-glycine salts formed with Betaine are still preferred in the invention ((CH 3) 3 N + -CH 2 -COO ") are stabilized. Particularly preferred corresponding compounds have a molar overall (Betaine + glycine) / Zr ratio of (0.1-3.0): 1, preferably (0.7-1.5): 1, and a betaine to glycine molar ratio of at least 0.001: 1. Corresponding compounds are disclosed, for example, in US 7105691. In a particularly preferred embodiment according to the invention, the particularly effective antiperspirant salt comprises a so-called "activated" salt, in particular one with a high HPLC peak 5-aluminum content, in particular with a peak 5 surface of at least 33%, particularly preferred at least 45%, based on the total area under peaks 2-5, as measured by HPLC of a 10% by weight aqueous solution of the active substance under conditions in which the aluminum species are resolved into at least 4 consecutive peaks (with peaks 2 - 5). Preferred aluminum zirconium salts having a high HPLC peak 5-aluminum content (also referred to as "E 5 AZCH") are disclosed, for example, in US 6436381 and US 6649152. Further, such activated "E 5 AZCH" salts are preferred, whose HPLC peak has a 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9 Titanium perspirants are those aluminum zirconium salts with a high HPLC peak 5-aluminum content, which are additionally stabilized with a water-soluble strontium salt and / or with a water-soluble calcium salt. Corresponding salts are disclosed, for example, in US Pat. No. 6,923,952.
Besonders bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen Anti- transpirant-Wirkstoff in einer Gesamtmenge von 5 - 40 Gew.-%, bevorzugt 10 - 38 Gew.-% und besonders bevorzugt 13 - 35 Gew.-%, ist, jeweils bezogen auf das Gesamtgewicht der kristallwasserfreien Aktivsubstanz (USP) in der Gesamtzusammensetzung.  Particularly preferred compositions according to the invention contain at least one antiperspirant active ingredient in a total amount of 5 to 40% by weight, preferably 10 to 38% by weight and more preferably 13 to 35% by weight, based in each case on the total weight the anhydrous active substance (USP) in the overall composition.
Als deodorierender Wrkstoff, dessen Wirkung zusammen mit einem der vorstehend genannten schweißhemmenden Wrkstoffe und zusammen mit einer Siliciumoxid-haltigen Verbindung, ausgewählt aus hydrophob modifizierten Kieselsäuren und hydrophob modifizierten Schichtsilikaten, in synergistischer Weise verbessert wird, ist mindestens ein Doppelsalz vom Alaun-Typ mit der allgemeinen Formel MIMI"(S04)2 x H20 enthalten, wobei M1 ein einwertiges Kation, ausgewählt aus Kalium-, Natrium-, Rubidium-, Cäsium- und Ammonium-Ionen, M1" ein dreiwertiges Kation, ausgewählt aus Aluminium-, Gallium-, Indium-, Scandium-, Titan- und Vanadium-Ionen, und x eine rationale Zahl im Bereich von 0 bis 12, einschließlich 0, darstellen. As the deodorant active whose activity is synergistically improved together with one of the above-mentioned antiperspirant active ingredients and together with a silicon oxide-containing compound selected from hydrophobically modified silicic acids and hydrophobically modified layered silicates, at least one alum-type double salt is the general one formula M I M I "(S0 4) 2 x H 2 0 contain, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium ions, M 1" is a trivalent cation, selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represent a rational number in the range of 0 to 12, inclusive 0.
Besonders bevorzugt sind die Doppelsalze mit M1" = Aluminiumion, insbesondere KAI(S04)2, KAI(S04)2 1 H20, KAI(S04)2 2 H20, KAI(S04)2 3 H20, KAI(S04)2 4 H20, KAI(S04)2 5 H20, KAI(S04)2 6 H20, KAI(S04)2 7 H20, KAI(S04)2 8 H20, KAI(S04)2 9 H20, KAI(S04)2 10 H20, KAI(S04)2 11 H20 und KAI(S04)2 12 H20, NH4AI(S04)2, NH4AI(S04)2-1 H20, NH4AI(S04)2-2 H20, NH4AI(S04)2-3 H20, NH4AI(S04)2-4 H20, NH4AI(S04)2-5 H20, NH4AI(S04)2-6 H20, Particularly preferred are the double salts with M 1 "= aluminum ion, in particular KAI (S0 4 ) 2 , KAI (S0 4 ) 2 1 H 2 0, KAI (S0 4 ) 2 2 H 2 0, KAI (S0 4 ) 2 3 H 2 0, KAI (S0 4 ) 2 4 H 2 0, KAI (S0 4 ) 2 5 H 2 0, KAI (S0 4 ) 2 6 H 2 0, KAI (S0 4 ) 2 7 H 2 0, KAI (S0 4 ) 2 8 H 2 0, KAI (S0 4 ) 2 9 H 2 0, KAI (S0 4 ) 2 10 H 2 0, KAI (S0 4 ) 2 11 H 2 0 and KAI (S0 4 ) 2 12 H 2 O, NH 4 Al (S0 4 ) 2 , NH 4 Al (S0 4 ) 2 -1 H 2 0, NH 4 Al (S0 4 ) 2 -2 H 2 0 , NH 4 Al (S0 4 ) 2 -3 H 2 O, NH 4 Al (S0 4 ) 2 -4 H 2 0, NH 4 Al (S0 4 ) 2 -5 H 2 0, NH 4 Al (S0 4 ) 2 -6H 2 0,
NH4AI(S04)2-7 H20, NH4AI(S04)2 8 H20, NH4AI(S04)2 9 H20, NH4AI(S04)2 10 H20, NH 4 Al (SO 4 ) 2 -7 H 2 O, NH 4 Al (SO 4 ) 2 8 H 2 O, NH 4 Al (SO 4 ) 2 9 H 2 O, NH 4 Al (SO 4 ) 2 ■ 10H 2 0,
NH4AI(S04)2 11 H20 und NH4AI(S04)2 12 H20, RbAI(S04)2, RbAI(S04)2 1 H20, NH 4 Al (S0 4 ) 2 11 H 2 O and NH 4 Al (SO 4 ) 2 12 H 2 O, RbAI (SO 4 ) 2 , RbAI (SO 4 ) 2 1 H 2 O,
RbAI(S04)2 2 H20, RbAI(S04)2 3 H20, RbAI(S04)2 4 H20, RbAI(S04)2 5 H20, RBAI (S0 4) 2 2H 2 0, RBAI (S0 4) 2 3 H 2 0, RBAI (S0 4) 2 4 H 2 0, RBAI (S0 4) 2 5 H 2 0,
RbAI(S04)2 6 H20, RbAI(S04)2 7 H20, RbAI(S04)2 8 H20, RbAI(S04)2 9 H20, RBAI (S0 4) 2 6H 2 0, RBAI (S0 4) 2 7H 2 0, RBAI (S0 4) 2 8 H 2 0, RBAI (S0 4) 2 9 H 2 0,
RbAI(S04)2 10 H20, RbAI(S04)2 1 1 HzO und RbAI(S04)2 12 H20, NaAI(S04)2, RbAI (S0 4 ) 2 10 H 2 O, RbAI (S0 4 ) 2 1 1 H z O and RbAI (S0 4 ) 2 12 H 2 O, NaAl (S0 4 ) 2 ,
NaAI(S04)2 1 H20, NaAI(S04)2 2 H20, NaAI(S04)2 3 H20, NaAI(S04)2 4 H20, NaAl (S0 4) 2 1 H 2 0, NaAl (S0 4) 2 2H 2 0, NaAl (S0 4) 2 3 H 2 0, NaAl (S0 4) 2 4 H 2 0,
NaAI(S04)2 5 H20, NaAI(S04)2 6 H20, NaAI(S04)2 7 H20, NaAI(S04)2 8 H20, NaAl (S0 4) 2 5 H 2 0, NaAl (S0 4) 2 6H 2 0, NaAl (S0 4) 2 7H 2 0, NaAl (S0 4) 2 8 H 2 0,
NaAI(SQ4)2 9 H2Q, NaAI(SQ4)2 10 H2Q, NaAI(SQ4)2 11 H2Q und NaAI(SQ4)2 12 H2Q, KSc(S04)2, KSc(S04)2 1 H20, KSc(S04)2 2 H20, KSc(S04)2 3 H20, KSc(S04)2 4 H20, KSc(S04)2 5 H20, KSc(S04)2 6 H20, KSc(S04)2 7 H20, KSc(S04)2 8 H20, KSc(S04)2 9 H20, KSc(S04)2 10 H20, KSc(S04)2 11 HzO und KSc(S04)2 12 H20, NH4Sc(S04)2, NaAl (SQ 4 ) 2 9 H 2 Q, NaAl (SQ 4 ) 2 10 H 2 Q, NaAl (SQ 4 ) 2 11 H 2 Q and NaAl (SQ 4 ) 2 12 H 2 Q, KSc (S0 4 ) 2 , KSc (S0 4 ) 2 1 H 2 0, KSc (S0 4 ) 2 2 H 2 0, KSc (S0 4 ) 2 3 H 2 0, KSc (S0 4 ) 2 4 H 2 0, KSc (S0 4 ) 2 5 H 2 0, KSc (S0 4 ) 2 6 H 2 0, KSc (S0 4 ) 2 7 H 2 0, KSc (S0 4 ) 2 8 H 2 0, KSc (S0 4 ) 2 9 H 2 0, KSc (S0 4 ) 2 10 H 2 0, KSc (S0 4 ) 2 11 H z O and KSc (S0 4 ) 2 12 H 2 0 , NH 4 Sc (SO 4 ) 2 ,
NH4Sc(S04)2 1 H20, NH4Sc(S04)2 2 H20, NH4Sc(S04)2 3 H20, NH4Sc(S04)2 4 H20, NH 4 Sc (SO 4 ) 2 1 H 2 O, NH 4 Sc (SO 4 ) 2 2 H 2 O, NH 4 Sc (SO 4 ) 2 3 H 2 O, NH 4 Sc (SO 4 ) 2 ■ 4H 2 0,
NH4Sc(S04)2 5 H20, NH4Sc(S04)2 6 H20, NH4Sc(S04)2 7 H20, NH4Sc(S04)2 8 H20, NH 4 Sc (S0 4) 2 5 H 2 0, NH 4 Sc (S0 4) 2 6H 2 0, NH 4 Sc (S0 4) 2 7 H 2 0, NH 4 Sc (S0 4) 2 8H 2 0,
NH4Sc(S04)2 9 H20, NH4Sc(S04)2 10 H20, NH4Sc(S04)2 1 1 HzO und NH4Sc(S04)2 12 H20, RbSc(S04)2, RbSc(S04)2 1 H20, RbSc(S04)2 2 H20, RbSc(S04)2 3 H20, RbSc(S04)2 4 H20, RbSc(S04)2 5 H20, RbSc(S04)2 6 H20, RbSc(S04)2 7 H20, RbSc(S04)2 8 H20, NH 4 Sc (SO 4 ) 2 9 H 2 O, NH 4 Sc (SO 4 ) 2 10 H 2 O, NH 4 Sc (SO 4 ) 2 1 1 H z O and NH 4 Sc (S0 4 ) 2 12 H 2 0, RBSC (S0 4) 2, RBSC (S0 4) 2 1 H 2 0, RBSC (S0 4) 2 2H 2 0, RBSC (S0 4) 2 3 H 2 0, RbSc (S0 4 ) 2 4 H 2 O, RbSc (S0 4 ) 2 5 H 2 0, RbSc (S0 4 ) 2 6 H 2 0, RbSc (S0 4 ) 2 7 H 2 0, RbSc S0 4 ) 2 8 H 2 0,
RbSc(S04)2 9 H20, RbSc(S04)2 10 H20, RbSc(S04)2 11 HzO und RbSc(S04)2 12 H20, NaSc(S04)2, NaSc(S04)2 1 H20, NaSc(S04)2 2 H20, NaSc(S04)2 3 H20, NaSc(S04)2 4 H20, NaSc(S04)2 5 H20, NaSc(S04)2 6 H20, NaSc(S04)2 7 H20, NaSc(S04)2 8 H20, RbSc (S0 4 ) 2 9 H 2 O, RbSc (S0 4 ) 2 10 H 2 0, RbSc (S0 4 ) 2 11 H z O and RbSc (S0 4 ) 2 12 H 2 0, NaSc S0 4 ) 2 , NaSc (S0 4 ) 2 1 H 2 0, NaSc (S0 4 ) 2 2 H 2 0, NaSc (S0 4 ) 2 3 H 2 0, NaSc (S0 4 ) 2 4 H 2 0, nasc (S0 4) 2 5 H 2 0, nasc (S0 4) 2 6H 2 0, nasc (S0 4) 2 7H 2 0, nasc (S0 4) 2 8 H 2 0 .
NaSc(S04)2 9 H20, NaSc(S04)2 10 H20, NaSc(S04)2 11 H20 und NaSc(S04)2 12 H20, KGa(S04)2, KGa(S04)2 1 H20, KGa(S04)2 2 H20, KGa(S04)2 3 H20, KGa(S04)2 4 H20, KGa(S04)2 5 H20, KGa(S04)2 6 H20, KGa(S04)2 7 H20, KGa(S04)2 8 H20, Nasc (S0 4) 2 9 H 2 0, nasc (S0 4) 2 10 H 2 0, nasc (S0 4) 2 11 H 2 0 and nasc (S0 4) 2 12 H 2 0, KGa ( S0 4 ) 2 , KGa (S0 4 ) 2 1 H 2 0, KGa (S0 4 ) 2 2 H 2 0, KGa (S0 4 ) 2 3 H 2 0, KGa (S0 4 ) 2 4 H 2 0, KGa (S0 4 ) 2 5 H 2 0, KGa (S0 4 ) 2 6 H 2 0, KGa (S0 4 ) 2 7 H 2 0, KGa (S0 4 ) 2 8 H 2 0 .
KGa(S04)2 9 H20, KGa(S04)2 10 H20, KGa(S04)2 11 H20 und KGa(S04)2 12 H20, KGa (S0 4 ) 2 9 H 2 0, KGa (S0 4 ) 2 10 H 2 0, KGa (S0 4 ) 2 11 H 2 0 and KGa (S0 4 ) 2 12 H 2 0,
NH4Ga(S04)2, NH4Ga(S04)2 1 H20, NH4Ga(S04)2 2 H20, NH4Ga(S04)2 3 H20, NH 4 Ga (SO 4 ) 2 , NH 4 Ga (SO 4 ) 2 1 H 2 O, NH 4 Ga (SO 4 ) 2 2 H 2 O, NH 4 Ga (SO 4 ) 2 3 H 2 0 .
NH4Ga(S04)2 4 H20, NH4Ga(S04)2 5 H20, NH4Ga(S04)2 6 H20, NH4Ga(S04)2 7 H20, NH4Ga(S04)2 8 H20, NH4Ga(S04)2 9 H20, NH4Ga(S04)2 10 H20, NH4Ga(S04)2 11 H20 und NH4Ga(S04)2 12 H20, RbGa(S04)2, RbGa(S04)2 1 H20, RbGa(S04)2 2 H20, NH 4 Ga (SO 4 ) 2 4 H 2 O, NH 4 Ga (SO 4 ) 2 5 H 2 O, NH 4 Ga (SO 4 ) 2 6 H 2 O, NH 4 Ga (SO 4 ) 2 7 H 2 O, NH 4 Ga (SO 4 ) 2 8 H 2 O, NH 4 Ga (SO 4 ) 2 9 H 2 O, NH 4 Ga (SO 4 ) 2 10 H 2 O, NH 4 Ga (SO 4 ) 2 11 H 2 O and NH 4 Ga (SO 4 ) 2 12 H 2 O, RbGa (SO 4 ) 2 , RbGa (SO 4 ) 2 1 H 2 O, RbGa (SO 4 ) 2 ■ 2H 2 0,
RbGa(S04)2 3 H20, RbGa(S04)2 4 H20, RbGa(S04)2 5 H20, RbGa(S04)2 6 H20, RbGa (S0 4 ) 2 3 H 2 0, RbGa (S0 4 ) 2 4 H 2 0, RbGa (S0 4 ) 2 5 H 2 0, RbGa (S0 4 ) 2 6 H 2 0,
RbGa(S04)2 7 H20, RbGa(S04)2 8 H20, RbGa(S04)2 9 H20, RbGa(S04)2 10 H20, RbGa (S0 4 ) 2 7 H 2 0, RbGa (S0 4 ) 2 8 H 2 0, RbGa (S0 4 ) 2 9 H 2 0, RbGa (S0 4 ) 2 10 H 2 0,
RbGa(S04)2 11 H20 und RbGa(S04)2 12 H20, NaGa(S04)2, NaGa(S04)2 1 H20, RbGa (S0 4 ) 2 11 H 2 0 and RbGa (S0 4 ) 2 12 H 2 0, NaGa (S0 4 ) 2 , NaGa (S0 4 ) 2 1 H 2 0,
NaGa(S04)2 2 H20, NaGa(S04)2 3 H20, NaGa(S04)2 4 H20, NaGa(S04)2 5 H20, NaGa (S0 4) 2 2H 2 0, NaGa (S0 4) 2 3 H 2 0, NaGa (S0 4) 2 4 H 2 0, NaGa (S0 4) 2 5 H 2 0,
NaGa(S04)2 6 H20, NaGa(S04)2 7 H20, NaGa(S04)2 8 H20, NaGa(S04)2 9 H20, NaGa (S0 4) 2 6H 2 0, NaGa (S0 4) 2 7H 2 0, NaGa (S0 4) 2 8 H 2 0, NaGa (S0 4) 2 9 H 2 0,
NaGa(S04)2 10 H20, NaGa(S04)2 1 1 H20 und NaGa(S04)2 12 H20, KTi(S04)2, NaGa (S0 4 ) 2 10 H 2 O, NaGa (S0 4 ) 2 1 1 H 2 0 and NaGa (S0 4 ) 2 12 H 2 0, KTi (S0 4 ) 2 ,
KTi(S04)2 1 H20, KTi(S04)2 2 H20, KTi(S04)2 3 H20, KTi(S04)2 4 H20, KTi(S04)2 5 H20, KTi(S04)2 6 H20, KTi(S04)2 7 H20, KTi(S04)2 8 H20, KTi(S04)2 9 H20, KTi(S04)2 10 H20, KTi(S04)2 11 H20 und KTi(S04)2 12 H20, NH4Ti(S04)2, NH4Ti(S04)2 1 H20, NH4Ti(S04)2-2 H20, NH4Ti(S04)2 3 H20, NH4Ti(S04)2 4 H20, NH4Ti(S04)2 5 H20, NH4Ti(S04)2 6 H20, KTi (S0 4 ) 2 1 H 2 0, KTi (S0 4 ) 2 2 H 2 0, KTi (S0 4 ) 2 3 H 2 0, KTi (S0 4 ) 2 4 H 2 0, KTi ( S0 4 ) 2 5 H 2 0, KTi (S0 4 ) 2 6 H 2 0, KTi (S0 4 ) 2 7 H 2 0, KTi (S0 4 ) 2 8 H 2 0, KTi (S0 4 ) 2 9 H 2 0, KTi (S0 4 ) 2 10 H 2 0, KTi (S0 4 ) 2 11 H 2 0 and KTi (S0 4 ) 2 12 H 2 0, NH 4 Ti (S0 4 ) 2 , NH 4 Ti (SO 4 ) 2 1 H 2 O, NH 4 Ti (SO 4 ) 2 -2 H 2 O, NH 4 Ti (SO 4 ) 2 3 H 2 0, NH 4 Ti (S0 4 ) 2 4 H 2 O, NH 4 Ti (SO 4 ) 2 5 H 2 O, NH 4 Ti (SO 4 ) 2 6 H 2 O,
NH4Ti(S04)2 7 H20, NH4Ti(S04)2 8 H20, NH4Ti(S04)2 9 H20, NH4Ti(S04)2 10 H20, NH 4 Ti (S0 4) 2 7 H 2 0, NH 4 Ti (S0 4) 2 8 H 2 0, NH 4 Ti (S0 4) 2 9 H 2 0, NH 4 Ti (S0 4) 2 ■ 10H 2 0,
NH4Ti(S04)2 1 1 H20 und NH4Ti(S04)2 12 H20, RbTi(S04)2, RbTi(S04)2 1 H20, NH 4 Ti (SO 4 ) 2 1 1 H 2 O and NH 4 Ti (SO 4 ) 2 12 H 2 O, RbTi (SO 4 ) 2 , RbTi (SO 4 ) 2 1 H 2 O,
RbTi(S04)2 2 H20, RbTi(S04)2 3 H20, RbTi(S04)2 4 H20, RbTi(S04)2 5 H20, RbTi (S0 4 ) 2 2 H 2 0, RbTi (S0 4 ) 2 3 H 2 0, RbTi (S0 4 ) 2 4 H 2 0, RbTi (S0 4 ) 2 5 H 2 0,
RbTi(S04)2 6 H20, RbTi(S04)2 7 H20, RbTi(S04)2 8 H20, RbTi(S04)2 9 H20, RbTi (S0 4 ) 2 6 H 2 0, RbTi (S0 4 ) 2 7 H 2 0, RbTi (S0 4 ) 2 8 H 2 0, RbTi (S0 4 ) 2 9 H 2 0,
RbTi(S04)2 10 H20, RbTi(S04)2 11 H20 und RbTi(S04)2 12 H20, NaTi(S04)2, RbTi (S0 4 ) 2 10 H 2 0, RbTi (S0 4 ) 2 11 H 2 0 and RbTi (S0 4 ) 2 12 H 2 0, NaTi (S0 4 ) 2 ,
NaTi(S04)2 1 H20, NaTi(S04)2 2 H20, NaTi(S04)2 3 H20, NaTi(S04)2 4 H20, NaTi (S0 4) 2 1 H 2 0, NaTi (S0 4) 2 2H 2 0, NaTi (S0 4) 2 3 H 2 0, NaTi (S0 4) 2 4 H 2 0,
NaTi(S04)2 5 H20, NaTi(S04)2 6 H20, NaTi(S04)2 7 H20, NaTi(S04)2 8 H20, NaTi (S0 4) 2 5 H 2 0, NaTi (S0 4) 2 6H 2 0, NaTi (S0 4) 2 7H 2 0, NaTi (S0 4) 2 8 H 2 0,
NaTi(SQ4)2 9 H2Q, NaTi(SQ4)2 10 H2Q, NaTi(SQ4)2 11 H2Q und NaTi(SQ4)2 12 H20. Besonders bevorzugt sind KAI(S04)2, KAI(S04)2 1 H20, KAI(S04)2 2 H20, KAI(S04)2 3 H20, KAI(S04)2 4 H20, KAI(S04)2 5 H20, KAI(S04)2 6 H20, KAI(S04)2 7 H20, KAI(S04)2 8 H20, KAI(S04)2 9 H20, KAI(S04)2 10 H20, KAI(S04)2 11 HzO und KAI(S04)2 12 H20. NaTi (SQ 4 ) 2 9 H 2 Q, NaTi (SQ 4 ) 2 10 H 2 Q, NaTi (SQ 4 ) 2 11 H 2 Q and NaTi (SQ 4 ) 2 12 H 2 0. Particularly preferred are KAI (S0 4 ) 2 , KAI (S0 4 ) 2 1 H 2 0, KAI (S0 4 ) 2 2 H 2 0, KAI (S0 4 ) 2 3 H 2 0, KAI (S0 4 ) 2 4 H 2 0, KAI (S0 4 ) 2 5 H 2 0, KAI (S0 4 ) 2 6 H 2 0, KAI (S0 4 ) 2 7 H 2 0, KAI (S0 4 ) 2 8 H 2 0, KAI (S0 4 ) 2 9 H 2 0, KAI (S0 4 ) 2 10 H 2 0, KAI (S0 4 ) 2 11 H z O and KAI (S0 4 ) 2 12 H 2 0.
Die Salze mit einem Kristallwassergehalt von weniger als 12 Molekülen pro Molekül Alaun entstehen beim Erhitzen von Alaun. Ab einer Temperatur von etwa 60 °C entweichen bereits bis zu 25 % des Kristallwassers, bevorzugte Temperaturen für eine weitere Entwässerung sind 500°C oder weniger, bevorzugt 300°C oder weniger, weiter bevorzugt 250°C oder weniger, besonders bevorzugt 200°C oder weniger, außerordentlich bevorzugt 90 - 150°C. Vollständig entwässerte Alaune (auch als gebrannter Alaun bezeichnet) oder teilweise entwässerte Alaune lassen sich, zumindest in höheren Konzentrationen, besser dispergieren als Alaune mit einem Kristallwassergehalt von weniger als 12 Molekülen pro Molekül. Nach Abschluss des Entwässerungsprozesses bis zum gewünschten Kristallwassergehalt wird der Alaun durch Mahlen oder andere Zerkleinerungs- und Sichtungsprozesse auf die gewünschte Teilchengröße gebracht. Für die erfindungsgemäßen Zusammensetzungen sind Alaunpartikel geeignet, die eine zahlenmittlere Partikelgröße von 0,1 - 150 μηι, bevorzugt 1 - 80 μηι, besonders bevorzugt 5 - 60 μηι und außerordentlich bevorzugt 10 - 30 μηι, aufweisen. Erfindungsgemäß bevorzugt sind nicht-entwässerte Alaune, also Doppelsalze vom Alaun-Typ b) mit der allgemeinen Formel M'M"'(S04)2 x H20 mit x = 12. Besonders bevorzugte erfindungsgemäße Zusammensetzungen enthalten als Doppelsalz vom Alaun-Typ b) das KAI(S04)2 12 H20. Die genannten Mengen und Kristallwassergehalte beziehen sich auf den bei der Herstellung der erfindungsgemäßen Zusammensetzungen eingesetzten Rohstoff. Da die erfindungsgemäßen Zusammensetzungen ÖI-in-Wasser-Emulsionen sind, liegen die Doppelsalze in der wässrigen Phase gelöst vor und haben damit im Produkt keinen Kristallwassergehalt, sondern sind dissoziiert. Salts with a water content of less than 12 molecules per molecule of alum are produced by heating alum. From a temperature of about 60 ° C up to 25% of the water of crystallization already escape, preferred temperatures for further dewatering are 500 ° C or less, preferably 300 ° C or less, more preferably 250 ° C or less, most preferably 200 ° C or less, most preferably 90-150 ° C. Completely dewatered alum (also known as burned alum) or partially dewatered alum can be better dispersed, at least in higher concentrations, than alums having a water content of less than 12 molecules per molecule. After completion of the dewatering process to the desired level of water of crystallization, the alum is brought to the desired particle size by milling or other crushing and screening processes. Alum particles suitable for the compositions according to the invention are those which have a number-average particle size of 0.1-150 μm, preferably 1-80 μm, particularly preferably 5-60 μm and extraordinarily preferably 10-30 μm. According to the invention preferably are non-dewatered alums, that double salts of the alum type b) having the general formula M'M '' (S0 4) 2 x H contain 2 0 with x = 12. Particularly preferred compositions according to the invention as a double salt of alum Type b) KAl (SO 4 ) 2 .12H 2 O. The amounts mentioned and the contents of water of crystallization relate to the raw material used in the preparation of the compositions according to the invention, since the compositions according to the invention are oil-in-water emulsions, the double salts are present dissolved in the aqueous phase before and thus have no crystal water content in the product, but are dissociated.
Weitere bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens ein Doppelsalz vom Alaun-Typ mit der allgemeinen Formel M'M"'(S04)2 x H20, wobei M1 ein einwertiges Kation, ausgewählt aus Kalium-, Natrium-, Rubidium-, Cäsium- und Ammonium-Ionen, darstellt, M1" ein dreiwertiges Kation, ausgewählt aus Aluminium-, Gallium-, Indium-, Scandium-, Titan- und Vanadium-Ionen, darstellt und x eine rationale Zahl im Bereich von 0 bis 12, einschließlich 0, bevorzugt 12, darstellt, in einer Gesamtmenge von 0,01 - 10 Gew.-%, bevorzugt 0,05 - 5 Gew.-%, besonders bevorzugt 0,1 - 2 Gew.-%, außerordentlich bevorzugt 0,3 - 1 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Further preferred compositions of the invention contain at least one double salt of the alum type having the general formula M'M '' (S0 4) 2 x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, Cesium and ammonium ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, including 0, preferably 12, represents, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 to 2 wt .-%, most preferably 0.3 - 1 wt .-%, each based on the total weight of the composition according to the invention.
Weitere bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens ein Doppelsalz vom Alaun-Typ b), ausgewählt ist aus KAI(S04)2, KAI(S04)2 1 H20, KAI(S04)2 2 H20, KAI(S04)2 3 H20, KAI(S04)2 4 H20, KAI(S04)2 5 H20, KAI(S04)2 6 H20, KAI(S04)2 7 H20, KAI(S04)2 8 H20, KAI(S04)2 9 H20, KAI(S04)2 10 H20, KAI(S04)2 11 HzO und KAI(S04)2 12 H20, sowie Mischungen hiervon, in einer Gesamtmenge von 0,01 - 10 Gew.-%, bevorzugt 0,05 - 5 Gew.-%, besonders bevorzugt 0,1 - 2 Gew.-%, außerordentlich bevorzugt 0,3 - 1 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Besonders bevorzugte erfindungsgemäße Zusammensetzungen enthalten KAI(S04)2 12 H20 in einer Gesamtmenge von 0,01 - 10 Gew.-%, bevorzugt 0,05 - 5 Gew.-%, besonders bevorzugt 0,1Further preferred compositions of the invention contain at least one double salt of the alum type b), is selected (from KAI S0 4) 2, KAI (S0 4) 2 1 H 2 0, KAI (S0 4) 2 2H 2 0, KAI (S0 4 ) 2 3 H 2 0, KAI (S0 4 ) 2 4 H 2 0, KAI (S0 4 ) 2 5 H 2 0, KAI (S0 4 ) 2 6 H 2 0, KAI (S0 4 ) 2 7 H 2 0, KAI (S0 4 ) 2 8 H 2 0, KAI (S0 4 ) 2 9 H 2 0, KAI (S0 4 ) 2 10 H 2 0, KAI (S0 4 ) 2 11 H z O and KAI (S0 4 ) 2 12 H 2 O, and mixtures thereof, in a total amount of 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 - 2 wt .-%, exceptionally preferably 0.3 - 1 wt .-%, each based on the total weight of the composition according to the invention. Particularly preferred compositions of the invention contain KAI (S0 4) 2 12 H 2 0 in a total amount from 0.01 to 10 wt .-%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1
- 2 Gew.-%, außerordentlich bevorzugt 0,3 - 1 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. - 2 wt .-%, most preferably 0.3 to 1 wt .-%, each based on the total weight of the composition according to the invention.
Zur Verbesserung der schweißhemmenden und deodorierenden Wirkung der Kombination aus Alu- miniumchlorhydroxiden und Aluminiumzirconiumchlorhydraten enthalten die erfindungsgemäßen Zusammensetzungen 0,0005 - 1 Gew.-%, bezogen auf die gesamte Zusammensetzung, mindestens einer Siliciumoxid-haltigen Verbindung, ausgewählt aus hydrophilen Kieselsäuren und/oder hydrophob modifizierten Kieselsäuren und/oder Schichtsilikaten.  To improve the antiperspirant and deodorant action of the combination of aluminum chlorhydroxides and aluminum zirconium chlorohydrates, the compositions according to the invention contain from 0.0005 to 1% by weight, based on the total composition, of at least one silicon oxide-containing compound selected from hydrophilic silicic acids and / or hydrophobic modified silicic acids and / or phyllosilicates.
Bevorzugte hydrophobierte Schichtsilikate sind ausgewählt aus hydrophobierten Montmorilloniten, hydrophobierten Hectoriten und hydrophobierten Bentoniten, besonders bevorzugt aus Disteardi- monium Hectorite, Stearalkonium Hectorite, Quaternium-18 Hectorite und Quaternium-18 Bento- nite. Bevorzugt werden diese hydrophobierten Schichtsilikate in Form eines Gels in einer Ölkompo- nente, bevorzugt in Cyclomethicone und/oder einer Nichtsilicon-Ölkomponente, wie z. B. Propylen- carbonat, bereitgestellt. Die Gelbildung erfolgt durch den Zusatz geringer Mengen an Aktivatoren, wie insbesondere Ethanol oder Propylencarbonat, aber auch Wasser. Derartige Gele sind beispielsweise unter der Handelsbezeichnung Bentone® oder Thixogel erhältlich. Bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen Aktivator in einer Gesamtmenge von 0,1 - 3 Gew.-%, bevorzugt 0,3 - 2,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Weitere bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen Aktivator, ausgewählt aus Ethanol, Propylencarbonat und Wasser sowie Mischungen hiervon, in einer Gesamtmenge von 0,1 - 3 Gew.-%, bevorzugt 0,3 - 2,0 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Erfindungsgemäß bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens ein hydrophobiertes Schichtsilikat in einer Gesamtmenge von 0,1 - 1 Gew.-%, bevorzugt 0,2Preferred hydrophobicized phyllosilicates are selected from hydrophobized montmorillonites, hydrophobized hectorites and hydrophobized bentonites, more preferably distearonium hectorites, stearalkonium hectorites, quaternium-18 hectorites and quaternium-18 bentonites. These hydrophobicized phyllosilicates are preferred in the form of a gel in an oil component, preferably in cyclomethicones and / or a non-silicone oil component, such as. For example, propylene carbonate. The gelation takes place by the addition of small amounts of activators, in particular ethanol or propylene carbonate, but also water. Such gels are for example available under the trade name Bentone ® or Thixogel. Preferred compositions according to the invention comprise at least one activator in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, in each case based on the total weight of the composition according to the invention. Further preferred compositions according to the invention comprise at least one activator selected from ethanol, propylene carbonate and water and mixtures thereof, in a total amount of 0.1-3% by weight, preferably 0.3-2.0% by weight, based in each case on the total weight of the composition of the invention. Compositions which are preferred according to the invention are characterized in that they contain at least one hydrophobized phyllosilicate in a total amount of 0.1-1% by weight, preferably 0.2
- 0,8 Gew.-%, besonders bevorzugt 0,3 - 0,5 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung, enthalten. - 0.8 wt .-%, particularly preferably 0.3 to 0.5 wt .-%, each based on the total weight of the composition according to the invention, included.
Erfindungsgemäß bevorzugte hydrophob modifizierte Kieselsäuren sind ausgewählt aus hydrophob modifizierten pyrogenen Kieselsäuren, z. B. den Handelsprodukten der Aerosil®-Serie von Evonik Degussa, besonders bevorzugt Silica Silylate und Silica Dimethyl Silylate. Hydrophobically modified silicas which are preferred according to the invention are selected from hydrophobically modified pyrogenic silicic acids, eg. As the commercial products of Aerosil ® series from Evonik Degussa, particularly preferably silica silylate, and silica dimethyl silylate.
Erfindungsgemäß bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass sie mindestens eine hydrophob modifizierte Kieselsäure, bevorzugt mindestens eine hydrophob modifizierte pyrogene Kieselsäure, in einer Gesamtmenge 0,1 - 1 Gew.-%, bevorzugt 0,2 - 0,8 Gew.-%, besonders bevorzugt 0,3 - 0,5 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung, enthalten.  Preferred compositions according to the invention are characterized in that they contain at least one hydrophobically modified silica, preferably at least one hydrophobically modified fumed silica, in a total amount of 0.1-1% by weight, preferably 0.2-0.8% by weight, especially preferably 0.3 to 0.5 wt .-%, each based on the total weight of the composition according to the invention.
Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten mindestens eine hydrophobierte pyrogene Kieselsäure und mindestens eine hydrophile Kieselsäure.  Further compositions preferred according to the invention comprise at least one hydrophobized fumed silica and at least one hydrophilic silica.
Erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind ausgewählt aus Siliciumdioxid, das nicht organisch oder anorganisch modifiziert ist und keine organische oder anorganische Beschich- tung aufweist. Das vorgenannte Merkmal„keine organische oder anorganische Beschichtung", bezieht sich erfindungsgemäß auf den Zustand des hydrophilen Siliciumdioxids, bevor es mit den übrigen Bestandteilen der erfindungsgemäßen Zusammensetzungen vermischt wird. Nach dem Vermischen ist es durchaus möglich, dass einzelne Rezepturbestandteile an der Oberfläche des hydrophilen Siliciumdioxids sorbiert sind; das Merkmal „keine organische oder anorganische Beschichtung" bleibt davon unbenommen. Auch möglicherweise sorbierte Gase gelten erfindungsgemäß nicht als Beschichtung. Erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind durch Fällung erhältlich. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren umfassen, bezogen auf das Gewicht der hydrophilen Kieselsäure, zu mindestens 80 Gew.-% sphärische Siliciumdioxid-Partikel. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren umfassen, bezogen auf das Gewicht der hydrophilen Kieselsäure, zu mindestens 80 Gew.-% Siliciumdioxid- Partikel mit einem zahlenmittleren Partikeldurchmesser im Bereich von 2 - 15 μηι, besonders bevorzugt im Bereich von 5 - 10 μηι. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren umfassen, bezogen auf das Gewicht der hydrophilen Kieselsäure, zu mindestens 80 Gew.- % Siliciumdioxid-Partikel mit einer Ölabsorptionskapazität von 0,7 - 1 ,5 cm3 flüssiges Paraffin pro Gramm trockenes Siliciumdioxid, gemessen nach DIN 53601 . Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind durch Fällung erhältlich und umfassen zu mehr als 80 Gew.-% sphärische Siliciumdioxid-Partikel. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind durch Fällung erhältlich und umfassen zu mehr als 80 Gew.-% Siliciumdioxid- Partikel mit einem zahlenmittleren Partikeldurchmesser im Bereich von 2 - 15 μηι, besonders bevorzugt im Bereich von 5 - 10 μηι. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind durch Fällung erhältlich und umfassen zu mehr als 80 Gew.-% sphärische Siliciumdioxid-Partikel mit einem zahlenmittleren Partikeldurchmesser im Bereich von 2 - 15 μηι, besonders bevorzugt im Bereich von 5 - 10 μηι. Weitere erfindungsgemäß bevorzugte hydrophile Kieselsäuren sind pyrogen, also nicht durch Fällung erhältlich. Bevorzugte hydrophile Kieselsäuren sind als Handelsprodukt SB-705 der Firma Miyoshi Kasei, erhältlich, ein sphärisches Kieselgel bzw. sphärische Siliciumdioxid-Partikel mit der INCI-Bezeichnung Silica, das einen zahlenmittleren Teilchendurchmesser von 5 - 6 μηι und eine spezifische Oberfläche von etwa 600 m2/g aufweist. Weitere bevorzugte hydrophile Kieselsäuren sind als Handelsprodukt Aerosil von Evonik Degussa erhältlich, beispielsweise Aerosil 130, Aerosil 200, Aerosil 255, Aerosil 300 oder Aerosil 380. Weitere bevorzugte hydrophile Kieselsäuren sind ebenfalls als Handelsprodukte erhältlich: CAB-O- SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB-O-SIL M-5 (Cabot), Cosmedia Silc (Cognis), Neosil PC 50 S (Ineos Silicas), Sorbosil BFG 54 (Ineos Silicas), Sorbosil AC33 (Ineos Silicas), Sorbosil AC 35 (Ineos Silicas), Sorbosil AC 37 (Ineos Silicas), Sorbosil AC 39 (Ineos Silicas), Wacker HDK N 20 (Wacker-Chemie), Wacker HDK S 13 (Wacker-Chemie), Wacker HDK T 30 (Wacker-Chemie), Wacker HDK V 15 (Wacker-Chemie). Hydrophilic silicas which are preferred according to the invention are selected from silicon dioxide which is not modified organically or inorganically and which does not contain any organic or inorganic coating. has direction. According to the invention, the above-mentioned feature "no organic or inorganic coating" refers to the state of the hydrophilic silica before it is mixed with the other constituents of the compositions according to the invention After mixing it is quite possible for individual constituents of the formulation to be present on the surface of the hydrophilic silica sorbed, the feature "no organic or inorganic coating" remains unaffected. Also possibly sorbed gases do not apply according to the invention as a coating. Hydrophilic silicas which are preferred according to the invention are obtainable by precipitation. Further hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of spherical silica particles. Further hydrophilic silicas which are preferred according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silicon dioxide particles having a number-average particle diameter in the range from 2 to 15 μm, particularly preferably in the range from 5 to 10 μm. Further preferred hydrophilic silicas according to the invention comprise, based on the weight of the hydrophilic silica, at least 80% by weight of silica particles having an oil absorption capacity of 0.7-1.5 cm 3 of liquid paraffin per gram of dry silicon dioxide, measured to DIN 53601. Further hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles. Further inventively preferred hydrophilic silicas are obtainable by precipitation and comprise more than 80 wt .-% silica particles having a number average particle diameter in the range of 2-15 μηι, more preferably in the range of 5-10 μηι. Further hydrophilic silicas which are preferred according to the invention are obtainable by precipitation and comprise more than 80% by weight of spherical silica particles having a number-average particle diameter in the range from 2 to 15 μm, particularly preferably in the range from 5 to 10 μm. Further inventively preferred hydrophilic silicas are pyrogenic, so not available by precipitation. Preferred hydrophilic silicic acids are available as commercial product SB-705 from Miyoshi Kasei, a spherical silica gel or spherical silica particles with the INCI name Silica having a number-average particle diameter of 5 to 6 μm and a specific surface area of about 600 m 2 / g. Further preferred hydrophilic silicic acids are available as a commercial product Aerosil from Evonik Degussa, for example Aerosil 130, Aerosil 200, Aerosil 255, Aerosil 300 or Aerosil 380. Further preferred hydrophilic silicas are also available as commercial products: CAB-O-SIL Fumed Silica (Cabot), CAB-O-SIL EH-5 (Cabot), CAB-O-SIL HS-5 (Cabot), CAB-O-SIL LM-130 (Cabot), CAB-O-SIL MS-55 (Cabot), CAB- O-SIL M-5 (Cabot), Cosmedia Silc (Cognis), Neosil PC 50S (Ineos Silica), Sorbosil BFG 54 (Ineos Silica), Sorbosil AC33 (Ineos Silica), Sorbosil AC 35 (Ineos Silica), Sorbosil AC 37 (Ineos Silicas), Sorbosil AC 39 (Ineos Silica), Wacker HDK N 20 (Wacker chemistry), Wacker HDK S 13 (Wacker chemistry), Wacker HDK T 30 (Wacker chemistry), Wacker HDK V 15 (Wacker -Chemistry).
Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten mindestens eine hydrophile Kieselsäure in einer Gesamtmenge von 0,0005 - 1 Gew.-%, bevorzugt 0,001 - 0,5 Gew.-%, besonders bevorzugt 0,01 - 0,4 Gew.-%, außerordentlich bevorzugt 0,05 - 0,3 Gew.-% und weiter bevorzugt 0,1 - 0,2 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung. Further compositions preferred according to the invention comprise at least one hydrophilic silica in a total amount of 0.0005-1% by weight, preferably 0.001-0.5% by weight, particularly preferably 0.01-0.4% by weight, even more preferably 0.05-0.3% by weight and more preferably 0.1-0.2% by weight, based in each case on the entire composition.
Die erfindungsgemäßen Antitranspirant-Emulsionen, konfektioniert als Creme, Gel oder Lösung, enthalten neben den schweißreduzierenden Wirkstoffen mindestens ein kosmetisches Öl. The antiperspirant emulsions according to the invention, formulated as a cream, gel or solution, contain, in addition to the perspiration-reducing active ingredients, at least one cosmetic oil.
Unter„Lösung" wird im Sinne der vorliegenden Anmeldung eine wasserdünne Flüssigkeit mit einer Viskosität von 0,1 - 900 mPas, gemessen unter den unten genannten Bedingungen, verstanden. Bei den kosmetischen Ölen unterscheidet man flüchtige und nicht-flüchtige Öle. Unter nicht- flüchtigen Ölen versteht man im Sinne der vorliegenden Anmeldung solche Öle, die bei 20 °C und einem Umgebungsdruck von 1013 hPa einen Dampfdruck von weniger als 2,66 Pa (0,02 mm Hg) aufweisen. Unter flüchtigen Ölen versteht man im Sinne der vorliegenden Anmeldung solche Öle, die bei 20 °C und einem Umgebungsdruck von 1013 hPa einen Dampfdruck von 2,66 Pa - 40000 Pa (0,02 mm - 300 mm Hg), bevorzugt 13 - 12000 Pa (0,1 - 90 mm Hg), besonders bevorzugt 15 - 8000 Pa, außerordentlich bevorzugt 300 - 3000 Pa, aufweisen. For the purposes of the present application, "solution" is understood as meaning a water-thin liquid having a viscosity of 0.1-900 mPas, measured under the conditions specified below.For cosmetic oils, a distinction is made between volatile and non-volatile oils For the purposes of the present application, oils are understood as meaning oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa. Volatile oils are understood in the context of the present application those oils which, at 20 ° C and an ambient pressure of 1013 hPa, have a vapor pressure of 2,66 Pa - 40,000 Pa (0,02 mm - 300 mm Hg), preferably 13 - 12000 Pa (0,1 - 90 mm Hg), more preferably 15-8000 Pa, most preferably 300-3000 Pa.
Erfindungsgemäß bevorzugte kosmetische Öle sind ausgewählt aus Siliconölen, zu denen z. B. Dialkyl- und Alkylarylsiloxane, wie beispielsweise Cyclopentasiloxan, Cyclohexasiloxan, Dimethyl- polysiloxan, niedermolekulares Phenyl Trimethicone und Methylphenylpolysiloxan, aber auch Hexamethyldisiloxan, Octamethyltrisiloxan und Decamethyltetrasiloxan zählen. Besonders bevorzugt sind flüchtige Siliconöle, die cyclisch sein können, wie z. B. Octamethylcyclotetrasiloxan, Decamethylcyclopentasiloxan und Dodecamethylcyclohexasiloxan sowie Mischungen hiervon, wie sie z. B. in den Handelsprodukten DC 244, 245, 344 und 345 von Dow Corning (Dampfdruck bei 20°C ca. 13 - 15 Pa) enthalten sind. Ebenfalls besonders bevorzugt sind flüchtige lineare Siliconöle mit 2 - 10 Siloxaneinheiten, insbesondere Hexamethyldisiloxan (L2), Octamethyltrisiloxan (L3), Decamethyltetrasiloxan (L4) sowie beliebige Zweier- und Dreiermischungen aus L2, L3 und/oder L4, bevorzugt solche Mischungen, wie sie z. B. in den Handelsprodukten Dow Corning® 2- 1 184, Dow Corning® 200 (0,65 cSt) und Dow Corning® 200 (1 ,5 cSt) von Dow Corning enthalten sind. Ein weiteres bevorzugtes flüchtiges Siliconöl ist ein niedermolekulares Phenyl Trimethicone mit einem Dampfdruck bei 20°C von etwa 2000 Pa, wie es beispielsweise von GE Bayer Silicones/Momentive unter der Bezeichnung Baysilone Fluid PD 5 erhältlich ist. Cosmetic oils preferred according to the invention are selected from silicone oils, to which z. As dialkyl and alkylaryl, such as cyclopentasiloxane, cyclohexasiloxane, dimethyl polysiloxane, low molecular weight phenyl trimethicone and Methylphenylpolysiloxan, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane. Particularly preferred are volatile silicone oils, which may be cyclic, such as. For example, octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane and dodecamethylcyclohexasiloxane and mixtures thereof, as described for. B. in the commercial products DC 244, 245, 344 and 345 of Dow Corning (vapor pressure at 20 ° C about 13 - 15 Pa) are included. Also particularly preferred are volatile linear silicone oils having 2 to 10 siloxane units, in particular hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ) and any mixtures of two and three of L 2 , L 3 and / or L 4 such mixtures, as they are for. In the commercial products Dow Corning® 2-1 184, Dow Corning® 200 (0.65 cSt) and Dow Corning® 200 (1.5 cSt) from Dow Corning. Another preferred volatile silicone oil is a low molecular weight phenyl trimethicone having a vapor pressure at 20 ° C of about 2000 Pa as available, for example, from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
Flüchtige Siliconöle sind hervorragend geeignete Trägeröle für erfindungsgemäß bevorzugte Antitranspirant-Zusammensetzungen, da sie ihnen ein angenehmes Hautgefühl und eine geringe Kleideranschmutzung verleihen. Erfindungsgemäß besonders bevorzugte Antitranspirant-Zusam- mensetzungen sind daher durch einen Gehalt an mindestens einem flüchtigen Siliconöl von 30 - 95 Gew.-%, bevorzugt 40 - 93 Gew.-%, besonders bevorzugt 50 - 90 Gew.-%, außerordentlich bevorzugt 55 - 85 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, gekennzeichnet. Neben oder an Stelle des mindestens einen flüchtigen Siliconöls kann auch mindestens ein flüchtiges Nichtsiliconöl enthalten sein. Bevorzugte flüchtige Nichtsiliconöle sind ausgewählt aus C8-C 6- Isoparaffinen, insbesondere aus Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, und Isohexadecan, sowie Mischungen hiervon. Bevorzugt sind C 0-C 3-Isoparaffin- Mischungen, insbesondere solche mit einem Dampfdruck bei 20°C von etwa 300 - 400 Pa, bevor- zugt 360 Pa. Auch dieses mindestens eine flüchtige Nichtsiliconöl ist bevorzugt in einer Gesamtmenge von 30 - 95 Gew.-%, bevorzugt 40 - 93 Gew.-%, besonders bevorzugt 50 - 90 Gew.-%, außerordentlich bevorzugt 55 - 85 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten. Volatile silicone oils are excellently suitable carrier oils for antiperspirant compositions which are preferred according to the invention, since they give them a pleasant feel on the skin and a low level of clothes soiling. Antiperspirant compositions which are particularly preferred according to the invention are therefore based on a content of at least one volatile silicone oil of 30-95% by weight, preferably 40-93% by weight, particularly preferably 50-90% by weight, very preferably 55%. 85 wt .-%, each based on the total composition characterized. In addition to or instead of the at least one volatile silicone oil, at least one volatile non-silicone oil may also be present. Preferred volatile non-silicone oils are selected from C 8 -C 6 isoparaffins, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, and isohexadecane, and mixtures thereof. Preference is given to C 0 -C 3 isoparaffine mixtures, in particular those having a vapor pressure at 20 ° C. of about 300-400 Pa, preferably given to 360 Pa. This at least one volatile non-silicone oil is also preferably in a total amount of 30-95% by weight, preferably 40-93% by weight, more preferably 50-90% by weight, most preferably 55-85% by weight, in each case based on the total composition.
Aufgrund des trockeneren Hautgefühls und der schnelleren Wirkstofffreisetzung sind als Trägeröl flüchtige Siliconöle, Isoparaffine, insbesondere Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan und Isoeicosan, sowie Mischungen von flüchtigen Siliconölen und Isoparaffinen, insbesondere Isododecan, Isohexadecan oder Isoeicosan, besonders bevorzugt. Besonders bevorzugte Isoparaffine sind ausgewählt aus Isodecan, Isoundecan, Isododecan, Isotridecan, sowie Mischungen von Isodecan, Isoundecan, Isododecan und/oder Isotridecan.  Because of the drier skin feel and the faster release of the active ingredient, volatile silicone oils, isoparaffins, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, and mixtures of volatile silicone oils and isoparaffins, in particular isododecane, isohexadecane or isoeicosane, are particularly preferred , Particularly preferred isoparaffins are selected from isodecane, isoundecane, isododecane, isotridecane, and mixtures of isodecane, isoundecane, isododecane and / or isotridecane.
Erfindungsgemäß bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass das mindestens eine unter Normalbedingungen flüssige Träger-Öl e) mindestens ein Isoparaffinöl, insbesondere Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan und Isoeicosan, besonders bevorzugt Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan sowie Mischungen von Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan und/oder Isohexadecan, umfasst.  Compositions which are preferred according to the invention are characterized in that the at least one carrier oil under normal conditions e) at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, particularly preferably isodecane, isoundecane, isododecane, isotridecane, Isotetradecane, isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexadecane.
Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten als unter Normalbedingungen flüssiges Träger-Öl e) eine Mischung aus e)i) einem flüchtigen Siliconöl, ausgewählt aus Cyclomethicone und linearen Polydimethylsiloxanen mit 2 - 10 Siloxaneinheiten, und e)ii) mindestens einem Isoparaffinöl, insbesondere Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan und Isoeicosan, besonders bevorzugt Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan sowie Mischungen von Isodecan, Isoundecan, Isododecan, Isotridecan, Isotetradecan, Isopentadecan und/oder Isohexadecan. Further compositions preferred according to the invention contain as carrier liquid under standard conditions e) a mixture of e) i) a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units, and e) ii) at least one isoparaffin oil, in particular isodecane, isoundecane , Isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, more preferably isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and mixtures of isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane and / or isohexadecane.
Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten als unter Normalbedingungen flüssiges Träger-Öl e) mindestens ein n-Alkan mit neun bis 15 Kohlenstoffatomen, also n- Nonan, n-Decan, n-Undecan, n-Dodecan, n-Tridecan, n-Tetradecan und n-Pentadecan sowie Mischungen hiervon. Besonders bevorzugt sind n-Tridecan, n-Tetradecan und n-Pentadecan sowie Mischungen hiervon. Ebenfalls besonders bevorzugt sind Mischungen von Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan, n-Tridecan, n-Tetradecan und n-Pentadecan. Ebenfalls besonders bevorzugt sind Mischungen von Isododecan, Isotridecan, Isotetradecan, Isopentadecan, Isohexadecan, n-Tridecan, n-Tetradecan und n-Pentadecan, bei denen der Anteil der n-Alkane 5 - 45 Gew.-%, bezogen auf das Gewicht der gesamten Mischung, ausmacht.  Further compositions preferred according to the invention contain as support liquid under standard conditions e) at least one n-alkane having nine to 15 carbon atoms, ie n-nonane, n-decane, n-undecane, n-dodecane, n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof. Particularly preferred are n-tridecane, n-tetradecane and n-pentadecane and mixtures thereof. Also particularly preferred are mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane. Likewise particularly preferred are mixtures of isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane, n-tridecane, n-tetradecane and n-pentadecane, in which the proportion of n-alkanes is 5-45% by weight, based on the weight of the total Mix, matter.
Neben den vorgenannten, üblicherweise als „flüchtigen" Siliconölen bezeichneten Substanzen sowie neben den vorgenannten flüchtigen Nichtsiliconölen können erfindungsgemäß besonders bevorzugte Antitranspirant-Zusammensetzungen weiterhin mindestens ein nichtflüchtiges kosmetisches Öl, ausgewählt aus nichtflüchtigen Siliconölen und nichtflüchtigen Nichtsiliconölen, enthalten. Das mindestens eine nichtflüchtige Öl gleicht den negativen Effekt des flüchtigen Öls auf das Rückstandsverhalten erfindungsgemäß bevorzugter Antitranspirant-Zusammensetzungen aus. Durch die relativ schnelle Verdunstung der flüchtigen Öle können feste, unlösliche Bestandteile, insbesondere die Antitranspirantwirkstoffe, auf der Haut als unschöner Rückstand Sichtbar werden. Diese Rückstände können erfolgreich mit einem nichtflüchtigen Öl maskiert werden. Außerdem können mit einem Gemisch aus nichtflüchtigem und flüchtigem Öl Parameter wie Hautgefühl, Sichtbarkeit des Rückstands und Stabilität der Suspension feinreguliert und besser an die Bedürfnisse der Verbraucher angepasst werden. In addition to the aforementioned substances, commonly referred to as "volatile" silicone oils, as well as the aforementioned volatile non-silicone oils, particularly preferred antiperspirant compositions according to the invention may further contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils Effect of volatile oil on the Residue behavior according to the invention preferred antiperspirant compositions. Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, can be seen on the skin as an unsightly residue. These residues can be successfully masked with a nonvolatile oil. In addition, with a mixture of non-volatile and volatile oils, parameters such as skin feel, residue visibility and suspension stability can be fine-tuned and better adapted to consumer needs.
Selbstverständlich ist es ebenfalls möglich, die erfindungsgemäßen Antitranspirant-Zusammenset- zungen mit einem geringen Anteil an flüchtigen Ölen oder sogar ohne flüchtige Öle zu formulieren. Bevorzugte nichtflüchtige Siliconöle sind ausgewählt aus höhermolekularen linearen Dimethylpoly- siloxanen, im Handel erhältlich z. B. unter der Bezeichnung Dow Corning® 200 Fluid mit kinematischen Viskositäten (25°C) im Bereich von 5 - 100 cSt, bevorzugt 6 - 50 cSt oder auch 5 - 10 cSt, und Baysilon® 350 M (mit einer kinematischen Viskosität (25°C) von etwa 350 cSt. Of course, it is also possible to formulate the antiperspirant compositions according to the invention with a low proportion of volatile oils or even without volatile oils. Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for. B. under the name Dow Corning ® 200 fluid with kinematic viscosities (25 ° C) in the range of 5 - 100 cSt, preferably 6 - 50 cSt or even 5 - 10 cSt, and Baysilon ® 350 M (with a kinematic viscosity (25 ° C) of about 350 cSt.
Erfindungsgemäß ebenfalls bevorzugte Siliconöle sind ausgewählt aus Siliconen der Formel -1), wobei x ausgewählt ist aus ganzen Zahlen von 1 - 20. Silicone oils which are likewise preferred according to the invention are selected from silicones of the formula (I), where x is selected from integers of 1-20.
Figure imgf000015_0001
Figure imgf000015_0001
(Sil-1)  (Sil-1)
Ein bevorzugtes Siliconöl der Formel (Sil-1) ist unter der INCI-Bezeichnung Phenyl Trimethicone in verschiedenen Qualitäten, Viskositäten und Flüchtigkeiten erhältlich. Ein nicht-flüchtiges Phenyl Trimethicone ist beispielsweise von Dow Corning unter der Bezeichnung Dow Corning 556 erhältlich.  A preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone in various grades, viscosities and volatilities. A non-volatile phenyl trimethicone is available, for example, from Dow Corning under the name Dow Corning 556.
Natürliche und synthetische Kohlenwasserstoffe, wie beispielsweise Paraffinöle, C 8-C30-Isoparaf- fine, insbesondere Isoeicosan, Polyisobutene oder Polydecene, die beispielsweise unter der Bezeichnung Emery® 3004, 3006, 3010 oder unter der Bezeichnung Ethylflo® von Albemarle oder Nexbase® 2004G von Nestle erhältlich sind, sowie 1 ,3-Di-(2-ethylhexyl)-cyclohexan (erhältlich z. B. unter dem Handelsnamen Cetiol®S von Cognis) gehören ebenfalls zu den erfindungsgemäß bevorzugten nichtflüchtigen Nichtsiliconölen. Fine natural and synthetic hydrocarbons such as paraffin oils, C 8 -C 30 -Isoparaf-, particularly isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
Weitere erfindungsgemäß bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Benzoesäureestern von linearen oder verzweigten C8.22-Alkanolen. Besonders bevorzugt sind Benzoesäure-C12-C15-alkylester, z. B. erhältlich als Handelsprodukt Finsolv® TN, Benzoesäure- isostearylester, z. B. erhältlich als Handelsprodukt Finsolv® SB, Ethylhexylbenzoat, z. B. erhältlich als Handelsprodukt Finsolv® EB, und Benzoesäureoctyldocecylester, z. B. erhältlich als Handels- produkt Finsolv® BOD. Derartige Benzoesäureesteröle sind besonders gut zur Maskierung von Antitranspirant-Wirkstoff-Rückständen geeignet, da ihr Brechungsindex den besonders wirksamen Aluminium-Zirkonium-Mischsalzen sehr nahe kommt. Further non-volatile non-silicone oils which are preferred according to the invention are selected from the benzoic acid esters of linear or branched C 8 . 22 -alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and Benzoesäureoctyldocecylester, z. Available as a trade Product Finsolv ® BOD. Benzoic acid ester oils of this type are particularly suitable for masking antiperspirant active substance residues, since their refractive index comes very close to the particularly effective aluminum-zirconium mixed salts.
Weitere erfindungsgemäß bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus verzweigten gesättigten oder ungesättigten Fettalkoholen mit 6 - 30 Kohlenstoffatomen. Diese Alkohole werden häufig auch als Guerbet-Alkohole bezeichnet, da sie nach der Guerbet-Reaktion erhältlich sind. Bevorzugte Alkoholöle sind Hexyldecanol (Eutanol® G 16), Octyldodecanol (Eutanol® G) und 2-Ethylhexylalkohol. Weitere bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus Mischungen aus Guerbetalkoholen und Guerbetalkoholestern, z.B. dem Handelsprodukt Cetiol® PGL (Hexyldecanol und Hexyldecyllaurat). Further non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction. Preferred oils are alcohol Hexyldecanol (Eutanol ® G 16) Octyldodecanol (Eutanol ® G) and 2-ethylhexyl alcohol. More preferred non-volatile non-silicone oils are chosen from mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
Weitere erfindungsgemäß bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Triglyceriden von linearen oder verzweigten, gesättigten oder ungesättigten, gegebenenfalls hydroxylier- ten C8_30-Fettsäuren, sofern diese unter Normalbedingungen flüssig sind. Die Verwendung natürlicher Öle, z.B. Sojaöl, Baumwollsaatöl, Sonnenblumenöl, Palmöl, Palmkernöl, Leinöl, Mandelöl, Rizinusöl, Maisöl, Rapsöl, Olivenöl, Sesamöl, Distelöl, Weizenkeimöl, Pfirsichkernöl und die flüssigen Anteile des Kokosöls, ist bevorzugt in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,2 - 3 Gew.-%, besonders bevorzugt 0,5 - 1 ,5 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Bevorzugt sind synthetische Triglyceridöle, insbesondere Capric/Caprylic Triglycerides, z. B. die Handelsprodukte Myritol® 318, Myritol® 331 (Cognis) oder Miglyol® 812 (Hüls) mit unverzweigten Fettsäureresten sowie Glyceryltriisostearin und ähnliche Triglyceride (= Glycerintriester) mit verzweigten Fettsäureresten, insbesondere in einer Gesamtmenge von 0,5 - 7 Gew.-%, bevorzugt 1 - 5 Gew.-%, besonders bevorzugt 2 - 3 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung. Further according to the invention preferred non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 _ th 30 fatty acids, provided that they are liquid under normal conditions. The use of natural oils, eg soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of the coconut oil is preferably in a total amount of 0, 1 to 5 wt .-%, preferably 0.2 to 3 wt .-%, particularly preferably 0.5 to 1, 5 wt .-%, each based on the total weight of the composition according to the invention. Preference is given to synthetic triglyceride oils, in particular Capric / Caprylic triglycerides, z. As the commercial products Myritol ® 318, Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin and similar triglycerides (= glycerol triester) with branched fatty acid residues, in particular in a total amount of 0.5 - 7 wt. %, preferably 1-5 wt .-%, particularly preferably 2-3 wt .-%, each based on the total weight of the composition according to the invention.
Weitere erfindungsgemäß besonders bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Dicarbonsäureestern von linearen oder verzweigten C6-C 0-Alkanolen, insbesondere Di-(2- ethylhexyl)adipat, Dioctyladipat, Dioctylsebacat, Diisopropylsebacat, Dioctylmalat, Dioctylmaleat, Dicaprylylmaleat, Diisooctylsuccinat, Di-2-ethylhexylsuccinat und Di-(2-hexyldecyl)-succinat. Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the dicarboxylic acid esters of linear or branched C 6 -C 0 -alkanols, in particular di (2-ethylhexyl) adipate, dioctyl adipate, dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2 ethylhexylsuccinate and di (2-hexyldecyl) succinate.
Weitere erfindungsgemäß besonders bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Estern der linearen oder verzweigten gesättigten oder nichtflüchtige Nichtsiliconöle ungesättigten Fettalkohole mit 6 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, die hydroxyliert sein können. Dazu zählen Hexyldecylstearat (z. B. Eutanol® G 16 S), Hexyldecyllaurat, Isononylisononanoat, 2-Ethylhexylpal- mitat (z. B. Cegesoft® C 24) und 2-Ethylhexylstearat (z. B. Cetiol® 868). Ebenfalls bevorzugt sind Isooctylstearat, Isononylstearat, Isocetylstearat, Isononylisononanoat, Isotridecylisononanoat, Cetearylisononanoat, 2-Ethylhexyllaurat, 2-Ethylhexylisostearat, 2-Ethylhexylcocoat, 2-Octyldode- cylpalmitat, Butyloctansäure-2-butyloctanoat, Diisotridecylacetat, n-Hexyllaurat, n-Decyloleat, Oleyloleat, Oleylerucat, Erucyloleat und Erucylerucat. Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or non-volatile non-silicone oils unsaturated fatty alcohols having 6 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated. These include hexyldecyl (z. B. Eutanol ® G 16 S), hexyldecyl laurate, isononyl isononanoate, 2-Ethylhexylpal- palmitate (z. B. Cegesoft ® C 24) and 2-ethylhexyl stearate (z. B. Cetiol ® 868). Also preferred are isooctyl stearate, isononyl stearate, isocetyl stearate, isononyl isononanoate, isotridecyl isononanoate, cetearyl isononanoate, 2-ethylhexyl laurate, 2-ethylhexyl isostearate, 2-ethylhexyl cocoate, 2-octyldodecyl palmitate, butyloctanoic acid 2-butyloctanoate, diisotridecylacetate, n-hexyl laurate, n-decyl oleate, oleyl oleate , Oleyl erucate, erucyl oleate and erucyl erucate.
Weitere erfindungsgemäß besonders bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Anlagerungsprodukten von 1 bis 5 Propylenoxid-Einheiten an ein- oder mehrwertige C8.22- Alkanole wie Octanol, Decanol, Decandiol, Laurylalkohol, Myristylalkohol und Stearylalkohol, z. B. PPG-2-Myristylether und PPG-3-Myristylether. Further inventively particularly preferred non-volatile non-silicone oils are selected from the addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 . 22 - Alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, e.g. PPG-2 myristyl ether and PPG-3 myristyl ether.
Weitere erfindungsgemäß besonders bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den Anlagerungsprodukten von mindestens 6 Ethylenoxid- und/oder Propylenoxid-Einheiten an ein- oder mehrwertige C3.22-Alkanole wie Glycerin, Butanol, Butandiol, Myristylalkohol und Stearylalkohol, die gewünschtenfalls verestert sein können, z. B. PPG-14-Butylether, PPG-9-Butylether, PPG-10-Butandiol, PPG-15-Stearylether und Glycereth-7-diisononanoat. Further non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 . 22 -alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for. PPG-14 butyl ether, PPG-9-butyl ether, PPG-10-butanediol, PPG-15 stearyl ether and glycereth-7-diisononanoate.
Weitere erfindungsgemäß besonders bevorzugte nichtflüchtige Nichtsiliconöle sind ausgewählt aus den symmetrischen, unsymmetrischen oder cyclischen Estern der Kohlensäure mit Fettalkoholen, z. B. Glycerincarbonat oder Dicaprylylcarbonat (z. B. Cetiol® CC). Further inventively particularly preferred non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. B. glycerol carbonate or dicaprylyl carbonate (z. B. Cetiol ® CC).
Weitere Öle, die erfindungsgemäß bevorzugt sein können, sind ausgewählt aus den Estern von Dimeren ungesättigter C 2-C22-Fettsäuren (Dimerfettsäuren) mit einwertigen linearen, verzweigten oder cyclischen C2-C 8-Alkanolen oder mit mehrwertigen linearen oder verzweigten C2-C6-Alka- nolen. Es kann erfindungsgemäß bevorzugt sein, Mischungen der vorgenannten Öle einzusetzen. Bevorzugte erfindungsgemäße Zusammensetzungen sind dadurch gekennzeichnet, dass das unter Normalbedingungen flüssige Trägeröl ausgewählt ist flüchtigen Siliconölen, nichtflüchtigen Siliconölen, flüchtigen Kohlenwasserstoffölen, verzweigten gesättigten oder ungesättigten Fettalkoholen mit 6 - 30 Kohlenstoffatomen, Triglyceriden von linearen oder verzweigten, gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C8.30-Fettsäuren, Dicarbonsäureestern von linearen oder verzweigten C2-C 0-Alkanolen, Estern von verzweigten gesättigten oder ungesättigten Fettalkoholen mit 2 - 30 Kohlenstoffatomen mit linearen oder verzweigten gesättigten oder ungesättigten Fettsäuren mit 2 - 30 Kohlenstoffatomen, die hydroxyliert sein können, Anlagerungsprodukten von 1 bis 5 Propylenoxid-Einheiten an ein- oder mehrwertige C8.22-Alkanole, Anlagerungsprodukten von mindestens 6 Ethylenoxid und/oder Propylenoxid-Einheiten an ein- oder mehrwertige C3.22- Alkanole, C8-C22-Fettalkoholestern einwertiger oder mehrwertiger C2-C7-Hydroxycarbonsäuren, symmetrischen, unsymmetrischen oder cyclischen Estern der Kohlensäure mit Fettalkoholen, den Estern von Dimeren ungesättigter C 2-C22-Fettsäuren (Dimerfettsäuren) mit einwertigen linearen, verzweigten oder cyclischen C2-C 8-Alkanolen oder mit mehrwertigen linearen oder verzweigten C2-C6-Alkanolen, sowie Mischungen der vorgenannten Substanzen. Further oils which may be preferred according to the invention are selected from the esters of dimers of unsaturated C 2 -C 22 -fatty acids (dimer fatty acids) with monovalent linear, branched or cyclic C 2 -C 8 -alkanols or with polyvalent linear or branched C 2 - C 6 -alkanols. It may be preferred according to the invention to use mixtures of the aforementioned oils. Preferred compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils, volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols containing 6 to 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 . 30 -fatty acids, dicarboxylic acid esters of linear or branched C 2 -C 0 -alkanols, esters of branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated, addition products of 1 to 5 propylene oxide units of mono- or polyhydric C 8 . 22 -alkanols, addition products of at least 6 ethylene oxide and / or propylene oxide units to monovalent or polyvalent C 3 . 22 - Alkanols, C 8 -C 22 fatty alcohol esters of monohydric or polyhydric C 2 -C 7 hydroxycarboxylic acids, symmetrical, unsymmetrical or cyclic esters of carbonic acid with fatty alcohols, the esters of dimers of unsaturated C 2 -C 22 fatty acids (dimer fatty acids) with monohydric linear, branched or cyclic C 2 -C 8 -alkanols or with polyfunctional linear or branched C 2 -C 6 -alkanols, and mixtures of the abovementioned substances.
Es kann erfindungsgemäß außerordentlich bevorzugt sein, Mischungen der vorgenannten Öle einzusetzen, um eine optimale Feinabstimmung der Produkteigenschaften, insbesondere des Rückstandsverhaltens, des Hautgefühls oder der Wirkstofffreisetzung, zu erzielen.  It may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils in order to achieve optimum fine-tuning of the product properties, in particular the residue behavior, the feel of the skin or the release of the active ingredient.
In einer weiteren bevorzugten Ausführungsform der Erfindung weist ein Anteil der Ölkomponenten von mindestens 80 Gew.-% einen Brechungsindex nD von 1 ,39 - 1 ,51 auf. Besonders bevorzugt ist es, wenn 5 - 40 - 50 Gew.-%, außerordentlich bevorzugt 10 - 12 - 25 - 30 Gew.-% der Ölkomponenten einen Brechungsindex nD von 1 ,43 - 1 ,51 , bevorzugt 1 ,44 - 1 ,49, besonders bevorzugt 1 ,45 - 1 ,47 - 1 ,485, bei 20 °C (gemessen bei λ = 589 nm) aufweisen. In a further preferred embodiment of the invention, a proportion of the oil components of at least 80 wt .-%, a refractive index n D of 1, 39 - 1, 51 on. It is particularly preferred if 5-40-50% by weight, even more preferably 10-12-25-30% by weight, of the oil components have a refractive index n D of 1.43-1.51, preferably 1.44-1 , 49, more preferably 1, 45-1, 47-1, 485, at 20 ° C (measured at λ = 589 nm).
Weitere bevorzugte erfindungsgemäße Zusammensetzungen sind dadurch gekennzeichnet, dass mindestens ein Öl in einer Gesamtmenge von 30 - 80 Gew.-%, bevorzugt 40 - 75 Gew.-%, beson- ders bevorzugt in einer Gesamtmenge von 50 - 73 Gew.-%, außerordentlich bevorzugt in einer Gesamtmenge von 56 - 70 Gew.-%, enthalten ist, jeweils bezogen auf das Gesamtgewicht der Zusammensetzung. Further preferred compositions according to the invention are characterized in that at least one oil in a total amount of 30-80 wt.%, Preferably 40-75 wt. preferably in a total amount of 50-73% by weight, most preferably in a total amount of 56-70% by weight, in each case based on the total weight of the composition.
Andere, besonders bevorzugte erfindungsgemäße ÖI-in-Wasser-Emulsionen enthalten einen geringen Anteil an einer Öl- oder Fettphase von 0,5 - 6,5 Gew.-%, bezogen auf das Gewicht der gesamten Emulsion, aus. Der geringe Anteil an dispergierter Öl- oder Fettphase führt zu einem verbesserten, nicht-fettenden Hautgefühl und unterstützt die deodorierende Wirkung.  Other particularly preferred oil-in-water emulsions of the present invention contain a minor amount of an oil or fat phase of from 0.5 to 6.5 percent by weight, based on the weight of the total emulsion. The low proportion of dispersed oil or fat phase leads to an improved, non-greasy skin feel and supports the deodorizing effect.
Die Öl- oder Fettphase der erfindungsgemäßen ÖI-in-Wasser-Emulsionen umfasst definitionsgemäß neben dem mindestens einen kosmetischen Öl e) auch gegebenenfalls enthaltene Duftstoffe sowie auch gegebenenfalls enthaltene Fettkomponenten, die bei 20 °C fest oder pastös vorliegen. Die Emulgatoren zählen definitionsgemäß nicht zur Öl- oder Fettphase. By definition, the oil or fat phase of the oil-in-water emulsions according to the invention comprises in addition to the at least one cosmetic oil e) also optionally contained fragrances as well as optionally contained fat components which are solid or pasty at 20 ° C. By definition, the emulsifiers do not belong to the oil or fat phase.
Bevorzugte bei 20 °C flüssige Öle e) sind ausgewählt aus linearen und verzweigten gesättigten ein- oder mehrwertigen C3 - C30-Alkanolen, die mit mindestens einer Propylenoxid-Einheit pro Molekül verethert sind, besonders bevorzugt ausgewählt aus Propanol, Glycerin, Propylenglycol, Butanol, Butandiol, Pentanol, Caprinalkohol, Caprylalkohol, Caprylylalkohol, Laurylalkohol, Tride- cylalkohol, Myristylalkohol, Palmitylalkohol, Cetylalkohol, Stearylalkohol, Arachidylalkohol und Behenylalkohol, die mit 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13, 14, 15, 16, 17, 18, 19 oder 20 Propy- lenoxideinheiten verethert sind, sowie Mischungen dieser Alkanolether. Preferred oils which are liquid at 20 ° C. are selected from linear and branched saturated mono- or polyhydric C 3 -C 30 -alkanols etherified with at least one propylene oxide unit per molecule, more preferably selected from propanol, glycerol, propylene glycol, Butanol, butanediol, pentanol, capric alcohol, caprylic alcohol, caprylyl alcohol, lauryl alcohol, tridecyl alcohol, myristyl alcohol, palmityl alcohol, cetyl alcohol, stearyl alcohol, arachidyl alcohol and behenyl alcohol, having 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13, 14, 15, 16, 17, 18, 19 or 20 propylene oxide units are etherified, and mixtures of these alkanol ethers.
Weitere bevorzugte bei 20 °C flüssige Öle e) sind ausgewählt aus Anlagerungsprodukten von mindestens 6 Propylenoxid-Einheiten pro Molekül an ein- oder mehrwertige C3.30-Alkanole, insbesondere an Butanol, Butandiol, Myristylalkohol und Stearylalkohol, besonders bevorzugt ausgewählt aus PPG-3-Myristylether, PPG-13-Butylether, PPG-14-Butylether, PPG-9-Butylether, PPG-10- Butandiol und PPG-15-Stearylether, sowie Mischungen hiervon. Further preferred oils which are liquid at 20 ° C. are selected from adducts of at least 6 propylene oxide units per molecule of mono- or polyhydric C 3 . 30 -alkanols, in particular butanol, butanediol, myristyl alcohol and stearyl alcohol, more preferably selected from PPG-3-myristyl ether, PPG-13-butyl ether, PPG-14-butyl ether, PPG-9-butyl ether, PPG-10-butanediol and PPG 15-stearyl ether, as well as mixtures thereof.
Weitere bevorzugte kosmetische Öle sind ausgewählt aus Propylenglycolmonoestern von verzweigten gesättigten C6 - C30-Alkancarbonsäuren, besonders bevorzugt ausgewählt aus Propylen- glycolmonoisostearat, Propylenglycolmonoisopalmitat, Propylenglycolmonoisobehenat, Propylen- glycolmonoisoarachinat, Propylenglycolmonoisomyristat, Propylenglycolmonoisocaprat, Propylen- glycolmonoisocaprinat und Propylenglycolmonoisocaprylat sowie Mischungen hiervon. Further preferred cosmetic oils are selected from propylene glycol monoesters of branched saturated C 6 -C 30 -alkanecarboxylic acids, more preferably selected from propylene glycol monoisostearate, propylene glycol monoisopalmitate, propylene glycol monoisobehenate, propylene glycol monoisoarachinate, propylene glycol monoisomyristate, propylene glycol monoisocaprate, propylene glycol monoisocaprate and propylene glycol monoisocaprylate and mixtures thereof.
Weitere bevorzugte kosmetische Öle sind ausgewählt ist aus verzweigten gesättigten C 0 - C30- Alkanolen, besonders bevorzugt ausgewählt aus Isostearylalkohol, Isocetylalkohol, Isomyristylalko- hol, Isotridecylalkohol, Isoarachidylalkohol, Isobehenylalkohol, Isocaprylalkohol, Isocaprinylalkohol, Isocaprylylalkohol, sowie Mischungen hiervon. More preferred cosmetic oils are selected from branched saturated C 0 - C 30 - alkanols, particularly preferably selected from isostearyl alcohol, isocetyl alcohol, Isomyristylalko- alcohol, isotridecyl alcohol, Isoarachidylalkohol, Isobehenylalkohol, Isocaprylalkohol, Isocaprinylalkohol, Isocaprylylalkohol, and mixtures thereof.
Weitere bevorzugte erfindungsgemäße ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass mindestens ein kosmetisches Öl in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,3 - 3 Gew.-% und besonders bevorzugt 0,5 - 2 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Emulsion, enthalten ist.  Further preferred oil-in-water emulsions according to the invention are characterized in that at least one cosmetic oil in a total amount of 0.1-5% by weight, preferably 0.3-3% by weight and particularly preferably 0.5- 2 wt .-%, each based on the total weight of the emulsion is included.
Überraschend wurde festgestellt, dass die Lagerstabilität der erfindungsgemäßen ÖI-in-Wasser- Emulsionen durch den Zusatz von mindestens einem nichtionischen Emulgator mit einem HLB- Wert im Bereich von 3 - 6 weiter gesteigert werden kann. Derartige lipophile Emulgatoren stabilisieren normalerweise Wasser-in-ÖI-Emulsionen. It has surprisingly been found that the storage stability of the oil-in-water emulsions according to the invention by the addition of at least one nonionic emulsifier with an HLB Value in the range of 3 - 6 can be further increased. Such lipophilic emulsifiers normally stabilize water-in-oil emulsions.
Bevorzugte nichtionische Emulgatoren mit einem HLB-Wert im Bereich von 3 - 6 sind ausgewählt aus linearen gesättigten und ungesättigten C 2 - C30-Alkanolen, die mit 1 - 4 Ethylenoxid-Einheiten pro Molekül verethert sind, wobei Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth und Beheneth mit jeweils 1 - 4 Ethylenoxid-Einheiten pro Molekül bevorzugt sind. Außerordentlich bevorzugt sind Steareth-1 , Steareth-2, Steareth-3, Ceteth-1 , Ceteth-2, Ceteth-3, Myristeth-1 , Myristeth-2, Laureth-1 Beheneth-2, Beheneth-3 und Beheneth-4, insbesondere Steareth-2. Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen enthalten mindestens einen nichtionischen Emulgator mit einem HLB-Wert im Bereich von 3 - 6 in einer Gesamtmenge von 1 ,8 - 3 Gew.-%, bevorzugt 2 - 2,8 Gew.-% und besonders bevorzugt 2,4 - 2,6 Gew.-%, jeweils bezogen auf das Gewicht der gesamten Emulsion. Preferred nonionic emulsifiers having an HLB in the range of 3 to 6 are selected from linear saturated and unsaturated C 2 to C 30 alkanols etherified with 1 to 4 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth , Trideceth, arachideth and beheneth each having 1-4 ethylene oxide units per molecule are preferred. Most preferred are steareth-1, steareth-2, steareth-3, ceteth-1, ceteth-2, ceteth-3, myristeth-1, myristeth-2, laureth-1 beheneth-2, beheneth-3 and beheneth-4, in particular steareth-2. Further oil-in-water emulsions preferred according to the invention contain at least one nonionic emulsifier having an HLB value in the range from 3 to 6 in a total amount of 1.8 to 3% by weight, preferably 2 to 2.8% by weight. and particularly preferably 2.4 to 2.6 wt .-%, each based on the weight of the total emulsion.
Weiterhin wurde überraschend festgestellt, dass die Lagerstabilität der erfindungsgemäßen Öl-inWasser-Emulsionen durch den Zusatz von mindestens einem nichtionischen Emulgator mit einem HLB-Wert im Bereich von 12 - 18 weiter gesteigert werden kann. Weitere erfindungsgemäß bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass mindestens ein nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 in einer Gesamtmenge von 1 ,8 - 3 Gew.-%, bezogen auf das Gewicht der gesamten Emulsion, enthalten ist, der ausgewählt ist aus linearen gesättigten und ungesättigten C 2 - C24-Alkanolen, die mit 7 - 40 Ethylenoxid-Einheiten pro Molekül verethert sind, wobei Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth und Beheneth mit jeweils 7 - 40 Ethylenoxid-Einheiten pro Molekül bevorzugt sind. Besonders bevorzugte nichtionische Emulgatoren mit einem HLB-Wert im Bereich von 12 - 18 sind ausgewählt aus Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth und Beheneth mit jeweils 7 - 40 Ethylenoxid- Einheiten pro Molekül, insbesondere Steareth-15, Steareth-20, Steareth-21 , Arachideth-20, Arachi- deth-21 , Beheneth-20, Beheneth-21 , Ceteth-20, Ceteth-30, Ceteth-15 und Myristeth-15. Furthermore, it has surprisingly been found that the storage stability of the oil-in-water emulsions according to the invention can be further increased by the addition of at least one nonionic emulsifier having an HLB value in the range of 12-18. Further inventively preferred compositions are characterized in that at least one nonionic emulsifier having an HLB value in the range of 3-6 in a total amount of 1, 8 - 3 wt .-%, based on the weight of the total emulsion, is contained is selected from linear saturated and unsaturated C 2 -C 24 alkanols etherified with 7 to 40 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth, trideceth, arachideth and beheneth each having 7 to 40 ethylene oxide units per molecule are preferred. Particularly preferred nonionic emulsifiers having an HLB value in the range of 12-18 are selected from steareth, ceteth, myristeth, laureth, trideceth, arachideth and beheneth, each having 7 to 40 ethylene oxide units per molecule, especially steareth-15, steareth-20 , Steareth-21, arachideth-20, arachideth-21, beheneth-20, beheneth-21, ceteth-20, ceteth-30, ceteth-15 and myristeth-15.
Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen enthalten mindestens einen nichtionischen Emulgator mit einem HLB-Wert im Bereich von 12 - 18 in einer Gesamtmenge von 1 - 2 Gew.-%, bevorzugt 1 ,2 - 1 ,8 Gew.-% und besonders bevorzugt 1 ,5 - 1 ,7 Gew.-%, jeweils bezogen auf das Gewicht der gesamten Emulsion. Further oil-in-water emulsions preferred according to the invention contain at least one nonionic emulsifier having an HLB value in the range from 12 to 18 in a total amount of 1 to 2% by weight, preferably 1 to 2 to 1% by weight. and particularly preferably 1, 5-1, 7 wt .-%, each based on the weight of the total emulsion.
Weitere erfindungsgemäß bevorzugte Zusammensetzungen sind dadurch gekennzeichnet, dass als nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 Steareth-2 und gleichzeitig als nichtionischer Emulgator mit einem HLB-Wert im Bereich von 12 - 18 Steareth-21 enthalten ist. Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass das Gewichtsverhältnis von nichtionischen Emulgatoren mit einem HLB-Wert im Bereich von 3 - 6 und nichtionischen Emulgatoren mit einem HLB-Wert im Bereich von 12 - 18 von 0,9 bis 3, bevorzugt 1 ,3 - 1 ,9 beträgt.  Further compositions preferred according to the invention are characterized in that they contain steareth-2 as nonionic emulsifier having an HLB value in the range from 3 to 6 and at the same time as nonionic emulsifier having an HLB value in the range from 12 to 18 steareth-21. Further preferred oil-in-water emulsions according to the invention are characterized in that the weight ratio of nonionic emulsifiers having an HLB value in the range of 3-6 and nonionic emulsifiers having an HLB value in the range of 12-18 from 0.9 to 3, preferably 1, 3 - 1, 9.
Weitere erfindungsgemäß besonders bevorzugte ÖI-in-Wasser-Emulsionen enthalten Steareth-2, Steareth-21 und PPG-15-Stearylether. Derartige Emulsionen zeichnen sich durch eine besonders hohe Lager- und Temperaturstabilität aus und tragen gleichzeitig zu einem verbesserten, nichtklebrigen Hautgefühl bei. Further oil-in-water emulsions which are particularly preferred according to the invention comprise steareth-2, steareth-21 and PPG-15-stearyl ether. Such emulsions are characterized by a particularly high storage and temperature stability and at the same time contribute to an improved, non-sticky skin feel.
Die erfindungsgemäßen ÖI-in-Wasser-Emulsionen zeichnen sich durch einen Gehalt an mindestens einem Polysaccharid aus. Überraschend wurde festgestellt, dass der Polysaccharid-Gehalt das Trocknen der Emulsion auf der Haut beschleunigt. Gegenüber einer Polysaccharid-freien Emulsion werden erfindungsgemäße Emulsionen von den Testpersonen als auf der Haut schneller trocknend wahrgenommen. Unter erfindungsgemäß geeigneten Polysacchariden werden sowohl nicht-modifizierte Polysaccharide, wie beispielsweise Xanthan oder Stärke, als auch chemisch modifizierte Polysaccharid-Derivate, wie beispielsweise Aluminiumstärkeoctenylsuccinat oder Hydroxypropylmethylcellulose, als auch physikalisch modifizierte Polysaccharide, beispielsweise eine durch thermische Behandlung vorverkleisterte Stärke, verstanden. Erfindungsgemäß bevorzugte Polysaccharide sind ausgewählt aus Stärken, insbesondere aus Mais, Kartoffeln und Weizen, deren Bestandteilen wie Amylose und Amylopektin, Stärkehydrolysaten und Stärkeabbauprodukten, wie Maltodextrin, den physikalisch oder chemisch modifizierten Stärkederivaten, insbesondere den anionischen Stärkederivaten Aluminiumstärkeoctenylsuccinat, Natriumstärkeoctenyl- succinat, Calciumstärkeoctenylsuccinat, Distärkephosphaten, Hydroxyethylstärkephosphaten, Hydroxypropylstärkephosphaten, Natriumcarboxymethylstärken und Natriumstärkeglycolat, Cellulose, den chemisch modifizierten Cellulosederivaten Methylcellulose, Hydroxypropylcellulose, Hydroxyethylcellulose, Hydroxypropylmethylcellulose, Hydroxypropylethylcellulose, Hydroxyethyl- methylcellulose und Carboxymethylcellulose. Polysaccharide, die Gums oder Gummen bilden, wie beispielsweise Guar-Gum, Xanthan-Gum, Alginate, insbesondere Natriumalginat, Gummi arabicum, Karaya-Gummi, Carrageenane, Johannisbrotkernmehl, Leinsamen-Gums und Agar-Agar, können ebenfalls enthalten sein, sind aber weniger bevorzugt. In einer besonders bevorzugten Ausführungsform sind die erfindungsgemäßen Zusammensetzungen frei von Polysaccharid-Gums. Erfindungsgemäße bevorzugte Polysaccharide sind ausgewählt aus anionischen und nichtionischen Polysacchariden sowie Mischungen hiervon. Bevorzugte anionische Polysaccharide sind ausgewählt aus Aluminiumstärkeoctenylsuccinat, Natriumstärkeoctenylsuccinat, Calciumstärkeoctenylsuccinat, Distärkephosphaten, Hydroxyethylstärkephosphaten, Hydroxypropylstärkephosphaten, Natriumcarboxymethylstärken, Natriumstärkeglycolat sowie Mischungen hiervon. Bevorzugte nichtionische Polysaccharid sind ausgewählt aus Stärken, Stärkehydrolysaten, Cellulose, Methylcellulose, Hydroxypropylcellulose, Hydroxyethylcellulose, Hydroxypropylmethylcellulose, Hydroxypropylethylcellulose, Hydroxyethylmethylcellulose sowie Mischungen hiervon. Besonders bevorzugte erfindungsgemäße Zusammensetzungen enthalten das mindestens eine Polysaccharid in einer Gesamtmenge von 0,01 - 1 ,0 Gew.-%, bevorzugt 0,05 - 0,5 und besonders bevorzugt 0,09 - 0,2 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Emulsion.  The oil-in-water emulsions according to the invention are distinguished by a content of at least one polysaccharide. Surprisingly, it has been found that the polysaccharide content accelerates the drying of the emulsion on the skin. Compared with a polysaccharide-free emulsion emulsions of the invention are perceived by the test persons as faster drying on the skin. Polysaccharides which are suitable according to the invention are understood to mean both unmodified polysaccharides, such as, for example, xanthan or starch, and chemically modified polysaccharide derivatives, such as, for example, aluminum starch octenylsuccinate or hydroxypropylmethylcellulose, and physically modified polysaccharides, for example a starch pregelatinized by thermal treatment. Preferred polysaccharides according to the invention are selected from starches, in particular from corn, potatoes and wheat, their constituents such as amylose and amylopectin, starch hydrolysates and starch degradation products, such as maltodextrin, the physically or chemically modified starch derivatives, in particular the anionic starch derivatives Aluminiumstärkeoctenylsuccinat, Natriumstärkeoctenylsuccinat, Calciumstärkeoctenylsuccinat, Distärkephosphaten , Hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches and sodium starch glycolate, cellulose, the chemically modified cellulose derivatives methyl cellulose, hydroxypropyl cellulose, hydroxyethyl cellulose, hydroxypropylmethyl cellulose, hydroxypropyl ethyl cellulose, hydroxyethyl methyl cellulose and carboxymethyl cellulose. Polysaccharides that form gums or gums, such as guar gum, xanthan gum, alginates, especially sodium alginate, gum arabic, karaya gum, carrageenans, locust bean gum, linseed gums, and agar-agar, may also be included but are less prefers. In a particularly preferred embodiment, the compositions according to the invention are free of polysaccharide gums. Preferred polysaccharides of the invention are selected from anionic and nonionic polysaccharides and mixtures thereof. Preferred anionic polysaccharides are selected from aluminum starch octenyl succinate, sodium starch octenyl succinate, calcium starch octenyl succinate, distarch phosphates, hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches, sodium starch glycolate and mixtures thereof. Preferred nonionic polysaccharides are selected from starches, starch hydrolysates, cellulose, methylcellulose, hydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and mixtures thereof. Particularly preferred compositions according to the invention contain the at least one polysaccharide in a total amount of 0.01-1.0 wt.%, Preferably 0.05-0.5 and particularly preferably 0.09-0.2 wt on the total weight of the emulsion.
Erfindungsgemäß außerordentlich bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass neben Steareth-2, Steareth-21 und PPG-15-Stearylether Aluminiumstärkeoctenylsuccinat als Polysaccharid enthalten ist. Dieses Polysaccharid ist beispielsweise unter den Handelsnamen Dry Flo und Dry Flo Plus von National Starch erhältlich. Weitere erfindungsgemäß außerordentlich bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass neben Steareth-2, Steareth-21 und PPG-15-Stearylether mindestens ein Distärkephosphat enthalten ist. Dieses Polysaccharid ist beispielsweise unter dem Handelsnamen Maize PO 4 PH„B" von Agrana erhältlich. Derartige Emulsionen zeichnen sich durch eine besonders hohe Lager- und Temperaturstabilität, ein hervorragendes, nicht-klebriges Hautgefühl und optimale Trocknungseigenschaften auf der Haut aus. Oil-in-water emulsions which are extraordinarily preferred according to the invention are characterized in that, in addition to steareth-2, steareth-21 and PPG-15-stearyl ether, aluminum starch octenyl succinate is contained as polysaccharide. This polysaccharide is available, for example, under the trade names Dry Flo and Dry Flo Plus from National Starch. Further according to the invention extraordinarily preferred oil-in-water emulsions are characterized in that, in addition to steareth-2, steareth-21 and PPG-15-stearyl ether, at least one distarch phosphate is contained. This polysaccharide is available, for example, from Agrana under the trade name Maize PO 4 PH "B." Such emulsions are distinguished by particularly high storage and temperature stability, an outstanding, non-sticky skin feel and optimal drying properties on the skin.
Der Anteil des Wassers an der erfindungsgemäßen Zusammensetzung beträgt vorzugsweise mindestens 60 Gew.-%, bevorzugt 65 bis 90 Gew.-%, besonders bevorzugt 70 - 85 Gew.-%, außerordentlich bevorzugt 75 - 80 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung.  The proportion of water in the composition according to the invention is preferably at least 60% by weight, preferably 65 to 90% by weight, particularly preferably 70-85% by weight, most preferably 75-80% by weight, based in each case on total composition.
Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass insgesamt maximal 3 Gew.-%, bevorzugt maximal 1 Gew.-% und besonders bevorzugt 0 Gew.-%, jeweils bezogen auf das Gewicht der gesamten Emulsion, an einwertigen - C3-Alka- nolen, wie Ethanol oder Isopropanol, enthalten ist. Die erfindungsgemäßen Emulsionen können unter bestimmten Bedingungen durch einen Zusatz an Ethanol oder Isopropanol, insbesondere in höheren Mengen, beispielsweise 5 Gew.-% und mehr, in ihrer Lager- und/oder Temperaturstabilität destabilisiert werden. Further inventively preferred oil-in-water emulsions are characterized in that a total of at most 3 wt .-%, preferably at most 1 wt .-% and particularly preferably 0 wt .-%, each based on the weight of the total emulsion, of monovalent - C 3 alkanols, such as ethanol or isopropanol. The emulsions according to the invention can be destabilized under certain conditions by an addition of ethanol or isopropanol, in particular in higher amounts, for example 5 wt .-% and more, in their storage and / or temperature stability.
Die erfindungsgemäßen ÖI-in-Wasser-Emulsionen wurden insbesondere für Roll-on-Produkte entwickelt, das heißt, für die Applikation mit einem Kugelapplikator oder Roll-on-Applikator. Für optimale Dosiereigenschaften darf die Emulsion weder zu niedrig-viskos noch zu hoch-viskos sein. Erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen sind daher durch eine Viskosität im Bereich von 1000 - 5000 mPas, bevorzugt 1500 - 4000 mPas und besonders bevorzugt 1700 - 2200 mPas gekennzeichnet. Diese Viskositätsangaben beziehen sich auf Messungen mit einem Brookfield-Viskosimeter, die 1 Tag nach Herstellung der Emulsion mit Spindel RV 4, bei einer Scherrate (Umdrehungszahl der Spindel) von 20 s" ohne Helipath bei einer Umgebungstemperatur und einer Probentemperatur von jeweils 20 °C durchgeführt werden. The oil-in-water emulsions according to the invention were developed in particular for roll-on products, that is to say for application with a ball applicator or roll-on applicator. For optimum dispensing properties, the emulsion must not be too viscous or too viscous. Oil-in-water emulsions preferred according to the invention are therefore characterized by a viscosity in the range from 1000 to 5000 mPas, preferably 1500 to 4000 mPas and particularly preferably 1700 to 2200 mPas. These viscosity data refer to measurements made with a Brookfield viscometer performed 1 day after preparation of the emulsion with spindle RV 4, at a shear rate (spindle speed) of 20 s " without helipath at an ambient temperature and a sample temperature of 20 ° C become.
In einer bevorzugten Ausführungsform enthalten die erfindungsgemäßen Zusammensetzungen zusätzlich zu den schweißhemmenden Wirkstoffen und zusätzlich zu den Komponenten b) und c) mindestens einen deodorierend wirkenden aromatischen Alkohol der Struktur (AA-1),  In a preferred embodiment, in addition to the antiperspirant active ingredients and in addition to the components b) and c), the compositions according to the invention contain at least one deodorising aromatic alcohol of the structure (AA-1),
Figure imgf000021_0001
Figure imgf000021_0001
7-11 wobei die Struktur (AA-1) folgendermaßen gekennzeichnet ist:  7-11 wherein the structure (AA-1) is characterized as follows:
R - R6 = unabhängig voneinander ein Wasserstoffatom, eine Alkylgruppe mit 1 bis 10 Kohlenstoffatomen, die linear oder verzweigt sein kann und die substituiert sein kann mit OH-Gruppen oder Alkoxy-Gruppen mit 1 bis 5 Kohlenstoffatomen, oder eine Alkenylgruppe mit 2 bis 10 Kohlenstoffatomen, die linear oder verzweigt sein kann und die substituiert sein kann mit OH-Gruppen oder Alkoxy-Gruppen mit 1 bis 5 Kohlenstoffatomen, R7 - R = unabhängig voneinander ein Wasserstoffatom, ein Halogenatom, insbesondere ein Chloratom, oder eine Alkylgruppe mit 1 bis 10 Kohlenstoffatomen, die linear oder verzweigt sein kann und die substituiert sein kann mit OH-Gruppen oder Alkoxy-Gruppen mit 1 bis 5 Kohlenstoffatomen, insbesondere mit einer Methoxygruppe, m = 0 oder 1 ist, n, o, p = unabhängig voneinander ganze Zahlen von 0 bis 10 sein können, wobei mindestens einer der Werte n, o, p 0 ist. Erfindungsgemäß bevorzugte deodorierend wirkende aromatische Alkohole der Struktur (AA-1) sind ausgewählt aus Phenoxyethanol, Phenoxyisopropanol (3- Phenoxy-propan-2-ol), Anisalkohol, 2-Methyl-5-phenyl-pentan-1 -ol, 1 ,1 -Dimethyl-3-phenyl-propan- 1 -ol, Benzylalkohol, 2-Phenylethan-1 -ol, 3-Phenylpropan-1 -ol, 4-Phenylbutan-1 -ol, 5-Phenylpentan- 1 -ol, 2-Benzylheptan-1 -ol, 2,2-Dimethyl-3-phenylpropan-1 -ol, 2,2-Dimethyl-3-(3'-methylphenyl)- propan-1 -ol, 2-Ethyl-3-phenylpropan-1 -ol, 2-Ethyl-3-(3'-methylphenyl)-propan-1 -ol, 3-(3'-Chlorphe- nyl)-2-ethylpropan-1 -ol, 3-(2'-Chlorphenyl)-2-ethylpropan-1 -ol, 3-(4'-Chlorphenyl)-2-ethylpropan-1 - ol, 3-(3',4'-Dichlorphenyl)-2-ethylpropan-1 -ol, 2-Ethyl-3-(2'-methylphenyl)-propan-1 -ol, 2-Ethyl-3-(4'- methylphenyl)-propan-1 -ol, 3-(3',4'-Dimethylphenyl)-2-ethylpropan-1 -ol, 2-Ethyl-3-(4'-methoxyphe- nyl)-propan-1 -ol, 3-(3',4'-Dimethoxyphenyl)-2-ethylpropan-1 -ol, 2-Allyl-3-phenylpropan-1 -ol und 2-n-Pentyl-3-phenylpropan-1 -ol. R - R 6 = independently of one another a hydrogen atom, an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or Alkoxy groups having 1 to 5 carbon atoms, or an alkenyl group having 2 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, R 7 - R = independently a hydrogen atom, a halogen atom, especially a chlorine atom, or an alkyl group having 1 to 10 carbon atoms, which may be linear or branched and which may be substituted by OH groups or alkoxy groups having 1 to 5 carbon atoms, especially by a methoxy group, m = 0 or 1, n, o, p = can independently be integers from 0 to 10, wherein at least one of the values n, o, p is 0. Deodorising aromatic alcohols of structure (AA-1) which are preferred according to the invention are selected from phenoxyethanol, phenoxyisopropanol (3-phenoxy-propan-2-ol), anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1,1 Dimethyl 3-phenylpropane-1-ol, benzyl alcohol, 2-phenylethane-1-ol, 3-phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptane -1-ol, 2,2-dimethyl-3-phenylpropan-1-ol, 2,2-dimethyl-3- (3'-methylphenyl) propan-1-ol, 2-ethyl-3-phenylpropan-1 - ol, 2-ethyl-3- (3'-methylphenyl) -propan-1-ol, 3- (3'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (2'-chlorophenyl) -2 -ethylpropan-1-ol, 3- (4'-chlorophenyl) -2-ethyl-propan-1-ol, 3- (3 ', 4'-dichlorophenyl) -2-ethyl-propan-1-ol, 2-ethyl-3 (2'-methylphenyl) -propan-1-ol, 2-ethyl-3- (4'-methylphenyl) -propan-1-ol, 3- (3 ', 4'-dimethylphenyl) -2-ethyl-propane-1 - ol, 2-ethyl-3- (4'-methoxyphenyl) -propan-1-ol, 3- (3 ', 4'-dimethoxyphenyl) -2-ethyl-propan-1-ol, 2-allyl-3-phenylpropane -1 -ol and 2-n-pentyl-3-phenylpropan-1-ol.
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000022_0001
Figure imgf000023_0001
Figure imgf000024_0001
Figure imgf000024_0001
Besonders bevorzugte Alkohole der Struktur AA-1 sind solche, bei denen m = 0 ist. Weitere besonders bevorzugte Alkohole der Struktur AA-1 sind solche, bei denen mindestens einer der Reste R , R2, R3, R4, R5 oder R6 H ist. Weitere besonders bevorzugte Alkohole der Struktur AA-1 sind solche, bei denen m = 0 und mindestens einer der Reste R , R2, R3, R4, R5 oder R6 H ist. Beispiele für die als Substituenten in den erfindungsgemäß verwendeten Verbindungen genannten C bis C5-Alkylreste sind die Gruppen Methyl, Ethyl, Propyl, Isopropyl, n-Butyl, tert.-Butyl, n-Pentyl, Amyl, Isoamyl. Ethyl, Methyl, Propyl, Isopropyl, n-Butyl, tert.-Butyl, n-Pentyl, Amyl, Isoamyl sind bevorzugte Alkylreste, besonders bevorzugt sind Methyl und n-Pentyl. Erfindungsgemäß bevorzugte Cr bis C4-Alkoxyreste sind beispielsweise eine Methoxy- oder eine Ethoxygruppe. Weiterhin können als bevorzugte Beispiele für eine Cr bis C5-Hydroxyalkylgruppe eine Hydroxymethyl-, eine 2-Hydroxyethyl-, eine 3-Hydroxypropyl- oder eine 4-Hydroxybutylgruppe genannt werden. Eine 2-Hydroxyethylgruppe ist besonders bevorzugt. Eine besonders bevorzugte C2- bis C4-Polyhydro- xyalkylgruppe ist die 1 ,2-Dihydroxyethylgruppe. Erfindungsgemäß bevorzugte Beispiele für Halogenatome sind F-, Cl- oder Br-Atome, Cl-Atome sind ganz besonders bevorzugt. Erfindungsgemäß besonders bevorzugte deodorierend wirkende aromatische Alkohole der Struktur (AA-1 ) sind ausgewählt aus Anisalkohol, 2-Methyl-5-phenyl-pentan-1 -ol, 1 ,1 -Dimethyl-3-phenyl-propan-1 -ol, 3- Phenylpropan-1 -ol, 4-Phenylbutan-1 -ol, 5-Phenylpentan-1 -ol, 2-Benzylheptan-1 -ol, 2,2-Dimethyl-3- phenylpropan-1 -ol und 2-n-Pentyl-3-phenylpropan-1 -ol. Außerordentlich bevorzugt ist 2-Benzylhep- tan-1 -ol. Particularly preferred alcohols of structure AA-1 are those in which m = 0. Further particularly preferred alcohols of the structure AA-1 are those in which at least one of the radicals R, R 2 , R 3 , R 4 , R 5 or R 6 is H. Further particularly preferred alcohols of the structure AA-1 are those in which m = 0 and at least one of the radicals R, R 2 , R 3 , R 4 , R 5 or R 6 is H. Examples of the C to C 5 -alkyl radicals mentioned as substituents in the compounds used according to the invention are the groups methyl, ethyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl. Ethyl, methyl, propyl, isopropyl, n-butyl, tert-butyl, n-pentyl, amyl, isoamyl are preferred alkyl radicals, particularly preferred are methyl and n-pentyl. C r to C 4 -alkoxy radicals preferred according to the invention are, for example, a methoxy or an ethoxy group. Furthermore, as preferred examples of a C r to C 5 -hydroxyalkyl group, a hydroxymethyl, a 2-hydroxyethyl, a 3-hydroxypropyl or a 4-hydroxybutyl group may be mentioned. A 2-hydroxyethyl group is particularly preferred. A particularly preferred C 2 to C 4 polyhydroxyalkyl group is the 1,2-dihydroxyethyl group. According to preferred examples of halogen atoms are F, Cl or Br atoms, Cl atoms are very particularly preferred. Particularly preferred deodorant aromatic alcohols of structure (AA-1) according to the invention are selected from anisalcohol, 2-methyl-5-phenyl-pentane-1-ol, 1, 1-dimethyl-3-phenyl-propan-1-ol, 3 Phenylpropan-1-ol, 4-phenylbutan-1-ol, 5-phenylpentan-1-ol, 2-benzylheptan-1-ol, 2,2-dimethyl-3-phenylpropan-1-ol and 2-n-pentyl 3-phenylpropane-1-ol. Extraordinary preference is given to 2-benzylheptene-1-ol.
Bevorzugte erfindungsgemäße Zusammensetzungen enthalten zusätzlich zu dem mindestens einen deodorierend wirkenden Doppelsalz vom Alaun-Typ b) und zusätzlich zur beanspruchten Komponente c) mindestens einen weiteren Deodorant-Wrkstoff. Bevorzugte derartige Deodorant- Wirkstoffe sind ausgewählt aus mineralischen Deodorant-Wrkstoffen, Geruchsabsorbern, anorganischen Feuchtigkeitsabsorbern, desodorierend wirkenden Ionenaustauschern, keimhemmenden Substanzen, präbiotisch wirksamen Substanzen sowie Enzyminhibitoren und, besonders bevorzugt, Kombinationen der genannten Deodorant-Wrkstoffe. Zu den mineralischen Deodorant-Wirkstoffen oder Feuchtigkeitsabsorbentien zählen bevorzugt geruchsabsorbierende und/oder Feuchtigkeit absorbierende Silicate wie z. B. Zeolithe, hydratisierte Natrium-Aluminium-Silikate, Magnesi- umaluminiumsilikate, Kaolin, lllit, Smectit Tone, Clay, Green Clay, Mica (Glimmer), Talk, unmodifi- zierte Bentonite, unmodifizierte Hectorite und Montmorillonite, aber auch antibakteriell wirksame Kupfersalze und Zinksalze, insbesondere Zinkchloride und Zinksulfate. Nicht-modifizierte Silicate dienen als Geruchsabsorber oder Feuchtigkeitsabsorber, die gleichzeitig die Theologischen Eigenschaften der erfindungsgemäßen Zusammensetzung vorteilhaft unterstützen. Zu den erfindungsgemäß besonders vorteilhaften Silicaten zählen vor allem nicht-modifizierte Schichtsilicate und unter diesen besonders Montmorillonit, Kaolinit, lllit, Beidellit, Nontronit, Saponit, Hectorit, Bentonit, Smectit und Talkum. Derartige mineralische Deodorant-Wirkstoffe oder Feuchtigkeitsabsorbentien sind bevorzugt in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,5 - 3 Gew.-%, besonders bevorzugt 0,7 - 2 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten. Weitere vorteilhafte Geruchsabsorber sind beispielsweise Zinkricinoleat, Cyclodextrine, bestimmte Metalloxide, wie z. B. Aluminiumoxid, sowie Chlorophyll. Preferred compositions according to the invention contain, in addition to the at least one deodorant double salt of the alum type b) and in addition to the claimed component c), at least one further deodorant active substance. Preferred such deodorant active ingredients are selected from mineral deodorant active substances, odor absorbers, inorganic moisture absorbers, deodorizing ion exchangers, germ-inhibiting substances, prebiotic substances and also enzyme inhibitors and, particularly preferred, combinations of said deodorant active substances. The mineral deodorant or moisture absorbents preferably include odor-absorbing and / or moisture-absorbing silicates such. As zeolites, hydrated sodium aluminum silicates, magnesium aluminum silicates, kaolin, lllite, smectite clays, clay, green clay, mica, talc, unmodified bentonites, unmodified hectorites and montmorillonites, but also antibacterial copper salts and zinc salts, especially zinc chlorides and zinc sulfates. Unmodified silicates serve as odor absorbers or moisture absorbers, which at the same time advantageously support the rheological properties of the composition according to the invention. The silicates which are particularly advantageous according to the invention include, in particular, unmodified phyllosilicates and, among these, in particular montmorillonite, kaolinite, IIIit, beidellite, nontronite, saponite, hectorite, bentonite, smectite and talcum. Such mineral deodorant or moisture absorbents are preferably in a total amount of 0.1 to 5 wt .-%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the entire composition, included. Further advantageous odor absorbers are, for example, zinc ricinoleate, cyclodextrins, certain metal oxides, such as. As alumina, and chlorophyll.
Unter keimhemmenden oder antimikrobiellen Wirkstoffen werden erfindungsgemäß solche Wrk- stoffe verstanden, die die Zahl der an der Geruchsbildung beteiligten Hautkeime reduzieren bzw. deren Wachstum hemmen. Zu diesen Keimen zählen unter anderem verschiedene Spezies aus der Gruppe der Staphylokokken, der Gruppe der Corynebakterien, Anaerokokken und Mikro- kokken. Als keimhemmende oder antimikrobielle Wrkstoffe erfindungsgemäß bevorzugt sind insbesondere Organohalogenverbindungen sowie -halogenide, quartäre Ammoniumverbindungen, eine Reihe von Pflanzenextrakten und Zinkverbindungen. Hierzu zählen u. a. Triclosan, Chlorhexidin und Chlorhexidingluconat, 3,4,4'-Trichlorcarbanilid, Bromchlorophen, Dichlorophen, Chlorothymol, Chloroxylenol, Hexachlorophen, Dichloro-m-xylenol, Dequaliniumchlorid, Domiphen- bromid, Ammoniumphenolsulfonat, Benzalkoniumhalogenide, Benzalkoniumcetylphosphat, Benz- alkoniumsaccharinate, Benzethoniumchlorid, Cetylpyridiniumchlorid, Laurylpyridiniumchlorid, Laurylisoquinoliniumbromid, Methylbenzedoniumchlorid. Weiterhin sind Phenol, Dinatriumdihydro- xyethylsulfosuccinylundecylenat, Natriumbicarbonat, Zinklactat, Natriumphenolsulfonat und Zink- phenolsulfonat, Ketoglutarsäure, Terpenalkohole wie z. B. Farnesol, Chlorophyllin-Kupfer-Komplexe, α-Monoalkylglycerinether mit einem verzweigten oder linearen gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C6 - C22-Alkylrest, besonders bevorzugt a-(2-Ethylhexyl)glyce- rinether, im Handel erhältlich als Sensiva® SC 50 (ex Schülke & Mayr), Carbonsäureester des Mono-, Di- und Triglycerins (z. B. Glycerinmonolaurat, Diglycerinmonocaprinat), Lantibiotika sowie Pflanzenextrakte (z. B. grüner Tee und Bestandteile des Lindenblütenöls) einsetzbar. According to the invention, germ-inhibiting or antimicrobial active substances are understood to mean those wrinkles which reduce the number of skin germs participating in the formation of the odor or inhibit their growth. These organisms include, among others, various species from the group of staphylococci, the group of corynebacteria, anaerococci and micrococci. Preferred germinal or antimicrobial active substances according to the invention are in particular organohalogen compounds and halides, quaternary ammonium compounds, a series of plant extracts and zinc compounds. These include triclosan, chlorhexidine and chlorhexidine gluconate, 3,4,4'-trichlorocarbanilide, bromochlorophene, dichlorophen, chlorothymol, chloroxylenol, hexachlorophene, dichloro-m-xylenol, dequalinium chloride, domiphen bromide, ammonium phenolsulfonate, benzalkonium halides, benzalkonium cetyl phosphate, benzalconium saccharinates, Benzethonium chloride, cetylpyridinium chloride, laurylpyridinium chloride, laurylisoquinolinium bromide, methylbenzedonium chloride. Furthermore, phenol, disodium dihydroxyethylsulfosuccinyl undecylenate, sodium bicarbonate, zinc lactate, sodium phenolsulfonate and zinc phenolsulfonate, ketoglutaric acid, terpene alcohols such as. As farnesol, chlorophyllin copper complexes, α-monoalkyl glycerol ether with a branched or linear saturated or unsaturated, optionally hydroxylated C 6 - C 22 alkyl, particularly preferably a- (2-ethylhexyl) glycerol, commercially available as Sensiva ® SC 50 (ex Schülke & Mayr), carboxylic acid esters of mono-, di- and triglycerol (eg glycerol monolaurate, diglycerol monocaprinate), lantibiotics and plant extracts (eg green tea and components of lime blossom oil).
Weitere bevorzugte Deodorant-Wrkstoffe sind ausgewählt aus sogenannten präbiotisch wirksamen Komponenten, worunter erfindungsgemäß solche Komponenten zu verstehen sind, die nur oder zumindest überwiegend die geruchsbildenden Keime der Hautmikroflora hemmen, nicht aber die erwünschten, das heißt, die nicht-geruchsbildenden Keime, die zu einer gesunden Hautmikro- flora gehören. Explizit sind hier die Wirkstoffe, die in den Offenlegungsschriften DE 10333245 und DE 10 2004 01 1 968 als präbiotisch wirksam offenbart sind, mit einbezogen; dazu gehören Nadelbaumextrakte, insbesondere aus der Gruppe der Pinaceae, und Pflanzenextrakte aus der Gruppe der Sapindaceae, Araliaceae, Lamiaceae und Saxifragaceae, insbesondere Extrakte aus Picea spp., Paullinia sp., Panax sp., Lamium album oder Ribes nigrum sowie Mischungen dieser Substanzen. Zu den Enzyminhibitoren gehören Stoffe, die die für die Schweißzersetzung verantwortlichen Enzyme, insbesondere die Arylsulfatase, ß-Glucuronidase, Aminoacylase, Cystathionin-beta- Lyase Esterasen, Lipasen und/oder Lipoxigenase, hemmen, z. B. Trialkylcitronensäureester, insbesondere Triethylcitrat, oder Zinkglycinat. Weitere bevorzugte Deodorant-Wrkstoffe sind ausgewählt aus Silbersalzen, insbesondere Silbercitrat, Dihydrogensilbercitrat, Silberlactat und Silbersulfat, löslichen Komplexsalzen des Silbers, kolloidalem Silber und Silberzeolithen. Further preferred deodorant active substances are selected from so-called prebiotically active components, which according to the invention are to be understood as meaning those components which inhibit only or at least predominantly the odor-causing germs of the skin microflora, but not the desired ones, that is, the non-odor-forming germs forming a healthy skin micro flora. Explicitly here are the active ingredients, which are disclosed in the published patent applications DE 10333245 and DE 10 2004 01 1 968 as prebiotically effective, also included; These include conifer extracts, in particular from the group of Pinaceae, and plant extracts from the group of Sapindaceae, Araliaceae, Lamiaceae and Saxifragaceae, in particular extracts from Picea spp., Paullinia sp., Panax sp., Lamium album or Ribes nigrum and mixtures of these substances. The enzyme inhibitors include substances which inhibit the enzymes responsible for the sweat decomposition, in particular the arylsulfatase, β-glucuronidase, aminoacylase, cystathionine beta-lyase esterases, lipases and / or lipoxigenase, e.g. B. trialkylcitric acid, in particular triethyl citrate, or zinc glycinate. Further preferred deodorant impurities are selected from silver salts, in particular silver citrate, dihydrogen silver citrate, silver lactate and silver sulfate, soluble complex salts of silver, colloidal silver and silver zeolites.
Bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen zusätzlichen Deodorant-Wrkstoff, ausgewählt aus Silbersalzen, löslichen Komplexsalzen des Silbers, kolloidalem Silber und Silberzeolithen, Arylsulfatase-Inhibitoren, ß-Glucuronidase-lnhibitoren, Aminoacy- lase-lnhibitoren, Cystathionin-beta-Lyase-lnhibitoren, Esterase-Inhibitoren, Lipase-Inhibitoren und Lipoxigenase-Inhibitoren, α-Monoalkylglycerinethern mit einem verzweigten oder linearen gesättigten oder ungesättigten, gegebenenfalls hydroxylierten C6 - C22-Alkylrest, insbesondere a-(2-Ethyl- hexyl)glycerinether, präbiotisch wirksamen Komponenten, Trialkylcitronensäureestern, besonders Triethylcitrat, Wirkstoffen, die die Zahl der an der Geruchsbildung beteiligten Hautkeime aus der Gruppe der Staphylokokken, Corynebakterien, Anaerokokken, Mikrokokken und Peptinophile reduzieren bzw. deren Wachstum hemmen, Zinkverbindungen, insbesondere Zinkphenolsulfonat und Zinkricinoleat, Organohalogenverbindungen, insbesondere Triclosan, Chlorhexidin, Chlorhexidin- gluconat und Benzalkoniumhalogeniden, quartären Ammoniumverbindungen, besonders Cetylpyri- diniumchlorid, Geruchsabsorbern, insbesondere Silikaten und Zeolithen, Natriumbicarbonat, Lanti- biotika, sowie Mischungen der vorgenannten Substanzen. Weitere bevorzugte erfindungsgemäße Zusammensetzungen enthalten mindestens einen zusätzlichen Deodorant-Wirkstoff in einer Gesamtmenge von 0,1 - 10 Gew.-%, bevorzugt 0,2 - 7 Gew.-%, besonders bevorzugt 0,3 - 5 Gew.-% und außerordentlich bevorzugt 0,4 - 1 ,0 Gew.-%, weiterhin bevorzugt 0,5 - 0,9 und 0,6 - 0,8 Gew.-%, bezogen auf das Gesamtgewicht der Aktivsubstanz in der Gesamtzusammensetzung. Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten mindestens einen weiteren mineralischen Deodorantwirkstoff oder Schweißabsorbent oder Feuchtigkeitsabsorbent, wobei besonders bevorzugte Zusammensetzungen den/die zusätzliche/n mineralischer/en Deodorant- wirkstoff/e oder Schweißabsorbentien oder Feuchtigkeitsabsorbent/ien in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,5 - 3 Gew.-%, besonders bevorzugt 0,7 - 2 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, enthalten. Preferred compositions according to the invention comprise at least one additional deodorant active ingredient chosen from silver salts, soluble complex salts of silver, colloidal silver and silver zeolites, arylsulfatase inhibitors, β-glucuronidase inhibitors, aminoacylase inhibitors, cystathionine beta-lyase inhibitors, esterase Inhibitors, lipase inhibitors and lipoxygenase inhibitors, α-monoalkyl glycerol ethers having a branched or linear saturated or unsaturated, optionally hydroxylated C 6 -C 22 -alkyl radical, in particular a- (2-ethylhexyl) glycerol ether, prebiotic components, trialkyl citric acid esters , in particular triethyl citrate, active substances which reduce or inhibit the growth of the number of odoriferous skin microorganisms from the group of staphylococci, corynebacteria, anaerococci, micrococci and peptinophiles, zinc compounds, in particular zinc phenolsulphonate and zinc ricinoleate, organohalogen compounds n, in particular triclosan, chlorhexidine, chlorhexidine gluconate and benzalkonium halides, quaternary ammonium compounds, especially cetylpyridinium chloride, odor absorbers, in particular silicates and zeolites, sodium bicarbonate, lantibiotics, and mixtures of the abovementioned substances. Further preferred compositions according to the invention contain at least one additional deodorant active ingredient in a total amount of 0.1-10% by weight, preferably 0.2-7% by weight, more preferably 0.3-5% by weight and most preferably 0.4 - 1, 0 wt .-%, further preferably 0.5 - 0.9 and 0.6 - 0.8 wt .-%, based on the total weight of the active substance in the total composition. Further compositions preferred according to the invention comprise at least one further mineral deodorant active or sweat-absorbent or moisture-absorbent, with particularly preferred compositions containing the additional mineral / deodorant active ingredient or sweat absorbents or moisture absorbents in a total amount of 0.1-5% by weight. -%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, each based on the total composition.
Weitere erfindungsgemäß bevorzugte Zusammensetzungen enthalten 0,01 - 5 Gew.-%, bevorzugt 0,05 - 2 Gew.-%, besonders bevorzugt 0,1 - 1 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung, einer aus einem natürlichen Mineralwasser, einem Thermalwasser oder einem natürlichen Heilwasser erhaltenen Mineralstoffmischung. Die Bezeichnung„natürliches Mineralwasser" richtet sich nach der Definition der deutschen Mineral- und Tafelwasserverordnung (MinTafWV, § 2). Als Mineralstoffmischung gilt der feste Rückstand der genannten Wässer. Erfindungsgemäß besonders bevorzugte Mineralstoffmischungen stammen aus dem Thermalwasser von La Toja (Spanien), Bad Blumau, Bad Radkersburg, Aachen, Wiesbaden (alle Deutschland), Karlsbad (Tschechien), La Bourboule, Enghien-les-bains, Allevard-les-bains, Digne, Nyrac-les-bains, Lons le Saunier, Eaux Bonnes, Rochefort, les Fumades, Saint Christau, Uriage-les-bains, la Roche-Posay (alle Frankreich) oder den natürlichen Mineralwässern oder Heilwässern von Evian, Volvic, Vichy, Avene, Vittel (alle Frankreich), Gerolstein oder Fachingen (Deutschland). Further inventively preferred compositions contain 0.01 to 5 wt .-%, preferably 0.05 to 2 wt .-%, particularly preferably 0.1 to 1 wt .-%, each based on the total composition, one of a natural mineral water , a thermal water or a natural healing mineral mixture obtained. The term "natural mineral water" is based on the definition of the German Mineral and Table Water Ordinance (MinTafWV, § 2) .The mineral residue is the solid residue of the named waters.Occupationally preferred mineral mixtures originate from the thermal water of La Toja (Spain), Bad Blumau, Bad Radkersburg, Aachen, Wiesbaden (all Germany), Carlsbad (Czech Republic), La Bourboule, Enghien-les-bains, Allevard-les-bains, Digne, Nyrac-les-bains, Lons le Saunier, Eaux Bonnes, Rochefort, les Fumades, Saint Christau, Uriage-les-bains, la Roche-Posay (all France) or the natural mineral or medicinal waters of Evian, Volvic, Vichy, Avene, Vittel (all France), Gerolstein or Fachingen ( Germany).
Antioxidative Stoffe können der oxidativen Zersetzung der Schweißkomponenten entgegenwirken und auf diese Weise die Geruchsentwicklung hemmen. Bevorzugte Antioxidantien sind Imidazol und Imidazolderivate (z. B. Urocaninsäure), Peptide, wie z. B. D,L-Carnosin, D-Carnosin, L-Car- nosin und deren Derivate (z. B. Anserin), Carotinoide, Carotine (z. B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Liponsäure und deren Derivate (z. B. Dihydroliponsäure), Aurothioglucose, Propylthiouracil und weitere Thioverbindungen (z. B. Thioglycerin, Thiosorbitol, Thioglycolsäure, Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl-, Lauryl-, Palmitoyl-, Oleyl-, γ-Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximin- verbindungen (z. B. Buthioninsulfoximine, Homocysteinsulfoximin, Buthioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen (z. B. pmol/kg bis μηιοΙ/kg), ferner Metallchelatoren (z. B. α-Hydroxyfettsäuren, EDTA, EGTA, Lactoferrin), Huminsäuren, Gallensäure, Gallenextrakte, Catechine, Bilirubin, Biliverdin und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z. B. γ-Linolensäure, Linolsäure, Arachidonsäure, Ölsäure), Folsäure und deren Derivate, Hydrochinon und dessen Derivate (z. B. Arbutin), Ubichinon und Ubichinol sowie deren Derivate, Vitamin C und dessen Derivate (z. B. Ascorbylpalmitat, -stearat, -dipalmi- tat, -acetat, Mg-Ascorbylphosphate, Natrium- und Magnesiumascorbat, Dinatriumascorbylphosphat und -sulfat, Kaliumascorbyltocopherylphosphat, Chitosanascorbat), Isoascorbinsäure und deren Derivate, Tocopherole und deren Derivate (z. B. Tocopherylacetat, -linoleat, -oleat und -succinat, Tocophereth-5, Tocophereth-10, Tocophereth-12, Tocophereth-18, Tocophereth-50, Tocopherso- lan), Vitamin A und Derivate (z. B. Vitamin-A-Palmitat), das Coniferylbenzoat des Benzoeharzes, Rutin, Rutinsäure und deren Derivate, Dinatriumrutinyldisulfat, Zimtsäure und deren Derivate, Koji- säure, Chitosanglycolat und -salicylat, Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajak- harzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Mannose und deren Derivate, Selen und Selen-Derivate (z. B. Selenmethionin), Silibene und Stilben-Derivate (z. B. Stilbenoxid, trans-Stilbenoxid). Erfindungsgemäß können geeignete Derivate (Salze, Ester, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) sowie Mischungen dieser genannten Wrkstoffe oder wasserfreie Pflanzenextrakte, die diese Antioxidantien enthalten, eingesetzt werden. Als lipophile, öllösliche Antioxidantien aus dieser Gruppe sind Tocopherol und dessen Derivate, insbesondere Tocopherylacetat, und Carotinoide sowie Butylhydroxytoluol und Butylhydroxyanisol bevorzugt. Die Gesamtmenge der Antioxidantien in bevorzugten erfindungsge- mäßen Zusammensetzungen beträgt 0,001 - 10 Gew.-%, vorzugsweise 0,05 - 5 Gew.-% und besonders 0,1 - 2 Gew.-%, bezogen auf die gesamte Zusammensetzung. Antioxidant substances can counteract the oxidative decomposition of the welding components and in this way inhibit odor development. Preferred antioxidants are imidazole and imidazole derivatives (eg urocaninic acid), peptides, such as e.g. B. D, L-carnosine, D-carnosine, L-carnosine and their derivatives (eg, anserine), carotenoids, carotenes (eg, α-carotene, β-carotene, lycopene) and their derivatives, Lipoic acid and its derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiouracil and other thio compounds (eg thioglycerol, thiosorbitol, thioglycollic acid, thioredoxin, glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl) , Ethyl, propyl, amyl, butyl, lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and derivatives thereof (esters, ethers, peptides , Lipids, nucleotides, nucleosides and salts) and sulfoximine compounds (eg buthionine sulfoximines, homocysteine sulfoximine, buthione sulfones, penta, hexa, heptathionine sulfoximine) in very low tolerated dosages (eg pmol / kg to μηιοΙ / kg) , metal chelators (eg, α-hydroxy fatty acids, EDTA, EGTA, lactof errin), humic acids, bile acids, bile extracts, catechins, bilirubin, biliverdin and their derivatives, unsaturated fatty acids and their derivatives (e.g. Gamma-linolenic acid, linoleic acid, arachidonic acid, oleic acid), folic acid and its derivatives, hydroquinone and its derivatives (eg arbutin), ubiquinone and ubiquinol and their derivatives, vitamin C and its derivatives (eg ascorbyl palmitate, stearate, dipalmi- tate, acetate, Mg ascorbyl phosphates, sodium and magnesium ascorbate, disodium ascorbyl phosphate and sulfate, potassium ascorbyl tocopheryl phosphate, chitosan ascorbate), isoascorbic acid and its derivatives, tocopherols and their derivatives (for example tocopheryl acetate, linoleate, oleate and succinate, tocophereth-5, tocophereth-10, tocophereth-12, tocophereth-18, tocophereth-50, tocopherolan), vitamin A and derivatives (eg vitamin A palmitate), the benzylic resin coniferyl benzoate, Rutin, rutinic acid and derivatives thereof, disodium rutinyl disulphate, cinnamic acid and its derivatives, kojic acid, chitosan glycolate and salicylate, butylhydroxytoluene, butylhydroxyanisole, nordihydroguaiacetic acid, nordihydroguiaretic acid, trihydroxybutyrophenone, Uric acid and its derivatives, mannose and its derivatives, selenium and selenium derivatives (e.g. Selenium methionine), silibene and stilbene derivatives (eg stilbene oxide, trans-stilbene oxide). According to the invention, suitable derivatives (salts, esters, sugars, nucleotides, nucleosides, peptides and lipids) as well as mixtures of these cited impurities or anhydrous plant extracts containing these antioxidants can be used. Preferred lipophilic, oil-soluble antioxidants from this group are tocopherol and its derivatives, in particular tocopheryl acetate, and carotenoids, as well as butylhydroxytoluene and butylhydroxyanisole. The total amount of antioxidants in preferred erfindungsge- Compositions is 0.001 to 10 wt .-%, preferably 0.05 to 5 wt .-% and especially 0.1 to 2 wt .-%, based on the total composition.
Auch komplexbildende Stoffe können die deodorierende Wirkung unterstützen, indem sie die oxi- dativ katalytisch wirkenden Schwermetallionen (z. B. Eisen oder Kupfer) stabil komplexieren. Bevorzugte erfindungsgemäße Zusammensetzungen enthalten daher mindestens einen Komplexbildner.  Even complex-forming substances can support the deodorizing effect by stably complexing the oxidatively catalytically active heavy metal ions (eg iron or copper). Preferred compositions according to the invention therefore contain at least one complexing agent.
In einer weiteren bevorzugten Ausführungsform enthalten die erfindungsgemäßen Öl-in-Wasser- Emulsionen mindestens eine organische UV-Filtersubstanz. Die erfindungsgemäß bevorzugten organischen UV-Filter sind ausgewählt aus den Derivaten von Dibenzoylmethan, Zimtsäureestern, Diphenylacrylsäureestern, Benzophenon, Campher, p-Aminobenzoesäureestern, o-Aminobenzoes- äureestern, Salicylsäureestern, Benzimidazolen, symmetrisch oder unsymmetrisch substituierten 1 ,3,5-Triazinen, monomeren und oligomeren 4,4-Diarylbutadiencarbonsäureestern und -carbon- säureamiden, Ketotricyclo(5.2.1 .0)decan, Benzalmalonsäureestern, Benzoxazol sowie beliebigen Mischungen der genannten Komponenten. Die organischen UV-Filter können öllöslich oder wasserlöslich sein. Die Benzoxazol-Derivate liegen vorteilhaft in gelöster Form in den erfindungsgemäßen kosmetischen Zubereitungen vor. Bevorzugte erfindungsgemäße Emulsionen enthalten mindestens eine organische UV-Filtersubstanz in einer Gesamtmenge von 0,1 - 30 Gew.-%, bevorzugt 0,5 - 20 Gew.-%, besonders bevorzugt 1 ,0 - 10 Gew.-% und außerordentlich bevorzugt 2 oder 3 - 7 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung.  In a further preferred embodiment, the oil-in-water emulsions according to the invention contain at least one organic UV filter substance. The organic UV filters preferred according to the invention are selected from the derivatives of dibenzoylmethane, cinnamic acid esters, diphenylacrylic acid esters, benzophenone, camphor, p-aminobenzoic acid esters, o-aminobenzoic acid esters, salicylic acid esters, benzimidazoles, symmetrically or asymmetrically substituted 1,3,5-triazines, monomers and oligomeric 4,4-diarylbutadiene carboxylic acid esters and carboxylic acid amides, ketotricyclo (5.2.1 .0) decane, benzalmalonic acid esters, benzoxazole and any desired mixtures of the stated components. The organic UV filters can be oil-soluble or water-soluble. The benzoxazole derivatives are advantageously present in dissolved form in the cosmetic preparations according to the invention. Preferred emulsions according to the invention comprise at least one organic UV filter substance in a total amount of 0.1-30% by weight, preferably 0.5-20% by weight, more preferably 1.0-10% by weight and most preferably 2 or 3 - 7 wt .-%, each based on the total composition.
Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass die Öl- oder Fettphase mindestens einen Duftstoff umfasst.  Further oil-in-water emulsions preferred according to the invention are characterized in that the oil or fat phase comprises at least one perfume.
Als Duftstoffkomponente können Parfüme, Parfümöle oder Parfümölbestandteile eingesetzt werden. Parfümöle bzw. Duftstoffe können erfindungsgemäß einzelne Riechstoffverbindungen, z. B. die synthetischen Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe sein. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxy- ethylisobutyrat, p-tert.-Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat (DMBCA), Phenylethylacetat, Benzylacetat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat, Benzylsalicylat, Cyclohexylsalicylat, Floramat, Melusat und Jasmecyclat. Zu den Ethern zählen beispielsweise Benzylethylether und Ambroxan , zu den Aldehyden z.B. die linearen Alkanale mit 8 - 18 C-Atomen, Citral, Citronellal, Citronellyloxy-acetaldehyd, Cyclamenaldehyd, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone, alpha-lsomethylionon und Methylcedryl- keton, zu den Alkoholen Anethol, Citronellol, Eugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene wie Limonen und Pinen. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Solche Parfümöle können auch natürliche Riechstoffgemische enthalten, wie sie aus pflanzlichen Quellen zugänglich sind, z.B. Pine-, Citrus-, Jasmin-, Patchouly-, Rosen- oder Ylang-Ylang-Öl. Ebenfalls geeignet sind Muskateller-Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeeröl, Vetiveröl, Olibanumöl, Galbanumöl und Laudanumöl sowie Orangenblütenöl, Neroliöl, Orangenschalenöl und Sandelholzöl. Besonders bevorzugte erfindungsgemäße kosmetische Emulsionen enthalten mindestens eine Duftstoffkomponente in einer Gesamtmenge von 0,00001 bis 4 Gew.-%, bevorzugt 0,5 - 2 Gew.-%, besonders bevorzugt 1 - 1 ,5 Gew.-%, jeweils bezogen auf die Gesamtzusammensetzung. As perfume component perfumes, perfume oils or perfume oil ingredients can be used. Perfume oils or fragrances can according to the invention individual fragrance compounds, eg. As the synthetic products of the ester type, ethers, aldehydes, ketones, alcohols and hydrocarbons. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate (DMBCA), phenylethyl acetate, benzyl acetate, ethylmethylphenylglycinate, allylcyclohexylpropionate, styrallylpropionate, benzylsalicylate, cyclohexylsalicylate, floramate, melusate and jasmecyclate. The ethers include, for example, benzyl ethyl ether and ambroxane, to the aldehydes, for example, the linear alkanals with 8 - 18 carbon atoms, citral, citronellal, citronellyloxy-acetaldehyde, cyclamen aldehyde, Lilial and Bourgeonal, to the ketones such as the Jonone, alpha-lsomethylionon and methylcedryl ketones, among the alcohols anethole, citronellol, eugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes such as limonene and pinene. Preferably, however, mixtures of different fragrances are used, which together produce an attractive fragrance. Such perfume oils may also contain natural fragrance mixtures as are available from vegetable sources, eg pine, citrus, jasmine, patchouly, rose or ylang-ylang oil. Also suitable are Muskateller sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, olibanum oil, galbanum oil and laudanum oil and orange blossom oil, neroli oil, orange peel oil and Sandalwood oil. Particularly preferred cosmetic emulsions according to the invention contain at least one perfume component in a total amount of 0.00001 to 4 wt .-%, preferably 0.5 to 2 wt .-%, particularly preferably 1-1, 5 wt .-%, each based on the total composition.
Weitere erfindungsgemäß bevorzugte ÖI-in-Wasser-Emulsionen sind dadurch gekennzeichnet, dass sie in einem Behälter mit Kugelapplikator oder Roll-on-Applikator verpackt ist.  Further inventively preferred oil-in-water emulsions are characterized in that they are packaged in a container with ball applicator or roll-on applicator.
Ein weiterer Gegenstand der vorliegenden Erfindung ist die kosmetische, nicht-therapeutische Verwendung einer erfindungsgemäßen ÖI-in-Wasser-Emulsion, zur schweißhemmenden Behandlung der Haut, insbesondere der Achselhaut und/oder der Fußhaut. Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention, for the antiperspirant treatment of the skin, in particular the armpit skin and / or the skin of the feet.
Ein weiterer Gegenstand der vorliegenden Erfindung ist die kosmetische, nicht-therapeutische Verwendung einer erfindungsgemäßen ÖI-in-Wasser-Emulsion zur schweißhemmenden Behandlung der Haut, insbesondere der Achselhaut und/oder der Fußhaut, mit nicht-fettendem Hautgefühl. Ein weiterer Gegenstand der vorliegenden Erfindung ist ein kosmetisches, nicht-therapeutisches Verfahren zur schweißhemmenden Behandlung der Haut, insbesondere der Achselhaut und/oder der Fußhaut, das dadurch gekennzeichnet ist, dass eine erfindungsgemäße ÖI-in-Wasser-Emulsion in einer wirksamen Menge auf die Haut aufgetragen wird.  Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for antiperspirant treatment of the skin, especially the armpit skin and / or the skin of the feet, with non-greasy skin feel. Another object of the present invention is a cosmetic, non-therapeutic method for antiperspirant treatment of the skin, in particular the underarm skin and / or the skin of the foot, which is characterized in that an inventive oil-in-water emulsion in an effective amount to the Skin is applied.
Ein weiterer Gegenstand der vorliegenden Erfindung ist die kosmetische, nicht-therapeutische Verwendung einer erfindungsgemäßen ÖI-in-Wasser-Emulsion zur desodorierenden Behandlung der Haut.  Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for the deodorizing treatment of the skin.
Ein weiterer Gegenstand der vorliegenden Erfindung ist die kosmetische, nicht-therapeutische Verwendung einer erfindungsgemäßen ÖI-in-Wasser-Emulsion zur desodorierenden Hautbehandlung mit nicht-fettendem Hautgefühl.  Another object of the present invention is the cosmetic, non-therapeutic use of an oil-in-water emulsion according to the invention for the deodorant skin treatment with a non-greasy feel on the skin.
Ein weiterer Gegenstand der vorliegenden Erfindung ist ein kosmetisches, nicht-therapeutisches Verfahren zur desodorierenden Hautbehandlung, das dadurch gekennzeichnet ist, dass eine erfindungsgemäße ÖI-in-Wasser-Emulsion in einer wirksamen Menge auf die Haut aufgetragen wird.  Another object of the present invention is a cosmetic, non-therapeutic method for deodorizing skin treatment, which is characterized in that an inventive oil-in-water emulsion is applied in an effective amount to the skin.
Die nachfolgenden Beispiele sollen den Gegenstand der Erfindung näher erläutern, ohne ihn jedoch hierauf zu beschränken. Alle Angaben in Gew.-%, soweit nicht anders angegeben.  The following examples are intended to illustrate the subject matter of the invention without, however, limiting it to it. All data in% by weight, unless stated otherwise.
Beispiel 1 : erfindungsgemäße Antitranspirant-Emulsionen (O/W) Example 1 Antiperspirant Emulsions (O / W) According to the Invention
Figure imgf000029_0001
Figure imgf000029_0001
Figure imgf000030_0001
Figure imgf000030_0001
Die Emulsion gemäß Beispiel 1 wies am ersten Tag nach der Herstellung eine Viskosität von 1800 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur.  The emulsion according to Example 1 had a viscosity of 1800 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
Beispiel 2: erfindungsgemäße Antitranspirant-Emulsion (O/W) Example 2 Antiperspirant Emulsion (O / W) According to the Invention
Figure imgf000030_0003
Figure imgf000030_0003
Die Emulsion gemäß Beispiel 2 wies am ersten Tag nach der Herstellung eine Viskosität von 2000 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur.  The emulsion according to example 2 had a viscosity of 2000 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
Beispiel 3: erfindungsgemäße Antitranspirant-Emulsion (O/W) Example 3 Antiperspirant Emulsion (O / W) According to the Invention
Figure imgf000030_0002
Figure imgf000030_0002
Figure imgf000031_0001
Figure imgf000031_0001
Die Emulsion gemäß Beispiel 3 wies am ersten Tag nach der Herstellung eine Viskosität von 2200 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur.  The emulsion according to example 3 had a viscosity of 2200 mPas on the first day after preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
Beispiel 4: erfindungsgemäße Antitranspirant-Emulsion (O/W) Example 4 Antiperspirant Emulsion (O / W) According to the Invention
Figure imgf000031_0002
Figure imgf000031_0002
Die Emulsion gemäß Beispiel 4 wies am ersten Tag nach der Herstellung eine Viskosität von 1700 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur. Beispiel 5: erfindungsgemäße Antitranspirant-Emulsion (O/W) The emulsion according to example 4 had a viscosity of 1700 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature. Example 5 Antiperspirant Emulsion (O / W) According to the Invention
Figure imgf000032_0001
Figure imgf000032_0001
Die Emulsion gemäß Beispiel 5 wies am ersten Tag nach der Herstellung eine Viskosität von 1800 mPas auf, gemessen mit einem Brookfield-Viskosimeter, Spindel RV 4, 20 s-1 , ohne Helipath, bei 20 °C Umgebungstemperatur und 20 °C Probentemperatur.  The emulsion according to Example 5 had a viscosity of 1800 mPas on the first day after the preparation, measured with a Brookfield viscometer, spindle RV 4, 20 s-1, without helipath, at 20 ° C. ambient temperature and 20 ° C. sample temperature.
Die Emulsionen gemäß den Beispielen 1 - 5 wurden jeweils in eine Flasche mit einem Rollapplika- tor eingefüllt und waren so verkaufsfertig. The emulsions according to Examples 1-5 were each filled into a bottle with a roller applicator and were thus ready for sale.

Claims

Patentansprüche: claims:
1 . ÖI-in-Wasser-Emulsion, enthaltend 1 . Oil-in-water emulsion containing
a. mindestens einen schweißhemmenden Wirkstoff, ausgewählt aus Aluminiumchlor- hydroxiden, Aluminiumzirconiumchlorhydraten und Mischungen hiervon, b. mindestens ein Doppelsalz vom Alaun-Typ mit der allgemeinen Formel MIMI"(S04)2 x H20, wobei M1 ein einwertiges Kation, ausgewählt aus Kalium-, Natrium-, Rubidium-, Cäsium- und Ammonium-Ionen, darstellt, M1" ein dreiwertiges Kation, ausgewählt aus Aluminium-, Gallium-, Indium-, Scandium-, Titan- und Vanadium-Ionen, darstellt und x eine rationale Zahl im Bereich von 0 bis 12, einschließlich 0, darstellt; a. at least one antiperspirant active selected from aluminum chlorohydroxides, aluminum zirconium chlorohydrates and mixtures thereof, b. at least one double salt of the alum type having the general formula M I M I "(S0 4) 2 x H 2 0, where M 1 is a monovalent cation selected from potassium, sodium, rubidium, cesium and ammonium Ions, M 1 "represents a trivalent cation selected from aluminum, gallium, indium, scandium, titanium and vanadium ions, and x represents a rational number in the range of 0 to 12, inclusive of 0;
c. 0,0005 - 1 Gew.-%, bezogen auf ihr Gewicht, mindestens einer Siliciumoxid- haltigen Verbindung, ausgewählt aus hydrophilen Kieselsäuren und/oder hydrophob modifizierten Kieselsäuren und/oder Schichtsilikaten, d. mindestens ein Polysaccharid,  c. 0.0005 - 1 wt .-%, based on their weight, of at least one silica-containing compound selected from hydrophilic silicic acids and / or hydrophobically modified silicas and / or phyllosilicates, d. at least one polysaccharide,
e. mindestens ein kosmetisches Öl,  e. at least one cosmetic oil,
wobei die Zusammensetzung als Creme, Gel, Lösung oder auf einem Substrat imprägniert konfektioniert ist.  wherein the composition is formulated as a cream, gel, solution or impregnated on a substrate.
2. Zusammensetzung gemäß Anspruch 1 , dadurch gekennzeichnet, dass das Doppelsalz vom Alaun-Typ b) ausgewählt ist aus KAI(S04)2, KAI(S04)2 1 H20, KAI(S04)2 2 H20, KAI(S04)2 3 H20, KAI(S04)2 4 H20, KAI(S04)2 5 H20, KAI(S04)2 6 H20, KAI(S04)2 7 H20, KAI(S04)2 8 H20, KAI(S04)2 9 H20, KAI(S04)2 10 H20, KAI(S04)2 1 1 HzO und KAI(S04)2 12 H20, sowie Mischungen hiervon. 2. The composition according to claim 1, characterized in that the double salt of alum type b) is selected from KAI (S0 4 ) 2 , KAI (S0 4 ) 2 1 H 2 0, KAI (S0 4 ) 2 2 H. 2 0, KAI (S0 4 ) 2 3 H 2 0, KAI (S0 4 ) 2 4 H 2 0, KAI (S0 4 ) 2 5 H 2 0, KAI (S0 4 ) 2 6 H 2 0 , KAI (S0 4 ) 2 7 H 2 0, KAI (S0 4 ) 2 8 H 2 0, KAI (S0 4 ) 2 9 H 2 0, KAI (S0 4 ) 2 10 H 2 0, KAI (S0 4 ) 2 1 1 H z O and KAI (S0 4 ) 2 12 H 2 0, as well as mixtures thereof.
3. Zusammensetzung gemäß Anspruch 1 oder 2, dadurch gekennzeichnet, dass das mindestens eine Polysaccharid in einer Gesamtmenge von 0,01 - 1 ,0 Gew.-%, bevorzugt 0,05 - 0,5 und besonders bevorzugt 0,09 - 0,2 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Emulsion, enthalten ist und ausgewählt ist aus anionischen und nichtionischen Polysacchariden sowie Mischungen hiervon. 3. Composition according to claim 1 or 2, characterized in that the at least one polysaccharide in a total amount of 0.01 - 1, 0 wt .-%, preferably 0.05 - 0.5 and particularly preferably 0.09 - 0, 2 wt .-%, each based on the total weight of the emulsion, is contained and is selected from anionic and nonionic polysaccharides and mixtures thereof.
4. Zusammensetzung gemäß Anspruch 1 , 2 oder 3, dadurch gekennzeichnet, dass das anionische Polysaccharid ausgewählt ist aus Aluminiumstärkeoctenylsuccinat, Natriumstärkeoctenyl- succinat, Calciumstärkeoctenylsuccinat, Distärkephosphaten, Hydroxyethylstärkephosphaten, Hydroxypropylstärkephosphaten, Natriumcarboxymethylstärken, Natriumstärkeglycolat sowie Mischungen hiervon. 4. A composition according to claim 1, 2 or 3, characterized in that the anionic polysaccharide is selected from aluminum starch octenyl succinate, sodium starch octenyl succinate, calcium starch octenyl succinate, distarch phosphates, hydroxyethyl starch phosphates, hydroxypropyl starch phosphates, sodium carboxymethyl starches, sodium starch glycolate and mixtures thereof.
5. Zusammensetzung gemäß Anspruch 1 , 2, 3 oder 4, dadurch gekennzeichnet, dass das nichtionische Polysaccharid ausgewählt ist aus Stärken, Stärkehydrolysaten, Cellulose, Methyl- cellulose, Hydroxypropylcellulose, Hydroxyethylcellulose, Hydroxypropylmethylcellulose, Hydroxypropylethylcellulose, Hydroxyethylmethylcellulose sowie Mischungen hiervon. 5. The composition according to claim 1, 2, 3 or 4, characterized in that the nonionic polysaccharide is selected from starches, starch hydrolysates, cellulose, methyl cellulose, hydroxypropylcellulose, hydroxyethylcellulose, hydroxypropylmethylcellulose, hydroxypropylethylcellulose, hydroxyethylmethylcellulose and mixtures thereof.
6. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4 oder 5, dadurch gekennzeichnet, dass mindestens ein nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 enthalten ist, der ausgewählt ist aus linearen gesättigten und ungesättigten C 2 - C30-Alkanolen, die mit 1 - 4 Ethylenoxid-Einheiten pro Molekül verethert sind, wobei Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth und Beheneth mit jeweils 1 - 4 Ethylenoxid-Einheiten pro Molekül bevorzugt sind. 6. The composition according to claim 1, 2, 3, 4 or 5, characterized in that at least one nonionic emulsifier having an HLB value in the range 3-6 is included, which is selected from linear saturated and unsaturated C 2 - C 30 Alkanols etherified with 1 to 4 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth, trideceth, arachideth and beheneth each having 1-4 ethylene oxide units per molecule being preferred.
7. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5 oder 6, dadurch gekennzeichnet, dass mindestens ein nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 in einer Gesamtmenge von 1 ,8 - 3 Gew.-%, bezogen auf das Gewicht der gesamten Emulsion, enthalten ist, der ausgewählt ist aus linearen gesättigten und ungesättigten C 2 - C24-Alkanolen, die mit 7 - 40 Ethylenoxid-Einheiten pro Molekül verethert sind, wobei Steareth, Ceteth, Myristeth, Laureth, Trideceth, Arachideth und Beheneth mit jeweils 7 - 40 Ethylenoxid-Einheiten pro Molekül bevorzugt sind. 7. The composition according to claim 1, 2, 3, 4, 5 or 6, characterized in that at least one nonionic emulsifier having an HLB value in the range of 3-6 in a total amount of 1, 8 - 3 wt .-%, based on the weight of the total emulsion selected from linear saturated and unsaturated C 2 -C 24 alkanols etherified with 7 to 40 ethylene oxide units per molecule, with steareth, ceteth, myristeth, laureth, trideceth , Arachideth and beheneth with in each case 7 to 40 ethylene oxide units per molecule are preferred.
8. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6 oder 7, dadurch gekennzeichnet, dass als nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 Steareth-2 und gleichzeitig als nichtionischer Emulgator mit einem HLB-Wert im Bereich von 12 - 18 Steareth-21 enthalten ist. 8. The composition according to claim 1, 2, 3, 4, 5, 6 or 7, characterized in that as nonionic emulsifier having an HLB value in the range of 3-6 steareth-2 and at the same time as a nonionic emulsifier having an HLB value in the range of 12 - 18 steareth-21 is included.
9. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7 oder 8, dadurch gekennzeichnet, dass mindestens ein weiterer mineralischer Deodorantwirkstoff oder Schweißabsorbent oder Feuch- tigkeitsabsorbent in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,5 - 3 Gew.-%, besonders bevorzugt 0,7 - 2 Gew.-%, jeweils bezogen auf die gesamte Zusammensetzung enthalten ist. 9. The composition according to claim 1, 2, 3, 4, 5, 6, 7 or 8, characterized in that at least one further mineral deodorant active or sweat-absorbing or moisture-absorbing agent in a total amount of 0.1-5 wt .-%, preferably 0.5 to 3 wt .-%, particularly preferably 0.7 to 2 wt .-%, in each case based on the total composition is contained.
10. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8 oder 9, dadurch gekennzeichnet, dass sie KAI(S04)2 12 H20 in einer Gesamtmenge von 0,01 - 10 Gew.-%, bevorzugt 0,05 - 5 Gew.-%, besonders bevorzugt 0,1 - 2 Gew.-%, außerordentlich bevorzugt 0,3 - 1 Gew.-%, jeweils bezogen auf das Gesamtgewicht der erfindungsgemäßen Zusammensetzung, enthält. 10. The composition according to claim 1, 2, 3, 4, 5, 6, 7, 8 or 9, characterized in that they KAI (S0 4 ) 2 12 H 2 0 in a total amount of 0.01 to 10 wt. -%, preferably 0.05 to 5 wt .-%, particularly preferably 0.1 to 2 wt .-%, most preferably 0.3 to 1 wt .-%, each based on the total weight of the composition according to the invention contains.
1 1 . Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8, 9 oder 10, dadurch gekennzeichnet, dass das kosmetische Öl Mischungen von Isododecan, Isotridecan, Isotetradecan, Isopenta- decan, Isohexadecan, n-Tridecan, n-Tetradecan und n-Pentadecan umfasst. 1 1. Composition according to Claim 1, 2, 3, 4, 5, 6, 7, 8, 9 or 10, characterized in that the cosmetic oil is mixtures of isododecane, isotridecane, isotetradecane, isopentadicane, isohexadecane, n-tridecane, n-butyl Tetradecane and n-pentadecane includes.
12. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10 oder 1 1 , dadurch gekennzeichnet, dass mindestens ein kosmetisches Öl in einer Gesamtmenge von 0,1 - 5 Gew.-%, bevorzugt 0,3 - 3 Gew.-% und besonders bevorzugt 0,5 - 2 Gew.-%, jeweils bezogen auf das Gesamtgewicht der Emulsion, enthalten ist. 12. The composition according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 or 1 1, characterized in that at least one cosmetic oil in a total amount of 0.1 to 5 wt .-%, preferably 0.3 to 3 wt .-% and particularly preferably 0.5 to 2 wt .-%, each based on the total weight of the emulsion is included.
13. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 oder 12, dadurch gekennzeichnet, dass mindestens ein nichtionischer Emulgator mit einem HLB-Wert im Bereich von 12 - 18 in einer Gesamtmenge von 1 - 2 Gew.-%, bevorzugt 1 ,2 - 1 ,8 Gew.-% und besonders bevorzugt 1 ,5 - 1 ,7 Gew.-%, jeweils bezogen auf das Gewicht der gesamten Emulsion, enthalten ist. 13. A composition according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 or 12, characterized in that at least one nonionic emulsifier having an HLB value in the range of 12-18 in a total amount of 1 - 2 wt .-%, preferably 1, 2 - 1, 8 wt .-% and particularly preferably 1, 5 - 1, 7 wt .-%, each based on the weight of the total emulsion contained.
14. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12 oder 13, dadurch gekennzeichnet, dass mindestens ein nichtionischer Emulgator mit einem HLB-Wert im Bereich von 3 - 6 in einer Gesamtmenge von 1 ,8 - 3 Gew.-%, bevorzugt 2 - 2,8 Gew.-% und besonders bevorzugt 2,4 - 2,6 Gew.-%, jeweils bezogen auf das Gewicht der gesamten Emulsion, enthalten ist. 14. The composition according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 or 13, characterized in that at least one nonionic emulsifier having an HLB value in the range of 3 - 6 in a total amount of 1, 8 to 3 wt .-%, preferably 2 to 2.8 wt .-% and particularly preferably 2.4 to 2.6 wt .-%, each based on the weight of the total emulsion included is.
15. Zusammensetzung gemäß Anspruch 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1 , 12, 13 oder 14, dadurch gekennzeichnet, dass das kosmetische Öl e) ausgewählt ist aus PPG-3-Myristylether, PPG-13- Butylether, PPG-14-Butylether, PPG-9-Butylether, PPG-10-Butandiol, PPG-15-Stearylether, Propylenglycolmonoisostearat, Propylenglycolmonoisopalmitat, Propylenglycolmonoisobehe- nat, Propylenglycolmonoisoarachinat, Propylenglycolmonoisomyristat, Propylenglycolmonoiso- caprat, Propylenglycolmonoisocaprinat, Propylenglycolmonoisocaprylat Isostearylalkohol, Iso- cetylalkohol, Isomyristylalkohol, Isotridecylalkohol, Isoarachidylalkohol, Isobehenylalkohol, Isocaprylalkohol, Isocaprinylalkohol, Isocaprylylalkohol, sowie Mischungen hiervon 15. The composition according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 1 1, 12, 13 or 14, characterized in that the cosmetic oil e) is selected from PPG-3 Myristyl ether, PPG-13-butyl ether, PPG-14-butyl ether, PPG-9-butyl ether, PPG-10-butanediol, PPG-15-stearyl ether, propylene glycol monoisostearate, propylene glycol monoisopalmitate, propylene glycol monoisohexylate, propylene glycol monoisoarachinate, propylene glycol monoiso-myristate, propylene glycol monoisocaprate, propylene glycol monoisocaprinate, Propylene glycol monoisocaprylate isostearyl alcohol, isocetyl alcohol, isomyristyl alcohol, isotridecyl alcohol, isoarachidyl alcohol, isobehenyl alcohol, isocapryl alcohol, isocaprinyl alcohol, isocaprylyl alcohol, and mixtures thereof
PCT/EP2011/062610 2010-07-23 2011-07-22 Double salt-containing antiperspirant roll-ons WO2012010684A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102010038358A DE102010038358A1 (en) 2010-07-23 2010-07-23 Double salt antiperspirant roll-ons
DE102010038358.9 2010-07-23

Publications (2)

Publication Number Publication Date
WO2012010684A2 true WO2012010684A2 (en) 2012-01-26
WO2012010684A3 WO2012010684A3 (en) 2013-11-21

Family

ID=44629004

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2011/062610 WO2012010684A2 (en) 2010-07-23 2011-07-22 Double salt-containing antiperspirant roll-ons

Country Status (2)

Country Link
DE (1) DE102010038358A1 (en)
WO (1) WO2012010684A2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
EP2999452B1 (en) 2013-05-20 2017-12-13 Unilever PLC Antiperspirant compositions
US10076474B2 (en) 2014-03-13 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076490B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10398633B2 (en) 2014-10-27 2019-09-03 Conopco, Inc. Anhydrous antiperspirant compositions
US10493011B2 (en) 2017-08-03 2019-12-03 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US10632052B2 (en) 2015-11-06 2020-04-28 Conopco, Inc. Antiperspirant compositions
US10660830B2 (en) 2015-11-06 2020-05-26 Conopco, Inc. Aerosol antiperspirant product
US10682293B2 (en) 2015-11-06 2020-06-16 Conopco, Inc. Aerosol antiperspirant product
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
US11357714B2 (en) 2020-07-21 2022-06-14 Chembeau LLC Diester cosmetic formulations and uses thereof

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102526311A (en) * 2012-02-21 2012-07-04 简福川 Chinese medicinal preparation for treating sweaty feet
MX360844B (en) * 2013-12-11 2018-11-20 Colgate Palmolive Co Antiperspirant/deodorant composition.
FR3028751B1 (en) * 2014-11-24 2018-01-05 L'oreal POWDER SYNTHETIC PHYLLOSILICATE AS A MATIFYING AGENT AND / OR HOMOGENIZING APPLICATION

Citations (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2259587A1 (en) 1974-02-04 1975-08-29 Procter & Gamble Zirconium or hafnium oxyhalide anti-perspirant cpds - used in compsns with aluminium cpds and amino acids
GB2299506B (en) 1995-04-03 1999-04-14 Unilever Plc Antiperspirant actives and compositions
DE20210904U1 (en) * 2002-07-19 2003-08-21 Holzlehner Martin Deodorant preparation for use on human skin
US20040141934A1 (en) * 2003-01-17 2004-07-22 Colgate-Palmolive Company Two-phase roll-on cosmetic product
DE102004011968A1 (en) 2004-03-10 2005-09-29 Henkel Kgaa Cosmetic or pharmaceutical composition e.g. useful for promoting the growth of desirable skin microorganisms comprises a plant extract with prebiotic activity on the skin
DE10333245C5 (en) 2003-07-21 2015-02-19 Henkel Ag & Co. Kgaa Prebiotic plant extracts
DE102006020380A1 (en) * 2006-04-28 2007-10-31 Henkel Kgaa Preparing oil-in-water emulsion, useful in e.g. cosmetic, comprises heating portion of water and oil-/fat phase; providing second and remaining portion of water; followed by mixing, homogenizing and providing polysaccharide and aroma agent
DE102006020382A1 (en) * 2006-04-28 2007-10-31 Henkel Kgaa Cosmetic oil-in-water emulsion, useful e.g. to treat skin, comprises oil or fat phase comprising a component e.g. branched saturated alkanol, water, a cosmetically active substance e.g. monomer and a polysaccharide

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
GB1347950A (en) 1971-03-08 1974-02-27 Bristol Myers Co Antiperspirant aerosol system
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4017599A (en) 1973-11-23 1977-04-12 Armour Pharmaceutical Company Aluminum-zirconium anti-perspirant systems with salts of amino acids
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6074632A (en) 1997-06-25 2000-06-13 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6245325B1 (en) 1998-08-19 2001-06-12 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6436381B1 (en) 2000-10-25 2002-08-20 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 al content
US6649152B2 (en) 2000-10-25 2003-11-18 The Gillette Company Aluminum-zirconium antiperspirant salts with high peak 5 Al content
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US20040009133A1 (en) 2002-07-12 2004-01-15 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US7105691B2 (en) 2003-06-26 2006-09-12 Colgate-Palmolive Company Aluminum / zirconium / glycine antiperspirant actives stabilized with Betaine
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) 2003-08-14 2005-08-02 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium or calcium

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10076490B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076489B2 (en) 2012-09-14 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
EP2999452B1 (en) 2013-05-20 2017-12-13 Unilever PLC Antiperspirant compositions
EP3295922B1 (en) * 2013-05-20 2024-04-17 Unilever IP Holdings B.V. Antiperspirant compositions
EP2999452B2 (en) 2013-05-20 2021-01-20 Unilever PLC Antiperspirant compositions
US9662285B2 (en) 2014-03-13 2017-05-30 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10076474B2 (en) 2014-03-13 2018-09-18 The Procter & Gamble Company Aerosol antiperspirant compositions, products and methods
US10398633B2 (en) 2014-10-27 2019-09-03 Conopco, Inc. Anhydrous antiperspirant compositions
US10729627B2 (en) 2014-10-27 2020-08-04 Conopco, Inc. Anhydrous antiperspirant compositions
US10632052B2 (en) 2015-11-06 2020-04-28 Conopco, Inc. Antiperspirant compositions
US10660830B2 (en) 2015-11-06 2020-05-26 Conopco, Inc. Aerosol antiperspirant product
US10682293B2 (en) 2015-11-06 2020-06-16 Conopco, Inc. Aerosol antiperspirant product
US10688147B2 (en) 2016-02-04 2020-06-23 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10286030B2 (en) 2016-02-04 2019-05-14 Alastin Skincare, Inc Compositions and methods for invasive and non-invasive procedural skincare
US11426442B2 (en) 2016-02-04 2022-08-30 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US11426443B2 (en) 2016-02-04 2022-08-30 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10086035B2 (en) 2016-02-04 2018-10-02 ALASTIN Skincare, Inc. Compositions and methods for invasive and non-invasive procedural skincare
US10493011B2 (en) 2017-08-03 2019-12-03 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US11052032B2 (en) 2017-08-03 2021-07-06 ALASTIN Skincare, Inc. Peptide compositions and methods for ameliorating skin laxity and body contour
US11752084B2 (en) 2017-08-03 2023-09-12 ALASTIN Skincare, Inc. Methods for fat reduction or elimination of lipid droplets
US11103455B2 (en) 2018-08-02 2021-08-31 ALASTIN Skincare, Inc. Liposomal compositions and methods of use
US11357714B2 (en) 2020-07-21 2022-06-14 Chembeau LLC Diester cosmetic formulations and uses thereof
US11491092B2 (en) 2020-07-21 2022-11-08 Chembeau LLC Hair treatment formulations and uses thereof
US11801211B2 (en) 2020-07-21 2023-10-31 Chembeau LLC Hair treatment formulations and uses thereof

Also Published As

Publication number Publication date
DE102010038358A1 (en) 2012-01-26
WO2012010684A3 (en) 2013-11-21

Similar Documents

Publication Publication Date Title
WO2012010684A2 (en) Double salt-containing antiperspirant roll-ons
EP2349185B1 (en) More effective anhydrous deodorant compositions applied as an aerosol
DE102010063250A1 (en) Hydrous antiperspirant compositions with improved residue masking
EP2451426A2 (en) Cosmetic compositions having suspensions of silver salts
EP3057665A1 (en) Cosmetic antiperspirants with lactates
WO2015055201A1 (en) Use of polysaccharides in antiperspirant cosmetic agents for protecting textiles
DE102009055255A1 (en) Anhydrous antiperspirant sprays with improved performance
WO2012010685A2 (en) Double salt-containing alcoholic antiperspirants
DE102009027050A1 (en) Antiperspirant sprays
EP2931224B1 (en) Anhydrous compositions active against body odours
EP3057564A1 (en) Cosmetic antiperspirants with amidosulphonic acids
WO2015055197A1 (en) Antiperspirant cosmetic agents having polyphosphoric acids
EP2442780A2 (en) Cosmetic compositions comprising silver lactate
EP3057666A1 (en) Cosmetic antiperspirants with aromatic sulphonic acids
DE102010038357A1 (en) Double salt antiperspirant sticks
EP3057568B1 (en) Use of methanesulfonic acid and its salts for activating and/or stabilizing antiperspirant aluminium salts
DE102009027052A1 (en) Antiperspirant compositions with silver citrate
EP3057565A2 (en) Antiperspirant cosmetic agents having polycarboxylic acids
EP3027167B1 (en) Water free oil/thickener-mixtures as base for cosmetic soft, solid- or stickpreparations
EP3057567A2 (en) Antiperspirant cosmetic agents having alpha-hydroxy acids
WO2014202235A1 (en) Anhydrous compositions against body odour
WO2014202234A1 (en) Water-free compositions
WO2010145920A2 (en) Cosmetic compositions comprising silver sulphate
WO2015085996A1 (en) Antiperspirant cosmetic compositions with lysozyme and/or bovine serum albumin and/or yoghurt protein
DE102013220782A1 (en) Antiperspirant cosmetic agent comprises cosmetic oils which are liquid at specific temperature and pressure, perfumes or waxes, antiperspirant aluminum salt, and substituted benzoate salt

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 11736088

Country of ref document: EP

Kind code of ref document: A2